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Stimulants such as cocaine continue to dominate the nations illicit drug problem. 
An effective medication for any aspect of cocaine addiction has not been developed. 
Cocaine binds, although not selectively, to the dopamine transporter (DAT) and disrupts 
normal dopamine (DA) neurotransmission between neurons. While the dopamine 
hypothesis for the mechanism of action of cocaine has been widely accepted, cocaine 
also possesses the ability to block the uptake of serotonin at the serotonin transporter (5-
HTT) and norepinephrine at the norepinephrine transporter (NET).  The purpose of the 
work described herein is directed towards synthesizing and testing compounds selective 
for the DAT, leading to the identification of candidates as potential pharmacotherapies 
for cocaine dependence.  
A series of disubstituted and trisubstituted [2.2.2] and [2.2.1]bicycles were 
synthesized and tested for inhibitor potency in [3H]WIN 35,428 (WIN) binding at the 
DAT and for inhibition of [3H]DA uptake.  Based on results from some of the 
pharmacology data new regio- and stereochemical isomers of bicyclic [2.2.1]heptanes 
and [2.2.2]octanes were synthesized. This will lead to further structure-activity-
relationships, which will provide a better understanding of the structural requirements 








AN INTRODUCTION TO THE DEVELOPMENT OF POTENTIAL 




First isolated from the coco leaves (erythroxylon coca) as a naturally occurring 
local anesthetic, (-) cocaine (1, Figure 1.1) has become problematic and a safety hazard 
due to its powerful reinforcing effects on individuals and society.1 Cocaine is a widely 
abused drug with strong addiction liabilities that need to be further understood. To date, 
an effective medication for any aspect of cocaine addiction does not exist. Our work is 
directed towards combining medicinal chemistry and preclinical pharmacology to design, 
synthesize, and test site-directed compounds leading to the identification of candidates as 
potential pharmacotherapies for cocaine dependence.2 While considerable effort has been 
expended in the study of the mechanism of action of cocaine, the details are still under 
investigation. Studies show cocaine binds, although not selectively, to the DAT3,4,5,6 and 


































1, Cocaine 2a, x= F, WIN 35,428
2b, x= H, WIN 35,065-2
3, GBR 12909
4, Methylphenidate 5,  LR5182
X
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neuron release DA into the synaptic cleft between neurons when an electrical impulse is 
transduced through the neuron. The DA released into the synapse binds to a receptor 
protein on the postsynaptic neuron. Upon binding to the receptor, DA activates the 
neuron and the electrical impulse is transduced through the receiving neuron. Once the 
receiving neuron has been activated, the DA is released by the receptor protein and taken 
back up into the presynaptic neuron via the DAT. When cocaine is present it blocks 
reuptake of DA back into the presynaptic neuron due to competitive binding between DA 
and cocaine at the DAT. Excess amounts of DA accumulate in the synapse, which 
prolongs neurotransmission and, in turn, produces a reinforcing effect or the 
characteristic cocaine high.8 Activation of postsynaptic receptors alone does not appear 
to be sufficient to lead to addiction. Rather, it is the rapid onset and short duration of 
action of cocaine and concomitant surge in available DA that presumably accounts for 
the rapid cycles observed clinically and the high addiction potential of cocaine. While the 
dopamine hypothesis for the mechanism of action of cocaine has been widely accepted, 
cocaine also possesses the ability to block the uptake of serotonin at the serotonin 
transporter (5-HTT) and norepinephrine at the norepinephrine transporter (NET).9,10  
Evidence exists for two distinct binding sites for dopamine and cocaine on the 
DAT, which may, or may not, overlap.11,12,13 This creates the possibility of producing a 
therapeutic agent that will block the binding of cocaine to the DAT, but will allow the 
reuptake of DA into the transmitting neuron (i.e., a cocaine antagonist). An alternate 

























Figure 1.2. Dopamine neurotransmission with/without cocaine present.7  
 
 5
but not cause the same degree of euphoria. The most promising of these drugs would be a 
long lasting, slow onset, cocaine agonist.     
To date, the search for compounds to be used in the development of safe and 
effective treatment agents for cocaine addiction has led to the synthesis of a number of 
tropane and non-tropane compounds. Among these compounds are WIN 35,428 and 
35,065-2 (2a and 2b, respectively),14 GBR 12909 (3),15 methylphenidate (4),16 and LR 
5182 (5)17 (Figure 1.1), which have all been reported to demonstrate potential as cocaine 
abuse therapeutic agents. The structural analogy of the WIN analogues to cocaine is 
obvious. The binding affinity of WIN 35,065-2 to the DAT is 8 times greater than that of 
cocaine. One of the main structural differences between cocaine and GBR 12909 is the 
non-tropane, disubstituted, piperazine ring. GBR 12909 binds potently to the DAT and 
produces a relatively modest and long lasting increase in the DA concentration in the 
synapse, which does not cause the same degree of euphoria as cocaine.  LR 5182, a 
potent stimulant, also does not contain the tropane core of cocaine, but molecular 
modeling suggests a high degree of analogy between the three-dimensional spatial 
arrangement of structural features (the phenyl ring and nitrogen) of cocaine and LR 5182. 
The stimulant properties of methylphenidate are also believed to arise from its structural 
homology with cocaine, and a common mode of binding the phenyl rings and the basic 
nitrogen at the DAT.  
The IC50 values for inhibition of [3H]DA uptake18 and the inhibition of ligand 
binding to the DA,19 norepinephrine (NE),20 and 5-hydroxytryptamine (5-HT, serotonin) 
transporters have been used as comparative measures to determine the extent of binding 
and the selectivity for the different biogenic amine transporters.21  
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Table 1.1. Binding Data for reference compounds. 
 
IC50(µM) 
Compound [3H]WIN 35,428 [3H] DA uptake 
(-)-cocaine (1) 0.160 ± 0.015 0.404 ± 0.026 
WIN 35,428 (2a) 0.0199 ± 0.001 0.0512 ± 0.00025 
WIN 35,065-2 (2b)28 0.023 ± 0.00528 0.0498 ± 0.0023*28 
Methylphenidate (4) 0.083 ± 0.0079 0.24 ± 0.0.19 
LR 5182 (5) 0.0142 ± 0.0016 0.0293 ± 0.0017 
GBR 12909 (3) 0.0140 ± 0.0006 0.0073 ± 0.0002 
*Reported as the Ki. 
The experiments were performed under the supervision of Dr. Margaret M. Schweri at 








The bicyclic LR5182 is potent for inhibition of both WIN binding and DA uptake 
(Table 1.1), leading to our interest in derivatives of LR 5182.  A number of LR 5182 
analogs show potential as therapeutic agents17 by combining the potency and selectivity 
of GBR derivatives in a conformationally restricted structure bearing more  
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similarity to cocaine. Modification of the rigid framework (stereochemistry, substituents 
on the framework and phenyl ring, type of amine, etc.) allow the determination of 
structure-activity relationships, which will aid in the development of therapeutic agents. 
The DAT has been cloned and the binding site for DA described.22 The human 
DAT (hDAT) is comprised of 620 amino acids, putatively arranged in 12 interconnected 
helices to form transmembrane channels (Figure 1.3). Each helical domain presents its 
polar amide linkages toward the core of the helix. This places the amino acid side chain 
on the outside of the helix facing the internal structure of the channel. Site-mutagenesis 
studies show that the aspartic acid residue lying within the putative hydrophobic 
transmembrane domain 1 (TMD 1) is crucial for DAT function (Figure 1.4). An 
explanation for this observation is that the carboxylic acid of aspartic acid 79 interacts 
with the amine of DA to play a crucial role in DA transport.11 This amino acid may also 
recognize the tropane nitrogen of cocaine to participate in cocaine binding. These studies 
also show two serines in TMD 7 (359 and 354) play an important role by hydrogen 
bonding to the two hydroxyl groups of DA. It is still uncertain whether cocaine interacts 
with the same amino acids of the DAT in the same manner. As of yet, no crystallographic 
data is available that clearly defines how the DAT is actually configured in membranes in 
its functional state.   
The development of structure-activity relationships has led to a proposed 
pharmacophore for cocaine (Figure 1.5). The model, proposed by Carroll et al.,23 consists 
of an electrostatic or hydrogen bond site on the DAT to interact with the basic amino 
group of cocaine. It is speculated that one or two additional hydrogen bonding sites in the 





























Recent studies have shown the replacement of the methyl ester group by 
ketones,26 heterocycles,27 amides,28 alkyl groups,29 and olefins30 did not decrease the 
potency at the DAT. A hydrophobic pocket, which is believed to accommodate the 
benzoate group, has also been suggested. An important structural feature of all uptake 
inhibitors is an aromatic ring situated in such a way that it may interact with this 
aromatic ring binding site of the transporter protein. Structure-activity studies have also 
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shown that halogens in the 3- or 4-position on this aromatic ring often increase the 
binding potency. A more elaborate pharmacophore, Figure 1.631, has been proposed 
which suggests: i) the tropane nitrogen and the phenyl ring should be in the same plane 
for optimal binding; ii) the distance from the nitrogen to the centroid of the phenyl should 
be 5 to 7 Ångstroms; iii) the distance from the nitrogen to the carbonyl should be 2.2 to 
4.5 Ångstroms; and iv) the distance from the centroid of the phenyl ring to the carbonyl 















Recently, a series of 2-substituted-6-amino-5-phenylbicyclo[2.2.2]octanes were 
synthesized and tested for inhibitor potency in [3H]WIN 35,428 (WIN) binding at the 
DAT and for inhibition of [3H]DA uptake (Table 1.2).32 The [3H]DA uptake data is not 
shown in Table 1.2 but shows the same trends as that for [3H]WIN 35,428 binding. Data 
presented in Table 1.2 indicates the endo-amines are more potent than the corresponding 
exo-amines and the ketones are similar in potency to the corresponding exo-acetates. The 
benzoate esters inhibited the uptake of [3H]DA better than the corresponding alcohols and 
the stereochemistry at C-2 has little effect on the potency. The endo-amino-endo-
benzoate 6 and the endo-amino-endo-4-chlorobenzoate 7 were the two most potent 
derivatives made from this series with an IC50= 270 nM and IC50=295 nM, respectively. 
Moving the halogen from the para position on the benzoate phenyl ring to the meta 
position did not affect the potency (7 vs 8). These values are comparable to that of (-) 
cocaine (IC50= 160 nM). Clearly, the second phenyl group present in benzoate 6, 
enhances the potency of these compounds. 
Preliminary research to extend this study focused on this secondary effect on 
binding to the DAT to determine the relative importance of the two phenyl rings (the 
benzoate at C-2 and the phenyl at C-5) and to further explore structure-activity 
relationships.33 One approach we took was to prepare esters 8 and 9,34 as analogs of 6. A 
second approach to determine structure-activity-relationships of substituted bicycloalkane 
analogs of 6 was to prepare the analog without the phenyl ring at C-5, i.e. 10.34 
Derivative 9 is the most potent compound with an IC50=33 nM (Table 1.2) for [3H]WIN 
binding and an IC50=137 nM for the DA uptake. Congener 9 shows high  
 12




 X Y Z [3H]WIN 
35,428 
X Y [3H]WIN 
35,428 
 C=O Ph 4.01 ± 0.40 C=O 10.3 ± 0.40 
 OH H Ph 1.77 ± 0.13 OH H 7.04 ± 0.29 
 H OH Ph 2.04 ± 0.24 H OH 9.92± 0.94 
 OCOCH3 H Ph 5.33 ± 0.36 OCOCH3 H 13.6 ± 1.43 
 H OCOCH3 Ph 12.2 ± 0.69 H OCOCH3 45.6 ± 6.24 
 OCOPh H Ph 0.358 ± 0.067 OCOPh H 2.20 ± 0.31 
6 H OCOPh Ph 0.270 ± 0.029 H OCOPh 2.27 ± 0.066
7 H OCOAr Ph 0.295 ± 0.036     
8 H OCOAr Ph 0.576 ± 0.056     
9 H OCOPh Ar 0.033 ± 0.0005     
10 H OCOPh H 21.7 ± 2.3     
Ar  = 4-chlorophenyl 














       6n
endo-amine
     6x
exo-amine
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binding affinity at the dopamine transporter, with about an 8-fold increase in potency 
over endo-amino-endo-benzoate 6. Derivative 10, with an IC50= 21700 nM, is 8 times 
less potent than endo-amino-endo-benzoate 7. Removal of the phenyl ring at C-5 clearly 
demonstrates a decreased interaction between the des-phenyl 10 and the aromatic ring 
binding site on the DAT. 
 
Scope of Thesis 
In Chapter 1 of this thesis, the effect of removing the phenyl at the C-5 position of 
the bicycle is further evaluated by isolating the other three desphenyl diastereomers of 
bicycloalkane analog 10, structure 11 (Figure 1.7). Extensive analysis of the structural 
changes allow for the development of SARs, which may be related to the fit of these 
compounds with the proposed active site. These compounds will provide guidance in the 
design of new derivatives with cocaine agonist and antagonist activity.  
To further evaluate the role of the phenyl substituent on the endo-amino 2,6-
disubstituted [2.2.2]bicycle 10 mentioned above, the ester functionality was excised35 
(Chapter 2). An arene was attached directly to the bicyclic framework or by a one or two 
carbon linker, e.g. arenes 12, Figure 1.7. These homologues will help determine the 
distance between the nitrogen and the phenyl ring for optimal binding. Increasing the 
number of carbons between the bicycle and the phenyl ring increases the flexibility, 
which may be needed to allow the phenyl ring to adopt a low energy conformation to 
bind to the active site. Lengthening the distance between the nitrogen and phenyl ring 
could render the distance too long, and as a result, decrease the potency of the 
 14
compounds. The excision of the ester is also expected to increase the half-life of the 
molecule in vivo, since it will not be subject to hydrolysis by esterases.     
Chapter 3 discusses another approach taken to further understand the role of the 
phenyl ring, the transposition of the benzoate from the C-2 position on the bicycle to the 
C-3 position, e.g. structure 13. Thus, extensive analysis of the structural changes allows 
for the development of SARs related to the fit of these compounds at the active site of the 
DAT. 
An additional challenge has been to construct compounds which fill the gap 
between carbons 2 and 3 on the disubstituted  [2.2.2]octanes discussed above. In Chapter 
4, an approach is described which is based on disubstituted [2.2.1]heptanes, structures 14 
and 15 (Figure 1.7). One can imagine the one-carbon bridge occupying a position so as to 
orient the phenyl substituent in an orientation between that occupied in the 2,5 and 2,6 
disubstituted [2.2.2]octanes. The benzoate is placed on the one-carbon bridge for a direct 
comparison with the compounds already made. The substituents on the bicycle are 
exchanged so as to place the benzoate on the two-carbon bridge and the dimethylamine 
on the one-carbon bridge, benzoates 15. By exchanging the substituents, a direct 
comparison of compounds containing an unsubstituted carbon adjacent to the amine or 
benzoate can be made with those compounds where the substituent is placed on the one 
carbon bridge. Placing the amine on the one-carbon bridge will also allow for a 
comparison with cocaine due to the resemblance in structure.   
Since the most potent compounds of the trifunctional [2.2.2]bicyclic series 
synthesized previously in the our group were benzoate esters,32 a challenge was to 
introduce a benzoate ester on the bicyclic [2.2.1]heptane skeleton to allow for comparison 
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to previously synthesized 2-(N,N-dimethylamino)methyl-3-phenyl bicyclo[2.2.1]heptanes 
(Chapter 5). Compounds 16 and 17,2 Figure 1.7, were of interest because of the difference 
in the inhibitor potency in [3H]WIN 35,428 (WIN) binding at the DAT. The only 
difference between compounds 16 and 17 is the trans stereochemistry at the C-2 and C-3 
position on the bicycle. This variation in the structures leads to a difference in potency of 
515 nM for the trans endo-amine 16 versus 2510 nM for the trans exo-amine 17, a 5-fold 
increase. Based on the trends seen with the series of 2-substituted-6-amino-5-
phenylbicyclo[2.2.2]octanes (Table 1.2), a benzoate ester of 18 may increase the potency 
of these amines. The placement of the 4-chloro substituent on the phenyl ring may also 
increase the potency of these compounds. 
The series of [2.2.1] and [2.2.2]bicycloalkane analogs already synthesized provide 
a guide in the design of new derivatives with cocaine agonist and antagonist activity.  
The synthetic work described will provide further insight into the development of SARs 
for inhibition of cocaine binding.  
 
Specific Goals 
The goals of this thesis are to design, synthesize, characterize and 
pharmacologically investigate new regio- and stereochemical isomers of bicyclic 
[2.2.1]heptanes and [2.2.2]octanes. This will lead to further structure-activity 
relationships, which will provide a better understanding of the structural requirements 
needed to bind at the DAT. This will in turn help identify potential pharmacotherapies for 
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Previous work in our group incorporated an oxygen functionality at the C-2 
position of 6-amino-5-phenylbicyclo[2.2.2]octanes.1 The more potent of these esters are 
the benzoates, containing two phenyl groups (the ester phenyl ring and the phenyl ring at 
C-5 of the bicyclic moiety). Based on the binding data shown in Table 1.2, the second 
phenyl group present in benzoate 6 enhances the potency of these compounds (Figure 
2.1). Since two phenyl rings are present, an uncertainty exists as to which phenyl ring 
binds to the hydrophobic pocket (aromatic binding region) of the various monoamine 
transporters. While attempting to determine with more certainty the influence of the 
phenyl rings (the benzoate at C-2 or the phenyl ring at C-5) on benzoate 6, three other 
stereoisomers of the desphenyl analog 10, congeners 26-28, were synthesized (Figure 
2.1). Using MM2 energy-minimized conformations2  the distances between the nitrogen 






































distance varied between 5.4 and 8.69 Ångstroms for benzoates 10, 26-28. The distance 
from the nitrogen to the plane of the phenyl ring was also calculated for each of these 
compounds, with the distance varying between 0.004 and 0.281 Ångstroms. Based on the 
pharmacophore suggested by Johnson et al,3 the distance from the nitrogen to the 
centroid of the phenyl ring should be 5 to 7 Ǻ to provide a good fit with the binding site. 
All benzoates met this criteria, except benzoate 28. Figure 2.2 shows an overlay of 
cocaine and benzoates 26a and 28. Comparison of the [3H]WIN 35,428 binding and the 
inhibition of [3H]DA uptake data will help to further characterize the binding affinity at 





Table 2.1. Measured distances between the nitrogen and the centroid of the phenyl ring 





Compound N-Phc N-Php 
Cocaine (1) 7.89 0.707 

















































aN-Phc = the distance between the nitrogen and the centroid of the phenyl ring 








The syntheses of benzoate stereoisomers 26a, 26b, 27, and 28 are shown in Figure 2.3. 
The mixture of endo- and exo-amino ketones 19 and 20 was previously synthesized.5 The 
4:1 diastereomeric mixture (determined by 1H NMR spectroscopy, based on ratio of 
signals δ 2.60 and δ 2.57 ppm) of endo-keto amine 19 and exo-keto amine 20 were 
separated by flash column chromatography. The relative stereochemistry of endo-amino 
ketone 19 was assigned using 1H NMR spectroscopy (Appendix A). The 1H NMR 
spectrum shows a peak at δ 2.18 ppm, which was assigned to the exo proton on C-3. This 
peak is coupled to the exo proton on C-5 by an in-plane W coupling, and shows cis 
coupling with the exo proton on C-6. Reduction of amino ketone 19 with NaBH4 in 
absolute EtOH provided a 2:3 mixture (determined by 1H NMR spectroscopy, based on 
ratio of signals δ 3.90 and δ 4.20 ppm) of diastereomeric endo- and exo-alcohols 21 and 
22. The reduction of ketone 20 with NaBH4 in absolute EtOH provided a 1:1 mixture 
(determined by 1H NMR spectroscopy, based on ratio of signals δ 4.02 and δ 3.89 ppm) 
of diastereomeric endo- and exo-alcohols 23 and 24. The diastereomers were separated 
using column chromatography. The assignment of the relative stereochemistry of exo-
amino alcohol 24 was done using 1H NMR spectroscopy (Appendix B). The carbinol 
proton at C-2 of exo-amino alcohol 24 shows a doublet of doublet of doublet of doublets 
at δ 3.89 ppm due to cis coupling (9.6 Hz) with the endo proton on C-3, trans coupling 
(3.3 Hz) with the exo proton on C-3, coupling to the bridgehead at C-1 (3.3 Hz), and an 
in- plane W-coupling (0.9 Hz) to the exo proton on C-7. This is the only arrangement 
of atoms on the bicycle which would allow the in-plane W-coupling. The relative 









































Reagents: a) NaBH4, EtOH, reflux; and b) ArCOCl, Et3N, DMAP, benzene. 
 
Figure 2.3. Synthesis of Derivatives 10, 26-28. 
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appropriate alcohol with benzoyl chloride gave the corresponding benzoate esters 26-28. 
The stereochemistry assignment for benzoate 10 was published previously.6 Benzoate 
26a must have the ester functionality exo at C-2 while maintaining the endo 
stereochemistry of the amino ketone at C-6. The stereochemistry assignment of exo-
amino-endo-benzoate 28 was established using single crystal x-ray crystallography 
(Appendix C). By process of elimination, compound 27 must contain the benzoate exo at 




The benzoate amines, 26-28, were tested to determine the IC50 values for the 
inhibition of [3H]WIN 35,428 binding to the DAT and the inhibition of [3H]DA uptake 
into synaptosomes according to established protocols.6 The inhibition of [3H]5-
hydroxytryptamine(5-HT, serotonin) was also tested using citalopram or paroxetine to 
determine the selectivity for the DAT. 
 
In Vitro Testing 
 
Inhibition of WIN Binding, Citalopram Binding, and [3H]DA Uptake 
 Previous work provided congener 61 which shows inhibition of [3H]WIN 35,428 
binding comparable to that of cocaine (IC50= 270 nM vs 160 nM, respectively, Table 
2.2). Additional experiments,7 show that derivative 9 is the most potent trisubstituted 
[2.2.2]bicyclooctane with an IC50 of 33 nM for [3H]WIN binding and an IC50=137 nM for 
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DA uptake. Derivative 9 (which contains a 4-chloro substituent on the C-5 phenyl ring) is 
eight times more potent than cocaine for [3H]WIN binding. We proposed that this 
increase in potency is due to a greater interaction between the aromatic ring binding 
region on the DAT and the 4-chlorophenyl ring at C-5 on the bicyclic framework. 
Desphenyl analogue 10 shows a low binding affinity at the dopamine transporter with 
about an 80-fold decrease in potency than endo-amino-endo-benzoate 6 (IC50= 21700 nM 
vs 270 nM, respectively).  
The exo-amino diastereomeric analogs of 10, benzoates 27 and 28, were tested for 
inhibition of [3H]WIN 35,428 binding (IC50 = 6460 nM and 9410 nM, respectively) and 
DA uptake (IC50 = 21800  nM and 30700 nM, respectively). Both analogs are less potent 
than exo-benzoate-endo-amine 26a, which is equipotent with cocaine for WIN binding 
(IC50 of 193 nM versus 160 nM, respectively). Analogue 26a is slightly selective for the 
DAT over the 5-HTT (1.60/.192= 8.4-fold). Thus, congener 26a constitutes a new lead 
compound for further exploration.  
Preliminary test results shows potency was lost by the inclusion of a 4-chloro 
substituent on the phenyl ring, benzoate 26b versus 26a (IC50 = 6500 nM versus 192 nM, 
respectively). This can be understood in terms of the para- chloro substituent increasing 
the size of the aryl substituent beyond the requirements needed for a good fit at the DAT. 
However, this is unusual since it has been demonstrated in the literature that substitution 
of the phenyl group with a halogen tends to increase the potency with which a drug binds 
to the DAT. A second sample of benzoate 26b was submitted to verify these results. 
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In Vivo Testing 
Drug Discrimination 
 In drug discrimination experiments with rats8, benzoate 26a shows very little 
activity at the 3 and 10 mg/kg dosage (Figure 2.4) compared with cocaine, which shows a 
slight increase in activity at 1mg/kg and 0.3 mg/kg, respectively (Figure 2.5). More than 
half of the rats tested at 30 mg/kg were able to discriminate the test drug injection from 
the saline injection of benzoate 26a (ED50= 29.17). Although benzoate 26a was 
equipotent as cocaine by comparing WIN binding (IC50= 192 nM vs IC50= 160 nM, 
respectively) the drug discrimination experiment shows a difference of 11-fold in potency 
(ED50 = 93.9 uM versus ED50 = 8.45 uM, respectively) when comparing benzoate 26a 
and cocaine. This difference could be due to cocaine getting to the brain faster than 
congener 26a. 
Locomotor Stimulation 
 The locomotor activity reported for analogue 26a is shown in Figure 2.6. Some 
unusual activity peaks in the control are seen at 90 and 200 minutes. Since these peaks 
are not common it is believed the activity is due to some outside aggravation in the 
environment affecting the rats. Analogue 26a was tested at 3, 10, and 30 mg/kg over 240 
minutes. The normal spike in activity is seen with all three concentrations, with the 10 
and 30 mg/kg reaching a maximum at almost 3,000 counts.  Cocaine shows counts of 
7,000 for a dose of 30 mg/kg, and 9,000 with a dose of 56 mg/kg, and a more gradual 
decrease in the locomotor stimulation (Figure 2.7). The decrease in locomotor activity  
compared to that of cocaine, maybe an indicator that congener 26a is consumed quicker  
by the body than cocaine.    
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Table 2.2. Data for [3H]WIN 35,428 binding, [3H]DA Uptake, and 5-HT[3H]CIT 
binding.9 
   IC50 (uM) or % Inhibition         
           Compound              [3H]WIN 35,428   [3H]DA Uptake          [3H]CIT               
Cocaine (1) 0.160 ± 0.015 0.404 ± 0.026 0.389 ± 0.020 









0.270 ± 0.029 
 
 
0.687 ± 0.015 
 
 






Ar= 4-chlorophenyl 9 
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58.3 ± 0.7 
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9.41 ± 0.57 
 
 
30.7 ± 1.6 
 
 
































Dose (mg/kg) R23 R27 R28 R30 R31 Mean
veh 0 0 1 1 0 0.4
3.0 0 1 1 3 0 1.0
10 0 2 1 4 0 1.4







Figure 2.4. Drug discrimination data for benzoate 26a. 
 












































































































































































 A series of 6-(N,N-dimethylamino)-2-benzylbicyclo[2.2.2]octanes was prepared 
by reduction of amino ketones 19 and 20, followed by benzoylation of the corresponding 
alcohols. No clear trends could be ascertained from the data in Table 2.1. The exo-
benzoate-endo-amine 26a is equipotent with cocaine for WIN binding (IC50 = 193 nM vs 
160 nM) and is 8-fold more selective for the DAT over the 5-HTT. The in vivo 
pharmacology indicates that congener 26a is 8-fold less potent than cocaine by drug 
discrimination (ED50 = 6.47 uM versus ED50 = 0.855 uM, respectively) and the locomotor 
activity is not as high as that for cocaine (3,000 counts versus 7,000 counts, respectively). 
The data obtained from the in vivo pharmacology testing can be interpreted in the 
following manner: 1) the drug discrimination results may be the result of a slower on-set, 
and 2) the locomotor activity may be the result of the drug being metabolized faster than 
cocaine. Further structure-activity relationships will be developed based on this new lead 





General Methods. All starting materials were used as received from Aldrich 
Chemical Company. Melting points were determined on a Mel-Temp apparatus and are 
uncorrected. 1H and 13C NMR spectra were obtained on a Varian Gemini spectrometer at 
300 MHz and 75 MHz, respectively, unless otherwise noted. COSY and HMQC spectra 
were recorded on a Bruker AMX 500 MHz. Fourier transform infrared spectra were 
obtained using a Nicolet 520 FTIR spectrometer. Gas chromatography-mass spectroscopy 
was performed on a HP 5890 gas chromatogram coupled to a VG 70SE mass 
spectrometer. Elemental analyses were obtained from Atlantic Microlabs, Norcross, 
Georgia. Tetrahydrofuran (THF) was dried over sodium benzophenone ketyl prior to 
distillation under nitrogen. Benzene was dried over 4 Å molecular sieves. Amines were 
dissolved in minimum amount of MeOH and were converted to HCl salts by the addition 
of 1.5 equivalents of concentrated 1 M HCl in diethyl ether. MeOH was added and the 
HCl was removed under reduced pressure. The resulting solid was recrystallized from 
MeOH/EtOAc or EtOAc/hexane. 
 
The synthesis of a mixture endo- and exo-6-(N,N-dimethylamino)bicyclo[2.2.2] 
octan-2-ones, 19 and 20 was reported previously.10 The exo-amino ketone isomer 20 
(0.424 g, 16.2% yield) was eluted from the silica column first (silica gel, 1:1:30 ethyl 
acetate:methanol:chloroform) and isolated as a brown liquid, followed by the endo-amino 
ketone isomer 19 (2.03 g, 77.7% yield), which was isolated as a brown solid.  
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endo 6-(N,N-Dimethylamino)bicyclo[2.2.2]octan-2-ones, 19. mp: 194-198 
°C.1H NMR (CDCl3): δ 1.53-1.63 (m, 3H), 1.73-1.83 (m, 2H), 1.93 (qt, J=13.2, 9.3, 3 Hz 
1H, C-5exo), 2.18 (dt, J=18, 2.4 Hz, 1H, C-3endo), 2.21-2.23 (m, 7H, C-4, N(CH3)2),  
2.30 (dt, J=18, 2.1 Hz, 1H, C-3exo), 2.40 (ddd, J=9.3, 4.5, 3 Hz, 1H, C-6exo) 2.60 (q, 
J=3 Hz, 1H, C-1). 13C (CDCl3): δ 22.09, 23.52, 27.98, 32.87, 42.96, 44.53, 45.45, 64.59 



























 exo 6-(N,N-Dimethylamino)bicyclo[2.2.2]octan-2-ones, 20. 1H NMR (CDCl3): 
δ 1.51-1.65 (m, 4H), 1.72-1.82 (m, 1H), 1.92 (tm, 1H, J=13.2 Hz), 2.06-2.22(m, 4H), 
2.22 (s, 6H, N(CH3)2), 2.57 (q, J=2.4 Hz, 1H, C-1). 13C (CDCl3): δ 16.51, 25.02, 27.83, 
3.52, 43.33, 43.89, 46.11, 60.13, 172.58 (C-2).  
 
6-(N,N-Dimethylamino)bicyclo[2.2.2]octan-2-ols (21-24). The conversion of 20 
to 23 and 24 is illustrated. A mixture of NaBH4 (196.3 mg, 5.19 mmol) in ethanol (15 
mL) was added to exo-amino ketone 20 (436 mg, 2.6 mmol) in 5 mL of ethanol. The 
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mixture was heated to reflux for 3 h, cooled to rat., and H2O (20 mL) was added. The 
ethanol was removed under reduced pressure. The mixture was extracted with CH2Cl2 (3 
× 10 mL), dried over MgSO4, and the solvent was removed under reduced pressure to 
obtain 320 mg (73% yield) of crude product. Flash column chromatography (silica gel; 
CH3OH eluant) provided alcohol 23 (Rf=0.32, , 40 mg, 18% yield) as a colorless oil and 
alcohol 24 (Rf=0.35, 68 mg, 31% yield) as a colorless oil.   
 
endo- 6-(N,N-Dimethylamino)bicyclo[2.2.2]octan-endo-2-ol and the HCl salt (21, 
21HCl). The spectroscopic data was previously reported.10 
 
endo- 6-(N,N-Dimethylamino)bicyclo[2.2.2]octan-exo-2-ol, 22. 26.6% yield, 
white crystalline solid, mp 53-56 ûC, Rf= 0.38 (CH3OH eluant). 1H NMR (CDCl3): δ 
1.16-1.41 (m, 3H), 1.47-1.58 (tm, J=12.3, 5.7, 3 Hz, 1H), 1.69-1.88 (m, 4H), 1.91 (sept, 
1H, J=2.7 Hz, C-4), 1.94-2.14 (m, 3H, C-1, C-6), 2.21 (s, 6H, N(CH3)2), 4.20 (dddd, 
J=9.3, 4.5, 2.7, 1.8 Hz, 1H, C-2). 13C (CDCl3): δ 18.30, 24.40, 25.83, 33.61, 34.59, 37.55, 
43.97 (N(CH3)2), 64.52 (C-6), 69.94 (C-2).  
 
exo-6-(N,N-Dimethylamino)bicyclo[2.2.2]octan-endo-2-ol, 23. 1H NMR (CDCl3) 
δ 1.21-1.36 (m, 4H), 1.48 (ddddd, J=13.8, 9.6, 6.3, 2.7, 1.2 Hz, 1H), 1.72 (sept, J=2.1 Hz, 
1H, C-4), 1.82-1.90 (m, 2H), 1.90 (p, J=1.8 Hz, 1H, C-1), 2.01 (dddd, J=13.5, 9.6, 3.9, 
2.4 Hz, 1H), 2.35 (s, 6H, N(CH3)2), 2.34 (tm, J=7.5 Hz, 1H, C-6), 4.02 (ddd, J=9.6, 5.1, 3 
Hz, 1H, C-2). 13C (CDCl3): δ 17.96, 24.42, 25.77, 34.22, 34.81, 36.18, 43.68 (N(CH3)2), 
57.55 (C-6), 69.07 (C-2).  
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exo-6-(N,N-Dimethylamino)bicyclo[2.2.2]-octan-exo-2-ol, 24.  1H NMR (CDCl3) 
δ 1.28-1.38 (m, 2H, C-5, C-3), 1.48-1.56 (m, 2H, C-7), 1.60-1.76 (m, 4H, C-8, C-4, C-5), 
1.80-2.00 (m, 3H, C-1, C-3, C-6), 2.22 (s, 6H, N(CH3)2), 3.89 (dtd, J=9.6, 3.3, 0.9Hz, 1H, 
C-2). 13C (CDCl3): δ 13.00, 25.11, 25.52, 33.11, 34.62, 36.54, 44.06 (N(CH3)2), 63.08 (C-





























6-(N,N-Dimethylamino)bicyclo[2.2.2]octan-2-yl benzoates (10-28). The 
conversion from 24 to 28 is illustrated. A solution of benzoyl chloride (103 µL, 0.888 
mmol) in 2 mL of benzene was added to a mixture of 24 (100 mg, 0.591 mmol), DMAP 
(1mg, mmol), and Et3N (412 µL, 0.2.96 mmol) in 3 mL of benzene. The mixture was 
stirred for 24 h at room temperature. The mixture was washed with 5% NaHCO3 (3 × 5 
mL), dried over MgSO4, and the solvent was removed under reduced pressure. Flash 
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column chromatography (silica gel; THF) provided benzoate 28 (Rf=0.50, 100 mg, 62% 
yield) as a yellow oil.  
 
endo-6-(N,N-Dimethylamino)bicyclo[2.2.2]octan-endo-2-yl benzoate and the HCl 
salt,(10, 10·HCl). The spectroscopic data was previously reported.10 
 
endo-6-(N,N-Dimethylamino)bicyclo[2.2.2]oct-exo-2-yl benzoate, 26a. 41.2% 
yield, pale yellow oil, Rf= 0.55 (THF eluant). 1H NMR (CDCl3) δ 1.25-1.39 (m, 1H), 
1.40-1.51 (m, 2H), 1.53-1.69 (m, 2H), 1.76-1.88 (m, 2H, C-4, C-3), 2.00 (dddd, J=15.9, 
10.8, 4.5, 3.6 Hz, 1H, C-7), 2.12-2.33 (m, 3H, C-1, C-3, C-6), 2.35 (s, 6H, N(CH3)2), 
5.38-5.45 (m, 1H, C-2), 7.43 (tm, J=7.2 Hz, 2H, Ar3,5), 7.55 (tt, J=7.2, 2.4 Hz, 1H, Ar4), 
8.04 (dm, J=6.6 Hz, 2H, Ar2,4). 13C (CDCl3) δ 18.94, 24.17, 25.37, 31.08, 33.28, 34.02, 
43.80, 64.17 (aliphatic); 128.27, 129.45, 132.67 (aryl); 166.23 (C=O). 
 
 26a·HCl. 51% yield. mp 223-226 oC. 1H NMR (D2O) δ 1.31-1.45 (m, 2H), 1.51-
1.67 (m, 2H), 1.88 (m, 1H, C-4), 1.97-2.19 (m, 3H), 2.40 (p, J=2.7 Hz, 1H, C-1), 2.84 (s, 
6H, N(CH3)2), 3.27-3.36 (m, 1H, C-6), 5.08-5.16 (m, 1H, C-2), 7.42 (t, J=7.2 Hz, 2H, 
Ar3,5), 7.57 (tt, J=7.5, 1.2 Hz, 1H, Ar4), 7.94 (dt, J=7.2, 1.2 Hz, 2H, Ar4,6). IR (neat): 
2953, 2710, 1716, 1650, 1288, 715 cm-1. MS (EI) M+ 273. Anal Elem Anal cald for 
C17H23O2NCl·0.33 H2O: C, 64.66; H, 7.87; N, 4.44; O, 11.81; Cl, 11.23. Found: C, 64.54; 
H, 7.74; N, 4.40; Cl, 11.42. 
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endo-6-(N,N-Dimethylamino)-4-clorophenylbicyclo[2.2.2]oct-exo-2-yl benzoate,  
26b. 96% yield, colorless oil, Rf= 0.35 (CH3OH:CH2Cl2 eluant). 1H NMR 
(CDCl3): δ 1.291.39 (m, 2H), 1.45 (dddd, J=16.5, 11.0, 5.0, 2.5 Hz, 1H), 1.55 (ddd, 
J=14.5, 6.5, 3.0 Hz, 1H, C-3 exo), 1.57-1.64 (m, 1H), 1.78 (dt, J=12.5, 3.0 Hz, 1H, C-5 
endo), 1.80 (sept, J=2.5 Hz, 1H, C-4), 1.96 (dddd, J=16.5, 8.5, 5.0, 3.0 Hz, 1H, C-8 
endo), 2.07 (ddd, J=9.0, 5.0, 3.0 Hz, 1H, C-6), 2.21 (qt, J=13.5, 10.0, 3.0 Hz, 1H, C-3 
endo), 2.25 (p, J=3.0 Hz, C-1), 2.26 (s, 6H, N(CH3)2), 5.35-5.42 (m, 1H, C-2), 7.83 (dt, 
J=7.5, 1.5 Hz, 2H, Ar2,6), 7.95 (dt, J=7.5, 1.5 Hz, 2H, Ar3,5). 13C NMR (CDCl3): δ 18.94, 
24.17, 25.37, 31.20, 33.61, 34.12, 43.97, 64.07, 70.14 (aliphatic), 128.57, 130.82, 139.03, 
165.31 (aryl).  
 
 26b·HCl. 60% yield. mp 220-225 oC. 1H NMR (D2O) δ 1.31-1.45 (m, 2H), 1.51-
1.67 (m, 2H), 1.88 (m, 1H, C-4), 1.97-2.19 (m, 3H), 2.40 (p, J=2.7 Hz, 1H, C-1), 2.84 (s, 
6H, N(CH3)2), 3.27-3.36 (m, 1H, C-6), 5.08-5.16 (m, 1H, C-2), 7.42 (t, J=7.2 Hz, 2H, 
Ar3,5), 7.57 (tt, J=7.5, 1.2 Hz, 1H, Ar4), 7.94 (dt, J=7.2, 1.2 Hz, 2H, Ar4,6). IR (neat): 
2947, 2683, 2479, 2354, 1716, 1300, 1018, 762 cm-1. MS (EI) M+ 307. Elem Anal cald 
for C17H24O2NCl2: C, 59.48; H, 6.71; N, 4.08; O, 8.32; Cl, 20.41. Found: C, 59.09; H, 
6.83; N, 4.05; Cl, 20.37. 
 
exo-6-(N,N-Dimethylamino)bicyclo[2.2.2]oct-endo-2-yl benzoate, 27. 68% yield, 
yellow oil, Rf=0.45 (THF eluant). 1H NMR (CDCl3) δ 1.35-1.45 (qt, J=13.8, 6.9, 3 Hz, 
1H), 1.51-1.67 (m, 3H), 1.70-1.82 (m, 4H), 1.95-2.13 (m, 2H), 2.20 (p, J=3 Hz, 1H, C-4), 
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2.25 (s, 6H, N(CH3)2), 5.10 (dt, J=9.6, 2.4 Hz, 1H), 7.45 (td, J=7.5, 1.5 Hz, 2H, Ar3,5), 
7.56 (tt, J=7.5, 1.5 Hz, 1H, Ar4), 8.05 (dt, J=6.9, 1.2 Hz, 2H, Ar3,5). 13C NMR (CDCl3) 
δ 13.90, 24.79, 25.39, 31.42, 33.30, 33.76, 44.05 (N(CH3)2), 62.28 (C-6), 72.86 (C-2) 



























27·HCl. 75.8% yield. mp 233-236 oC. 1H NMR (D2O) δ 1.38-1.52 (m, 2H), 1.52-
1.70 (m, 3H), 1.84-1.91 (m, 1H), 1.91-2.10 (m, 1H), 2.10-2.16 (m, 1H), 2.41-2.47(m, 1H) 
2.80 (s, 3H, NCH3), 2.86 (s, 3H, NCH3), 3.21-3.30 (m, 1H), 5.03-5.10 (m, 1H, C-2), 7.45 
(td, J=7.5, 1.5 Hz, 2H, Ar3,5), 7.60 (tt, J=7.5, 1.2 Hz, 1H, Ar4), 7.97 (dt, J=7.2, 1.5 Hz, 
2H, Ar2,6). IR: 2940, 2670, 1729, 1281, 1110, 715 cm-1. MS (EI) M+ 273. Elem Anal cald 
for C17H24O2NCl·0.30 H2O: C, 64.77; H, 7.87; N, 4.44; O, 11.67; Cl, 11.25. Found: C, 
64.29; H, 7.68; N, 4.36; Cl, 11.86 
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exo-6-(N,N-Dimethylamino)bicyclo[2.2.2]oct-exo-2-yl benzoate, 28. 61.9% yield, 
pale yellow oil, Rf= 0.50 (THF eluant). 1H NMR (CDCl3) δ 1.34-1.62 (m, 5H), 1.87-2.01 
(m, 3H), 2.14-2.26 (m, 2H), 2.22 (s, 6H, N(CH3)2 ), 2.40 (dddd, J=9, 6, 2.1, 1.5 Hz, 1H, 
C-6), 5.20 (ddd, J=9.9, 4.8, 3 Hz, 1H, C-2), 7.45 (td, J=7.5, 1.5 Hz, 2H, Ar3,5), 7.57 (tt, 
J=7.5, 1.5 Hz, 1H, C4), 8.04 (dt, J=6.9, 1.5 Hz, 2H, Ar2,6). 13C NMR (CDCl3) δ 17.51, 
24.53, 25.60, 31.75, 33.59, 34.23, 43.96 (N(CH3)2), 58.42 (C-6), 72.90 (C-2)(aliphatic); 
128.34, 129.49, 130.76, 132.80 (aryl); 166.15 (C=O). 
28·HCl. 57.6% yield. mp  220-225 oC. 1H NMR (D2O) δ 1.40-1.54 (m, 4H), 1.56-
1.59 (m, 2H), 1.85-1.93 (m, 1H), 2.10-2.30 (m, 2H), 2.38-2.44 (m, 1H), 2.76 (s, 3H, 
N(CH3)2), 2.84 (s, 3H, N(CH3)2), 3.48-3.56 (tm, J=7.5 Hz, 1H, C-6), 5.16 (dt, J=9.6, 4.2 
Hz,1H, C-2), 7.45 (t, J=7.5 Hz, 2H, Ar3,5), 7.60 (tt, J=7.5, 1.8 Hz, 1H, Ar4), 7.94 (dt, 
J=6.9, 1.8 Hz, 2H, Ar2,6). IR (neat):  2947, 2611, 2479, 1722, 1275, 715 cm-1. MS (EI) 
M+ 273. Elem Anal cald for C17H24O2NCl·0.85 H2O: C, 62.80; H, 7.97; N, 4.31; O, 
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The work in this chapter is a continuation of the work described in Chapter 2. In 
Chapter 2, a series of 6-amino-[2.2.2]bicyclo-2-benzoates (26-28)  was synthesized and 
pharmacologically assessed. The phenyl substituent was introduced through a benzoate 
ester linkage at the C-2 position of the bicycle. endo-Amino-exo-benzoate 26 is 
equipotent with cocaine for WIN binding (IC50 of 193 nM versus 160 nM, respectively) 
and provided a new lead compound. To further elucidate the structure-activity 
relationships for binding to the DAT, the synthesis of compounds in which a phenyl ring 
is directly attached to the bicycle at C-2 or is linked by one or two carbons was 
undertaken. These homologues will help determine the optimal distance between the 
nitrogen and the phenyl ring, while allowing us to investigate the effect of removing the 
ester functionality. All of the molecules synthesized will be tested in vitro for their ability 
to inhibit the binding of [3H]WIN 35,428 to rat striatal tissue membrane preparations and 
the uptake of  [3H]dopamine (DA) into rat striatal synaptosomes. In vitro inhibition of 
 46
[3H]citalopram binding to the serotonin transporter (5-HT) will also be measured to 
establish the relative selectivity of the congeners for the various transporters. Results of 




Phenylmagnesium bromide was added to endo-amino ketone 19 at 20 °C in 
ether. GC/MS of crude product showed that only one diastereomer was formed during the 
reaction. The phenyl reagent was delivered to the least sterically hindered face of the 
bicycle to give solely the endo-amino-exo-phenyl compound  29. Purification by column 
chromatography afforded endo-amino-exo-phenyl compound  29. The assignment of the 
relative stereochemistry was done using 1-D and 2-D nuclear magnetic resonance 
spectroscopy (Appendix D). Dehydration of 29 with p-TSA gave the unsaturated amine 
30, which gave a doublet of doublets at δ 6.64 ppm in the 1H NMR spectrum with 
coupling constants of 6.9 Hz and 1.8 Hz. This is consistent for the vinylic proton at the C-
3 position on the bicycle, which couples to the bridgehead proton at C-4 with a small 
dihedral angle and the bridgehead proton at C-1 (i.e., via long-range allylic coupling). 
Alkene 30 was hydrogenated to afford a 1:3 mixture of endo- and exo-phenyl amines 32 
and 31, which were separated by column chromatography.  The stereochemical 
assignment of amine 31 was established using nuclear magnetic spectroscopy and 






































































Reagents: a) aryl magnesium bromide, ether, - 20 C; b) p-TSA, toluene, reflux; c) H2, 
Pd/C, 40 psi; and d) 50 % w/w Rainey Ni/H2O, H2, CH3OH, 60 psi. 
Scheme 3.1. Synthesis of 2,6-disubsttuted compounds 30-32 and 39-42. 
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2-Amino-6-benzylbicyclo[2.2.2]octanes 
Amino ketone 19 was treated with benzyl magnesium chloride to give a single 
product by GC/MS, which was assigned as the endo-amino-exo-phenyl alcohol 33. Just 
like the phenyl grignard mentioned in the paragraph above, the benzyl reagent was 
delivered to the least sterically hindered face of the bicycle. Since the two benzylic 
protons are adjacent to a stereocenter, the benzylic protons are diastereotopic and appear 
as a pair of doublets at δ 2.89 ppm and δ 2.65 ppm with a coupling constant of 13.8 Hz. 
The endo-amino-exo-phenyl alcohol 33 was dehydrated by treatment with p-TSA to give 
a 9:1 ratio (determined by 1H NMR spectroscopy) of endocyclic unsaturated amine 35 
and a mixture of cis and trans exocyclic alkenes, 37. Without any further purification, 
this mixture of alkenes was hydrogenated over Pd/C to obtain a 10:1 mixture of exo-
benzyl-endo-amine 39 and endo-benzyl-endo-amine 41. Since the hydrogenation 
conditions gave mostly exo- benzyl diastereomer 39, alternate routes were explored to 
obtain the endo-benzyl amine 41. Some of the methods attempted were: 1) a Barton 
reductive deoxygenation1 of alcohol 33, 2) hydroboration of the mixture of 35 and 37 
with borane2, and 3) hydrogenations of the mixture of 35 and 37 with either Pd/C or 
Rainey nickel and different solvents (methanol, ethyl acetate, H2O, hexane). The 
hydrogenation with 50% w/w of Rainey nickel in H2O and methanol provided a 50:50 
mixture of the endo-benzyl amine 39 and the exo-benzyl amine 41 (determined by 1H 
NMR spectroscopy, based on the dimethylamine singlet at δ 2.10 ppm and δ 1.99 ppm, 
respectively). The diastereomers were separated using column chromatography to obtain 
the two pure diastereomers 39 and 41. The structural assignment of benzyl 39 was done 
by 1- and 2-dimensional NMR spectroscopy (Appendix F) and based on the differences 
 49
in chemical shifts of the benzyl protons in the free amine. (Appendix F). The benzylic 
protons directly above the dimethylamine, as is the case for endo-benzyl-endo-amine 41, 
should be shifted further downfield than the corresponding diastereomer, exo-benzyl-
endo-amine 39, due to the electrochemical environment being influenced by the 
electronegative nitrogen.  
 
2-Amino-6-phenethylbicyclo[2.2.2]octanes  
Addition of phenethylmagnesium bromide to amino ketone 19 in the same 
manner as the benzyl Grignard, gave the exo-phenethyl-endo amino 34 (determined by 
GC/MS) and 30% of the reduced endo-alcohol 21 (determined by GC/MS and 1H NMR 
spectroscopy). The mixture was dehydrated with p-TSA to give a 3:1 mixture (based on 
the 1H NMR spectrum) of cis and trans exocyclic alkenes 38 and endocyclic alkene 36. 
The mixture was hydrogenated to obtain a 20:1 exo:endo mixture (determined by the 1H 
NMR spectrum, based on the 6 proton singlet for the dimethylamine at δ 2.20 ppm and δ 
2.17 ppm) of diastereomers exo-phenethyl amine 40 and endo-phenethyl amine 42. 
Hydrogenation with 50% w/w Rainey nickel in H2O and methanol provided a 60:40 
mixture of the exo-phenethyl amine 40 and the endo-benzyl amine 42. The hydrogenation 
of the phenethyl diastereomers required harsher conditions than the benzyl or phenyl 
analogs (40 psi overnight vs 60 psi for 3 days). The mixture of 40 and 42 was separated 
using column chromatography to obtain the two pure diastereomers. The structure of 
endo-phenethyl-endo-amine 42 was determined by single crystal x-ray diffraction 
(Appendix G). The two benzylic protons appear at different chemical shifts in the 1H 
NMR spectrum (δ 2.70 ppm and δ 2.58 ppm), which may be due to the dimethylamine 
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functionality inhibiting rotation of the benzylic group. In contrast, the two benzylic 
protons for the exo-phenethyl amino 40 are identical and appear as a doublet of doublets 





Inhibition of WIN Binding and [3H]DA Uptake. 
 The phenyl amines, 30-32, were tested to determine the IC50 values for the 
inhibition of ligand binding to the DAT according to established protocols (Table 3.1).3,4,5 
The potency of the phenyl amines was increased with excision of the ester when 
comparing endo-benzoate10 with endo-arene-endo-amine 32 (IC50= 21700 nM versus 
IC50= 1300 nM, respectively). exo-Arene-endo-amine 31 has an IC50= 20900 nM versus 
IC50= 192 nM for compound 26a, which suggests potency was lost by the excision of the 
ester functionality when the phenyl ring is exo on the bicycle. Preliminary data shows 
exo-arene-endo-amine 31 to be over 20-fold selective for the 5-HT over the DAT. The 
endo-arene-endo-amine 32 has an IC50 of 1300 nM, which is more potent by 16-fold than 
the exo-arene-endo-amine 31, which has an IC50 of 20900 nM. An unexpected result was 
the potency of the unsaturated endo-amine 30 with an IC50 of 740 nM, which is similar in 
potency as the endo-amino-exo-benzoate 26a (IC50= 192 nM) and exo-arene-endo-amine 
32 (1300 nM). The potency increases by placing the arene moiety exo or by the increased 











        Compound               [3H]WIN 35,428  [3H]DA Uptake     5-HT[3H]CIT 
Cocaine (1) 0.160 ± 0.015 0.404 ± 0.026 0.389 ± 0.020 









21.7 ± 2.3  
 
 
58.3 ± 0.7 
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benzoate may occupy a space similar to the phenyl ring on the unsaturated compound 30 
and arene 32. It will be interesting to determine the pharmacological data on the benzyl 
and phenethyl analogs of 31, to investigate the increased length between the nitrogen and 





 A series of 6-(N,N-dimethylamino)-2-benzylbicyclo[2.2.2]octanes was prepared 
by Grignard addition to amino ketone 19. Comparison of the WIN binding of benzoate 
ester 26a, with an IC50 of 192 nM vs phenyl analog 31, with an IC50 of 1300 nM, shows 
the potency was lost by the excision of the ester. Preliminary data shows exo-arene-endo-
amine 31 to be over 20-fold selective for the 5-HT over the DAT. The endo-arene-endo-
amine 32 is more potent by 16-fold at the DAT than the exo-arene-endo-amine 31 (IC50= 
1300 nM vs IC50= 20900 nM, respectively) and more potent by 16-fold than the endo-
amino-endo-benzoate 10 (IC50= 1300 nM vs IC50= 21700 nM). The potency of 
unsaturated endo-amine 30, with an IC50 of 740 nM, is similar to that of the endo-amino-
exo-benzoate 26a (IC50= 192 nM) and endo-amine-endo-arene 32 (IC50= 1300 nM). The 
tether of the benzoate ester may allow the phenyl ring to fit in a similar binding space as 
the phenyl ring on the unsaturated compound 30. It will be interesting to obtain the 
pharmacological data on the benzyl and phenethyl analogs of 31, as these arenes have an 
increased length between the nitrogen and the phenyl ring. These homologues will help 








General Methods. The general methods can be found in the experimental section 
of Chapter 2.  
 
6-endo-(N,N,-Dimethylamino-2-exo-phenylbicyclo[2.2.2]octan-endo-2-ol (29). 
A solution of 3 M phenylmagnesium bromide in ether (4.08 mL, 11.98 mmol) at -20 °C 
was added  dropwise a solution of amino ketone 19 (500 mg, 2.99 mmol) in ether (100 
mL). The mixture was stirred for 4 h, H2O (50 mL) was added, and solvent was removed 
by reduced pressure. The aqueous layer was made acidic with 1 M HCl, washed with 
CH2Cl2 (3 x 50 mL), and then made basic with NaOH pellets, and extracted with CH2Cl2 
(3 x 100 mL). The organic extracts were combined, dried over MgSO4, and the solvent 
was removed under reduced pressure to afford 550 mg of crude endo-amino alcohol 29. 
Purification by column chromatography (5:1 methanol:chloroform as the eluant) afforded 
endo-alcohol-endo-amine 29 (Rf=0.40, 400 mg, 54 % yield) as a white crystalline solid. 
mp 53-56 ûC. 1H NMR (CDCl3): δ 1.251.29 (m, 1H, C-7exo), 1.371.42 (m, 1H, C-8), 
1.43-1.55 (m, 2H, C-7 endo, C-8), 1.81 (qt, J=13.2, 7.5, 1.8, 1.8 Hz, 1H, C-5 endo), 1.92 
(dddd, J=13.2, 9.3, 3.9, 2.4 Hz, 1H, C-5 exo), 2.00 (dt, J=14, 2.1 Hz, 1H, C-3endo), 2.02-
2.06 (m, 1H, C-4) 2.12-2.15 (m 1H, C-1), 2.28 (ddd, J=9.0, 7.2, 1.5 Hz, 1H, C-6), 2.31-
2.41 (m, 7H, C-3 exo, N(CH3)2), 7.24 (tt, J=7.5, 1.5 Hz, 1H, Ar4), 7.36 (tt, J=7.5, 1.5 Hz, 
2H, Ar2,6), 7.60 (dt, J=8.0, 1.5 Hz, 2H, Ar3,5). 13C NMR (CDCl3): δ 21.07, 23.10, 26.11, 
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29·HCl. mp 125-127°C, white solid. 1H NMR (CDCl3): δ 1.25-2.20 (m, 9H), 
2.45-3.2 (m, 7H), 3.35 (br s, 1H, C-6), 4.35 (br s, 1H, OH), 7.10-7.45 (m, 5H, aromatic), 
9.05 (br s, 1H, HCl). IR (neat): 3407, 2953, 2874, 2578, 2440, 2295, 1472, 1446, 1031, 
755 cm-1. Elem Anal cald for C16H24NOCl·0.8 H2O: C, 64.87; H,8.71; N, 4.73; O, 9.72; 
Cl, 11.97. Found C, 64.59; H, 8.62; N, 4.61; Cl, 12.22.  
 
6-endo-(N,N,-Dimethylamino)-2-phenylbicyclo[2.2.2]octan-2-ene (30). p-
Toluene sulfonic acid (620 mg, 3.26 mmol)was added to a solution of endo-amino 
alcohol 29 (400 mg, 1.63 mmol) in toluene (100 mL). The mixture was heated at reflux 
with a Dean-Stark trap overnight. The flask was cooled, 5% NaOH was added (50 mL), 
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and the mixture was stirred for 2h. The organic layer was dried over Mg SO4, and the 
solvent removed under reduced pressure to afford crude product (375 mg, quant yield). 
Purification by column chromatography (5:1 chloroform:methanol) afforded 30 as a 
white solid (290 mg, 78% yield, Rf= 0.25). 1H NMR (CDCl3): δ 1.261.33 (m, 2H, C-5 
endo, C-8 endo), 1.41 (dddd, 1H, J=16.0, 11.5, 4.5, 3.5 Hz, 1H, C-7 endo), 1.51 (dddd, 
J=16.5, 11.5, 4.5, 2.0 Hz, 1H, C-8 exo), 1.67 (dddd, J=15.5, 9.5, 3.0, 2.5 Hz, 1H, C-7 
exo), 1.85 (ddd, J=12.5, 9.0, 3.0 Hz, 1H, C-5 exo), 2.12 (s, 6H, N(CH3)2), 2.73-2.76 (m, 
2H, C-4, C-6) 3.38 (p, J=2.5 Hz, 1H, C-1), 6.64 (dd, J=6.5, 1.5 Hz, 1H, C-3),  7.21 (tt, 
J=7.0, 1.5 Hz, 1H, Ar4), 7.32 (tt, J=7.5, 1.5 Hz, 2H, Ar2,6), 7.47 (dt, J=7.0, 1.5 Hz, 2H, 
Ar3,5). 13C NMR (CDCl3): δ 24.48, 25.96, 30.68, 31.84, 33.88, 42.26, 65.28 (aliphatic), 
124.61, 126.79, 128.54, 129.06, 138.66, 141.14 (aryl).  
 
30·HCl. mp: 191-194 ºC, white solid. 1H NMR (D2O): δ 1.09-1.29 (m, 2H), 1.35-
1.53 (m, 2H), 1.58 (d, J=11.1 Hz, 1H), 2.04 (t, J=11.7 Hz, 1H), 2.46 (s, 3H, N(CH3)2), 
2.56 (s, 3H, N(CH3)2), 2.78 (br s, 1H), 3.44 (br s, 1H) 3.55 (br s, 1H), 6.77 (d, J=6.6 Hz, 
1H, C-3), 7.22 (d, J=6.6 Hz, 1H, Ar4), 7.30 (t, J=8.1 Hz, 2H, Ar2,6), 7.43 (d, J=7.5 Hz, 
2H, Ar3,5).  IR (neat): 2953, 2868, 2657, 2479, 2354, 1722, 1466, 762, 702 cm-1. MS (EI) 
M+ 227. Elem Anal cald for C16H22NCl·0.29 H2O: C, 71.43; H, 8.46; N, 5.21; O, 1.72; 
Cl, 13.18. Found: C, 71.43; H, 8.34; N, 5.27; Cl, 13.42. 
 
 
2-endo-(N,N-Dimethylamino)-6-phenylbicyclo[2.2.2]octanes (31 and 32). A 
mixture of unsaturated amine 30 (200 mg, 0.88 mmol) and carbon on palladium (25 mg) 
in 20 mL of ethyl acetate was shaken under H2 (40 psi) overnight. The reaction mixture 
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was filtered through celite 503 and the solvent was removed under reduced pressure to 
afford 195 mg of a mixture of endo- and exo-phenyl amines. The mixture was separated 
by column chromatography (5:1 chloroform:methanol) to afford exo-phenyl-endo-amine 
31 as a colorless liquid (100 mg, 50% yield, Rf= 0.55) and endo-phenyl-endo-amine 32 as 
a colorless liquid (30 mg, 15% yield, Rf= 0.35). 
2-endo-(N,N-Dimethyl)amino-6-exo-phenylbicyclo[2.2.2]octane (31). 1H NMR 
(CDCl3): δ 1.23 (ddddd, J=16.5, 11.0, 5.0, 3.0, 2.0 Hz, 1H, C-8 exo), 1.39-1.45 (m, 2H, 
C-3 endo, C-7 exo), 1.54 (dddd, J=14.5, 9.5, 6.0, 3.0 Hz, 1H, C-8 endo), 1.72 (ddd, 
J=13.0, 8.0, 2.5 Hz, 1H, C-5 exo), 1.75-1.83 (m, 3H, C-1, C-4, C-8 endo), 1.87 (dddd, 
J=15.5, 9.0, 4.5, 2.5 Hz, 1H, C-3 exo), 1.96 (dddd, J=15.5, 9.0, 4.5, 2.5 Hz, 1H, C-5 
endo), 2.00 (ddd, J=9.0, 6.0, 2.0 Hz, 1H, C-2), 2.29 (s, 6H, N(CH3)2), 3.31 (qt, J=10.5, 
8.0, 1.5 Hz, 1H, C-6),  7.15-7.19 (m, 1H, Ar4), 7.28-7.32 (m, 4H, Ar2,3,5,6). 13C NMR 
(CDCl3): δ 20.15, 24.88, 25.66, 31.98, 33.87, 34.36, 34.73, 43.82, 65.71 (aliphatic), 


























31·HCl. mp: 211-214 ºC, white solid. 1H NMR (CDCl3): δ 1.24-152 (m, 2H), 
1.61-1.84 (m,2H), 1.89-2.16 (m, 5H), 2.28 (t, J= 13.8 Hz, 1H, C-5), 2.84 (s, 3H, 
N(CH3)2), 2.89 (s, 3H, N(CH3)2), 3.09 (br s, 1H, C-2), 3.87 (t, J= 8.8 Hz, 1H, C-6), 7.15-
7.40 (m, 5H, aromatic), 12.05 (br s, 1H, HCl). IR (neat): 2953, 2874, 2683, 2486, 2124, 
1643, 1485, 702 cm-1. MS (EI) M+ 229. Elem Anal cald for C16H24NCl·0.9 H2O·0.2 HCl: 
C, 66.61; H, 8.80; N, 4.85; O, 4.99; Cl, 14.75. Found: C, 66.04; H, 8.44; N, 4.78; Cl, 
14.75.   
 
2-endo-(N,N-Dimethyl)amino-6-endo-phenylbicyclo[2.2.2]octane (32).  1H NMR 
(CDCl3): δ 1.41-1.55 (m, 2H), 1.56-1.64 (m, 2H), 1.70 (s, 6H, N(CH3)2), 1.73-1.84 (m, 
2H), 1.85-1.91 (m, 3H, C-2, C-4), 2.01 (sept, J=2.0 Hz, 1H, C-1), 2.06 (dddd, J=14.0, 
11.0, 3.5, 2.0 Hz, 1H, C-5 endo), 2.98 (t, J=10.0 Hz, 1H, C-6), 7.11 (tt, J=7.0, 1.5 Hz, 
1H, Ar4), 7.22 (tt, J=8.0, 2.0 Hz, 2H, Ar2,4), 7.44 (d, J=7.5 Hz, 2H, Ar3,5). 13C NMR 
(CDCl3): δ 23.70, 25.57, 29.44, 31.54, 34.52, 35.25, 42.12, 43.91, 66.71 (aliphatic), 
125.22, 127.25, 129.13, 145.83 (aryl).  
 
32·HCl. mp: 124-127 °C, white solid. 1H NMR (D2O): δ 1.36-1.60 (m, 4H), 1.78-
1.90 (m, 1H), 1.95-2.00 (m, 1H), 2.05-2.20 (m, 3H), 2.22-2.36 (6H, N(CH3)2), 2.39 (br s, 
1H), 3.05-3.25 (m, 1H), 7.19 (t, J=7.2 Hz, 1H, Ar4), 7.32 (t, J=7.5 Hz, 2H, Ar2,6), 7.40 (d, 
J=7.5 Hz, 2H, Ar3,5). IR (neat): 2960, 2868, 2683, 1729, 1650, 1466, 1262, 1077, 1025, 
808, 709 cm-1. MS (EI) M+ 229. Elem Anal cald for C16H24NCl: C, 72.29; H, 9.10; N, 
5.27; Cl, 13.34. Found: C, 72.14; H, 8.97; N, 5.17; Cl, 13.47. 
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6-endo-Amino-2-exo-benzylbicyclo[2.2.2]octan-endo-2-ol (33). A solution of 1 
M benzylmagnesium chloride in THF (6.32 mL, 6.32 mmol) at -20 °C was added  
dropwise to a solution of amino ketone 19 (500 mg, 2.99 mmol) in ether (100 mL). The 
mixture was stirred for 4 h, H2O (50 mL) was added, and the solvent was removed by 
reduced pressure. The aqueous layer was made acidic with 1 M HCl, washed with 
CH2Cl2 (3 x 50 mL), the aqueous layer was then made basic with NaOH pellets, and 
extracted with CH2Cl2 (3 x 100 mL). The organic extracts were combined, dried over 
MgSO4, and the solvent was removed under reduced pressure to afford 568 mg of endo-
alcohol-endo-amine 33 as a yellow liquid (73.3 % yield). 1H NMR (CDCl3): δ 1.271.48 
(m, 3H) 1.54 (dt, J=13.8, 2.1 Hz, 1H, C-3), 1.58-1.90 (m, 6H), 2.03-2.10 (m, 7H, 
N(CH3)2), 2.65 (d, J=13.8 Hz, 1H, C-9), 2.89 (d, J=13.8 Hz, 1H, C-9), 7.15-7.37 (m, 5H, 
aromatic). 13C NMR (CDCl3): δ 21.49, 23.59, 25.98, 32.13, 32.86, 42.81, 45.12, 47.18, 
64.82, 73.99 (aliphatic), 125.73, 127.50, 130.58, 138.71 (aryl).  
33·HCl. (very hygroscopic). 1H NMR (D2O): δ 1.23-1.55 (m, 5H), 1.59 (dt, J= 
14.7, 2.1 Hz, 1H, C-3), 1.68-1.80 (m, 1H), 1.81-1.87 (m, 1H, C-4), 1.97 (br s, 1H, C-1), 
2.00-2.12 (m, 1H), 2.41 (s, 3H, N(CH3)2), 2.61 (s, 3H, N(CH3)2), 2.77 (s, 2H, C-9), 3.01 
(t, J= 7.8 Hz, 1H, C-6), 7.12-7.26 (m, 5H, aromatic). MS (EI) M+ 259. Elem Anal cald 
for C17H26NCl: C, 62.37; H, 9.08; N, 4.28; Cl, 10.83. Found: C, 62.21; H, 8.69; N, 4.12.; 
Cl, 11.63. 
 
2-endo-(N,N-Dimethylamino)-6-benzylbicyclo[2.2.2]octanes (39 and 41). p-
Toluene sulfonic acid (739 mg, 3.88 mmol)was added to a solution of endo-amino 
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alcohol 33 (503 mg, 1.94 mmol) in toluene (100 mL). The mixture was heated at reflux 
with a Dean-Stark trap overnight. The flask was cooled, 5% NaOH was added (50 mL), 
and the mixture was stirred for 2h. The organic layer was dried over Mg SO4, and the 
solvent removed under reduced pressure to afford crude product (403 mg, 86 % yield). 
The crude mixture was used without further purification.   
A mixture of unsaturated amines 35 and 37 (200 mg, 0.88 mmol) in methanol (20 
mL) and 50 % w/w Rainey Nickel in H2O (40 mg) was shaken under H2 (40 psi) 
overnight. The reaction mixture was filtered through celite 503 and the solvent was 
removed under reduced pressure to afford 200 mg (quant yield) of a mixture of 1:1 
endo:exo benzyl amines. The mixture was separated by column chromatography (1:1:1 
acetone:chloroform:methanol) to afford exo-benzyl-endo-mine 39 (30 mg, 15% yield, 
Rf= 0.45) as a pale yellow oil and endo-benzyl-endo-amine 41 (20 mg, 10% yield, Rf= 
0.35) as a pale yellow oil. 
 
2-endo-(N,N-Dimethyl)amino- 6-exo-benzylbicyclo[2.2.2]octane (39). 1H NMR 
(CDCl3): δ 1.23 (dm, J=13.2 Hz, 1H, C-3), 1.35-1.60 (m, 6H, C-3, C-5, C-7, C-8), 1.65 
(sept, J=2.7 Hz, 1H, C-4), 1.77 (tt, J=12.9, 3.9 Hz, 1H, C-5), 1.85-1.93 (m, 2H, C-1, C-
2), 1.95-2.10 (p, J= Hz, 1H, C-6), 2.10 (s, 6H, N(CH3)2), 2.95 (d, J= 7.8 Hz, 1H, C-9), 
7.09-7.26 (m, 5H, aromatic).  
 
39·HCl. mp: 218 ºC, decomposed, white solid. 1H NMR (D2O): δ 1.03-1.16 (m, 
1H), 1.30-1.76 (m, 8H), 2.05-2.20 (m, 3H), 2.48 (t, J= 12 Hz, 1H, C-9), 2.70 (s, 6H, 
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N(CH3)2), 3.16 (t, J= 9 Hz, 1H, C-2), 7.12-7.27 (m, 5H, aromatic). MS (EI) M+ 243. IR 
(neat): 2917, 2580, 2472, 1449, 707 cm-1. 
   
2-endo-(N,N-Dimethyl)amino-6-endo-benzylbicyclo[2.2.2]octane (41). 1H NMR 
(CDCl3): δ 1.01 (qt, J= 12.0, 7.2 Hz, 1H, C- endo), 1.24-1.38 (m, 3H, C-3 exo, C-5 exo, 
C-8), 1.42-1.48 (m, 1H, C-8), 1.45 (ddd, J=11.0, 9.6, 2.1 Hz, 1H, C-8), 1.50 (br sm, 1H, 
C-1), 1.64 (decet, J=1.2 Hz, 1H, C-4), 1.73-1.81 (m, 2H, C-7), 1.83-1.91 (m, 2H, C-2, C-
5), 1.99 (s, 6H, N(CH3)2), 2.20 (p, J=8.4, 1H, C-6), 2.49 (dd, J= 13.2, 9.3 Hz, 1H, C-9), 
2.67 (dd, J= 13.2, 6.6 Hz, 1H, C-9), 7.14 (t, J= 4.5 Hz, 1H, Ar4), 7.18 (d, J= 3.9 Hz, 2H, 
Ar2,6) 7.23 (t, J=4.5 Hz, 2H, Ar3,5). 13C NMR (CDCl3): δ 19.97, 25.00, 25.54, 29.04, 




























41·HCl. mp 212-215ûC, white solid. 1H NMR (D2O): δ 1.35-1.90 (m, 9H), 1.98-
2.30 (m, 3H), 2.65-3.15 (m, 7H), 3.45 (m, 1H, C-2), 7.05-7.60 (m, 5H, aromatic), 11.50 
(br s, 1H, HCl). MS (EI) M+ 243. IR (neat): 2940, 2868, 2664, 2585, 2479, 1663, 1466, 
709 cm-1. 
 
6-endo-Amino-2-exo-phenethylbicyclo[2.2.2]octan-endo-2-ol (34). A solution 
of 3 M phenethylmagnesium bromide in THF (17.9 mL, 17.9 mmol) was added dropwise 
to amino ketone 19 (1.50 g, 8.98 mmol) in ether (100 mL) at -20 °C. The mixture was 
stirred for 4 h, H2O (50 mL) was added, and the solvent was removed by reduced 
pressure. The mixture was stirred for 4 h, H2O (50 mL) added, and solvent was removed 
by reduced pressure. The aqueous layer was made acidic with 1 M HCl, washed with 
CH2Cl2 (3 x 50 mL), the aqueous layer was then made basic with NaOH pellets, and 
extracted with CH2Cl2 (3 x 100 mL). The organic extracts were combined, dried over 
MgSO4, and the solvent was removed under reduced pressure to afford 1.09 g of endo-
alcohol-endo-amine 34 as a pale yellow liquid with 30 % of the reduced endo-amino-
endo-alcohol 21. The endo-alcohol-endo-amine 34 was purified by column 
chromatography (silica gel, 5:3:1 methanol:acetone:chloroform eluant) to obtain 253 mg 
of pure product (10 % yield). 1H NMR (CDCl3): δ 1.281.40 (m, 3H) 1.51 (dt, J=13.5, 
2.1 Hz, 1H, C-3), 1.57-1.90 (m, 6H), 2.01 (br s, 1H, C-1), 2.13-2.25 (m, 2H), 2.27 (s, 6H, 
N(CH3)2), 2.77 (t, J=8.4 Hz, 2H, C-10), 7.13-7.32 (m, 5H, aromatic). 13C NMR (CDCl3): 
δ 21.50, 23.29, 25.98, 29.29, 32.78, 33.86, 43.15, 44.57, 65.14, 73.26 (aliphatic), 125.42, 
128.25, 128.48, 143.65 (aryl).  
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34·HCl. (very hygroscopic). 1H NMR (CDCl3): δ 0.70-1.00 (m, 1H), 1.23-2.44 
(m, 14H), 2.60-3.40 (m 8H), 4.55(br s, 1H, OH), 7.05-7.40 (m, 5H, aromatic), 9.70 (br s, 
1H, HCl). Elem Anal cald for C18H28NOCl·0.3 H2O: C, 67.39; H, 8.89; N, 4.37; O, 4.99; 
Cl, 14.37. Found: C, 67.01; H, 9.05; N, 4.27; Cl, 14.51. 
 
2-endo-2-(N,N-Dimethyl)amino-6-phenethylbicyclo[2.2.2]octanes (40 and 42). 
p-Toluene sulfonic acid (1.8 g, 9.52 mmol) was added to a mixture of endo-alcohol-endo-
amine 34 (1.3 g, 4.76 mmol) in toluene (100 mL). The mixture was heated at reflux with 
a Dean-Stark trap overnight. The flask was cooled, 5% NaOH (25 mL) was added, and 
the mixture was stirred for 2h. The organic layer was separated, dried over Mg SO4, and 
the solvent removed under reduced pressure to afford the crude product mixture of 
unsaturated products 40 and 42 (1.2 g, quant yield). The crude mixture was used without 
further purification.   
A mixture of unsaturated amines 40 and 42 (600 mg, 2.35 mmol) in methanol (20 
mL) and 50 % w/w Rainey Nickel in H2O (100 mg) was shaken under H2 (65 psi) for 3 d. 
The mixture was filtered through celite 503 and the solvent was removed under reduced 
pressure to afford 400 mg (66% yield) of a mixture of 3:2 exo:endo  phenethyl amines. 
The mixture was separated by column chromatography (1:1:1 acetone:CHCl3:CH3OH) to 
afford exo-phenethyl-endo-amine 40 (57 mg, 9% yield, Rf= 0.33) and endo-phenethyl-
endo-amine 42 (60 mg, 10% yield, Rf= 0.42). 
 
2-endo-(N,N-Dimethyl)amino-6-exo-phenethylbicyclo[2.2.2]octane (40). 1H NMR 
(CDCl3): δ 0.97 (qt, J= 12, 6.9, 1.8 Hz, 1H, C-5), 1.21-1.46 (m, 4H), 1.56-1.69 (m, 4H), 
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1.70-1.88 (m, 3H), 1.88-2.00 (m, 2H), 2.20 (s, 6H, N(CH3)2), 2.58 (dd, J= 10.5, 6.3 Hz, 
1H, C-10), 7.13-7.30 (m, 5H, aromatic). 13C NMR (CDCl3): δ 20.53, 25.07, 25.71, 29.29, 
31.35, 34.16, 34.28, 34.36, 37.85, 43.91, 65.79 (aliphatic), 125.42, 128.13, (overlap) 
143.11 (aryl). 
 
40·HCl. mp: 219-222 ûC, white solid. 1H NMR (D2O): δ 0.65-1.40 (m, 1H), 1.16-
1.85 (m, 12H), 1.980 (t, J= 9.6 Hz, 1H), 2.52 (s, 3H, N(CH3)2), 2.67 (s, 3H, N(CH3)2), 
3.07 (t, J= 6.3 Hz, 1H), 7.05-7.25 (m, 5H, aromatic). IR (neat): 2933, 2861, 2578, 2466, 
1453, 709 cm-1. MS (EI) M+ 257. Elem Anal cald for C18H28NCl·0.65 H2O: C, 70.75; H, 
9.66; N, 4.58; O, 3.40; Cl, 11.60. Found: C, 70.47; H, 9.29; N, 4.47; Cl, 11.64. 
 
2-endo-(N,N-Dimethyl)amino-6-endo-phenethylbicyclo[2.2.2]octane (42). 1H 
NMR (CDCl3): δ 1.23-1.33 (m, 1H, C-5), 1.46-1.57 (m, 5H, C-8, C-7, C-5), 1.59-1.67 
(m, 1H, C-6), 1.73 (br s, 1H, C-4), 1.77-1.83 (m, 2H, C-3), 1.87 (br s, 1H, C-1), 1.93-2.01 
(m, 3H, C-2, C-9), 2.17 (s, 6H, N(CH3)2), 2.58 (dt, J= 15, 10 Hz, 1H, C-10), 2.70 (dd, J= 
15, 5 Hz, 1H, C-10), 7.18-7.34 (m, 5H, aromatic). 13C NMR (CDCl3): δ 23.52, 25.61, 
28.84, 30.62, 34.35, 35.09, 35.97, 38.09, 44.35, 67.08 (aliphatic), 125.35, 128.11, 128.55, 



























42·HCl. mp: 220-223ûC, white crystalline solid. 1H NMR (CDCl3): δ 1.26-1.54 
(m, 4H), 1.58-1.72 (m, 3H), 1.72-1.82 (m, 2H), 1.82-1.90 (m, 2H), 1.90-2.02 (m, 1H), 
2.06-2.19 (m, 1H), 2.36-2.48 (m, 1H), 2.50-2.62 (m, 1H), 2.71 (s, 3H, N(CH3)2), 2.76-
2.94 (m, 4H, N(CH3)2), 7.05-7.30 (m, 5H, aromatic), 11.37 (br s, 1H, HCl). MS (EI) M+ 
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Another approach taken to further understand the role of the phenyl ring on the 6-
amino-[2.2.2]bicyclo -2-benzoates (10-28, Chapter 3) was to transpose the benzoate from 
the C-2 position on the bicycle to the C-3 position. This places the benzoate one carbon 
over on the same bridge, e.g. compounds 55-58. The transposition of the benzoate one 
carbon over increases the length between the nitrogen and the phenyl ring, which should 
influence the binding of the inhibitor at the DAT. Thus, extensive analysis of the 
structural changes will allow for the development of SARs related to the fit of these 




The transposition of the ester functionality from the C-2 position to the C-3 
position was achieved employing a new synthetic strategy shown in Scheme 4.1. Diels- 








































































           
Reagents: a) 170-190 °C melt, 6 h; b) H2O, heat; c) Pb(OAc)4, dioxane, pyridine; d) 
HOCH2CH2OH, p-TSA·H2O, C6H6, reflux, 1h; e) 1) NH(CH3)2·H2O, Et3N, CH3OH, 4 Ǻ 
molecular sieves, 2) H2, Pd/C, 40 psi; f) HCl, CH2Cl2; g) NaBH4, EtOH, reflux; h) 
PhCOCl, Et3N, DMAP, C6H6, 50 °C; and i) TTP, DEAD, benzoic acid, THF.   
 
Scheme 4.1. Synthesis of 2-Amino-5-benzylbicyclo[2.2.2]octanes 55-58. 
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adduct 43 in low yield (5-11%).1 The product was purified by triturating the crude 
product with a 3:7 mixture of boiling ethyl acetate and diethyl ether. Although the 
reaction proceeded in low yield, the starting materials are cheap and the purification is 
trivial. The anhydride 43 was hydrolyzed to the cis diacid 44 by heating in H2O. The 
diacid 44 was oxidatively decarboxylated with lead tetraacetate to form the enedione 44. 
The 1H NMR spectrum of enedione 45 shows a peak at δ 6.56, which integrates to 2Hs 
which can be assigned to the two vinylic protons. Enedione 45 was ketalized with an 
equimolar quantity of ethylene glycol to give a mixture of diacetal, acetal, and starting 
material.2 Hydrogenation of the mixture gave a 6:71:23 ratio of diacetal, acetal 46, and 
starting material (determined by 1H NMR). The mixture was purified by column 
chromatography using a 1:1 hexane:ether eluant. The starting material could be recovered 
directly from the column and by hydrolysis of the diacetal. The monoacetal 46 was 
reductively aminated with dimethylamine hydrochloride to afford a 5:1 mixture of the 
endo:exo diastereomeric amino acetals 47 and 48 (determined by 1H NMR, based on the 
appearance of the 6H proton singlet for the dimethylamino group at δ 2.19 ppm and δ 
2.20 ppm), which were separated by column chromatography on alumina with 
chloroform as the eluant. The separate amino acetals were deprotected with 1 M HCl and 
CH2Cl2 to give the corresponding amino ketones 49 and 50. The amino ketones were then 
reduced to afford a 3:2 ratio of endo-amino alcohols 51 and 52 and a 1:1 ratio of exo-
amino alcohols 53 and 54, respectively. The structure of endo-amino alcohol 52 was 
determined by x-ray diffraction (Appendix H). The amino alcohols 51-54 were purified 
by column chromatography. The hydroxy amines 52 and 54 were benzoylated to afford 
the corresponding benzoates 56 and 58, and benzoates 55 and 57 were obtained by 
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Mitsunobu chemistry of hydroxy amines 52 and 54. The structure of benzoate 57 was 
confirmed by x-ray analysis (Appendix I).       
 
Pharmacology 
 Benzoates 55-58 were submitted for pharmacological testing and the results are 
pending.   
 
Conclusions 
 A series of new regioisomers, benzoates 55-58, were synthesized using Diels-
Alder chemistry to construct the bicycle. The bicycle was formed by reacting 
hydroquinone with maleic anhydride. This strategically places ketones at the C-2 and C-5 
position of the bicyclooctane skeleton. This was used to introduce a benzoate and an 
amine moiety. The transposition of the benzoate relative to the 6-amino-[2.2.2]bicyclo-2-
benzoates (10-28) lengthens the distance between the nitrogen and phenyl, and as a 
result, will provide more insight into the active site of the DAT. While the pharmacology 
data is still pending for benzoates 55-58, the new substitution pattern on the bicycle, with 
the amine at C-2 and the benzoate at C-5, will allow for a direct comparison with 







General Methods. The general methods can be found in the experimental section 
of Chapter 2.  
 
5,7-Dioxo bicyclo[2.2.2]octane-2,3-dicarboxylic anhydride (43). Maleic 
anhydride (500 g, 5.1 mol) was heated to 130ûC and hydroquinone (321 g, 2.9 mol) was 
added to the flask. The mixture was then heated to 190 ûC for 6 h, cooled to 60 ûC, and a 
mixture of ethyl acetate (300 mL) and diethyl ether (700 mL) was added to the flask. The 
mixture was heated at reflux for 30 min and 57 g of the insoluble anhydride 43 was 
isolated by filtration (11.5% yield, mp 252-256 ûC, lit mp 265-270 ûC). 1H NMR 
(DMSO-d6): δ 2.35 (dd, J=20.1, 3.0 Hz, 1H, C-6 endo), 2.68 (dd, J=19.2, 2.7 Hz, 1H, C-
8), 2.77 (dd, J=19.2, 3 Hz, 1H, C-8), 2.80 (dt, J= 20.4, 2.7 Hz, 1H, C-6 exo), 2.98 (q, J= 
3 Hz, 1H, C-1), 3.01 (q, J=3.6 Hz, 1H, C-4), 3.80 (ddd, J=10.2, 3.6, 2.1 Hz, 1H, C-2), 
3.96 (dd, J=10.2, 3.6 Hz, 1H, C-3). 13C (DMSO-d6): δ 36.90, 37.54, 40.72, 42.97, 44.98, 
46.92, 171.40, 171.48, 206.11, 207.02.  
 
  5,7-Dioxo bicyclo[2.2.2]octane-2,3-dicarboxylic acid (44). The cis diacid 44 
was obtained by recrystallizing the anhydride (58 g) from H2O (100% yield). mp: 262-
265 ºC, lit mp 264-266û. 1H NMR (DMSO-d6): δ 2.35-2.49 (m, 2H), 2.66-2.87 (m, 4H), 
3.34 (dd, J=11.1, 1.8 Hz, 1H, C-2), 3.45 (dd, J= 11.1, 2.7 Hz, 1H, C-3). 13C (DMSO-d6): 
δ 36.11, 38.11, 39.77, 43.76, 45.98, 47.98, 172.08, 173.98, 208.40, 208.94.  
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Bicyclo[2.2.2]oct-7-ene-2,5-dione (45). Pyridine (568 mL, 7.0 mol) was added 
dropwise to a mixture of diacid  44 (63.2 g, 0.280 mol) and lead tetraacetate (282.2 g, 
0.636 mol) in dioxane ( mL) at 0 ûC. The mixture was then heated to 60 ûC for min, 
cooled, and 2 M HNO3 (2000 mL) was added. The mixture was extracted with 
chloroform (2000 mL x 3), the organic extracts were combined and washed with 
saturated NaHCO3 (500 mL x 1), dried over MgSO4, and the solvent was removed under 
reduced pressure to obtain 8 g of crude product. Pure product (4.3 g, 11.2% yield) was 
obtained by flash column chromatography (20% ethyl acetate/ PET ether, Rf= 0.55) as a 
pale brown solid. mp 101-105 ûC lit mp 95-99 ûC1. 1H NMR (CDCl3): δ 2.33 (dd, J=18.6, 
2.7 Hz, 2H, C-3, C-5), 2.43 (dd, J=18.6, 2.1 Hz, 2H, C-3, C-5), 3.43-3.47 (m, 2H, C-1, C-
4), 6.50-6.56 (m, 2H, C-7, C-8). 13C (CDCl3): δ 34.89, 49.76, 132.06, 207.50.  
 
5-(Ethylenedioxy)bicyclo[2.2.2]octan-2-one (46). A mixture of dione 45 (4.28 g, 
31 mmol), p-toluene sulfonic acid (300 mg, 1.58 mmol), and ethylene glycol (1.12 g, 31 
mmol) in 70 mL of benzene was heated to reflux for 1 h. The mixture was cooled and 5% 
NaOH was added to the mixture. The solution was stirred for 4 hours and the solvent 
removed under reduced pressure. The aqueous layer was extracted with CH2Cl2 (3 x 100 
mL), the organic extracts were collected, dried over MgSO4, and the solvent was 
removed by reduced pressure to obtain 5.4 g of crude product. The crude acetal was 
dissolved in methanol (50 mL), Pd/C catalyst was added, and the mixture was stirred 
overnight, under 40 psi. The mixture was filtered through celite, and the solvent removed 
under reduced pressure to obtain 5.3 g of crude product. The acetal 46 (3.65 g, 63% yield, 
Rf= 0.40)) was obtained by flash column chromatography (1:1 hexane:ether) as a 
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colorless oil. 1H NMR (CDCl3): δ 1.43-1.55 (m, 1H), 1.65-1.84 (m, 2H), 1.93- 2.14 (m, 
5H), 2.34 (p, J= 3 Hz, 1H), 2.51 (dt, J= 19.5, 3 Hz, 1H, C-3), 3.80-3.97 (m, 4H). 13C 
(CDCl3): δ 20.35, 20.99, 36.27, 38.64, 40.31, 44.27, 64.02, 64.35, 109.02 (OCO), 215.14 
(C=O).  
 
2-(N,N-Dimethylamino)-5-(ethylenedioxy)bicyclo[2.2.2]octanes (47 and 48). A 
mixture of ketone 65 (3.4 g, 18.6 mmol), dimethylamine hydrochloride (9.1 g, 112 
mmol), triethylamine (22.6 g, 223 mmol), and 4 Å molecular sieves (70 g) in 200 mL of 
methanol was stirred overnight, followed by the addition of Pd/C catalyst and H2 (40 psi). 
The mixture was stirred for 3 d, filtered through celite, and the solvent removed under 
reduced pressure to obtain 3.7 g of crude product (89% yield). The diastereomers were 
separated by flash column chromatography (alumina, chloroform) to obtain 1.68 g of 
endo-amine 47 (41.1% yield, Rf= 0.40) as a colorless oil and 0.367 g of exo-amine 48 
(9% yield, Rf= 0.45) as a pale yellow solid.    
 
2-endo-(N,N-Dimethylamino)-5-(ethylenedioxy)bicyclo[2.2.2]octane (47). 1H 
NMR (CDCl3): δ 1.36 (dddd, J= 12.3, 8.7, 5.1, 1.5 Hz, 1H), 1.43 (dq, J= 11.1, 3 Hz, 1H, 
C-3endo), 1.55-1.86 (m, 7H), 1.99 (sextet, J= 2.4 Hz, 1H, C-1), 2.12 (dt, J= 14.4, 2.1 Hz, 
1H, C-6), 2.19 (s, 6H, N(CH3)2), 3.79-3.99 (m, 4H, C-9, C-10). 13C (CDCl3): δ 20.50, 
24.02, 28.79, 30.47, 33.34, 35.07, 43.78, 63.49, 63.79, 63.91, 110.10 (C-5). 
 
2-exo-(N,N-Dimethylamino)-5-(ethylenedioxy)bicyclo[2.2.2]octane (48). 1H NMR 
(CDCl3): δ 1.27 (ddd, J= 12.3, 4.8, 2.7 Hz, 1H, C-3exo), 1.31-1.40 (m, 1H), 1.52 (dddd, 
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J= 13.8, 9.3, 5.4, 1.2 Hz, 1H), 1.65-1-83 (m, 4H), 1.89 (dd, J= 14.4, 3 Hz, 1H, C-6), 1.92-
2.08 (m, 3H), 2.20 (s, 6H, N(CH3)2), 3.81-4.00 (m, 4H, C-9, C-10). 13C (CDCl3): δ 18.03, 
21.46, 29.06, 30.32, 32.84, 40.43, 44.07, 63.59, 63.84, 63.91, 99.81 (C-5). 
 
5-(N,N-Dimethylamino)bicyclo[2.2.2]octan-2-ones (49 and 50). The 
transformation from 47 to 49 is illustrated. Acetal 47 (1.8 g, 8.53 mmol) was hydrolyzed 
in CH2Cl2 (50 mL) with 1M HCl (20 mL) overnight. The organic layer was separated, 
dried over MgSO4, and the solvent removed under reduced pressure to obtain ketone 49 
(1.5 g, 100% yield) as a pale yellow oil. 
 
5-endo-(N,N-Dimethylamino)bicyclo[2.2.2]octan-2-one (49). 1H NMR (CDCl3): δ 
1.58-1.83 (m, 5H), 1.96-2.12 (m, 3H), 2.21 (s, 6H, N(CH3)2), 2.28 (p, J=3 Hz, 1H, C-1), 
2.34 (sextet, J=2.7 Hz, 1H, C-4), 2.57 (dt, J=18.9, 2.4 Hz, 1H, C-3). 13C (CDCl3): δ 
22.75, 24.20, 30.46, 31.63, 38.81, 42.95, 43.63, 63.00, 217.50.  
 
5-exo-(N,N-Dimethylamino)bicyclo[2.2.2]octan-2-one (50). (240 mg, 100% yield, 
pale yellow oil). 1H NMR (CDCl3): δ 1.46 (ttd, J=12.3, 3, 0.9 Hz, 1H), 1.64 (qd, J=17.1, 
9.6, 2.1 Hz, 1H, C-6), 1.76 (dddd, J=15.6, 10.2, 4.2, 2.4 Hz, 1H), 1.89 (tt, J=13.5, 3.3 Hz, 
1H) 1.96-2.11 (m, 4H), 2.12 (p, J=3 Hz, 1H, C-1), 2.22-2.34 (m, 2H), 2.26 (s, N(CH3)2, 




5-(N,N-Dimethylamino)bicyclo[2.2.2]octan-2-ols (51-54). The transformation 
from 49 to 51 and 52 is illustrated. NaBH4 (0.600 mg, 15.8 mmol) was added to a 
mixture of ketone 49 (1.32 g, 7.90 mmol) in 100 mL of ethanol. The mixture was heated 
to reflux for 4 h, H20 (50 mL) was added, and the solvent removed under reduced 
pressure. The mixture was extracted with CH2Cl2 (3 x 50 ml), the organic layers 
combined, dried over MgSO4, and the solvent removed under reduced pressure to obtain 
1.1 g of crude product (82% yield). The two diastereomers were separated by flash 
column chromatography (silica, 10:5:1: methanol:acetone:chloroform) to afford 380 mg 
(29% yield, Rf= 0.32) of endo-alcohol 52 as a colorless oil and 290 mg (22% yield, Rf= 
0.44) of exo-alcohol 51 as a white solid.  
 
5-endo-(N,N-Dimethylamino)bicyclo[2.2.2]octan-endo-2-ol (52). 1H NMR 
(CDCl3): δ 1.25-1.57 (m, 6H), 1.60-1.78 (m, 2H), 1.81-2.00 (m, 4H), 2.27 (s, 6H, 
N(CH3)2), 3.73-3.77 (m, 1H). 13C (CDCl3): δ 22.25, 23.46, 25.55, 27.50, 30.96, 31.93, 


























5-endo-(N,N-Dimethylamino)bicyclo[2.2.2]octan-exo-2-ol (51). mp 35- 40 ûC. 1H 
NMR (CDCl3): δ 1.15-1.43 (m, 3H), 1.61-1.72 (m, 2H), 1.79-1.92 (m, 4H), 2.00-2.25 (m, 
9H, N(CH3)2), 3.90 (ddd, J= 9, 3.6, 1.5 Hz, 1H, C-2). 13C (CDCl3): δ 17.21, 25.01, 27.28, 
31.57, 32.13, 32.48, 43.74, 63.52, 68.51.    
 
5-exo-(N,N-Dimethylamino)bicyclo[2.2.2]octan-endo-2-ol (54). colorless oil, Rf= 
0.0.40). 1H NMR (CDCl3): δ 1.16 (dtd, J=12.6, 3.3, 1.2 Hz, 1H), 1.22-1.35 (m, 3H), 1.52-
1.79 (m, 3H), 1.85 (sextet, J= 2.7 Hz, 1H), 1.99-2.15 (m, 3H), 2.23 (s, N(CH3)2, 6H), 
2.45 (br s, 1H, OH), 3.89 (dt, J=9.3, 2.7 Hz, C-2) 13C (CDCl3): δ 17.72, 23.36, 27.28, 
27.36, 32.22, 37.41, 43.56, 64.09, 68.48.   
 
5-exo-(N,N-Dimethylamino)bicyclo[2.2.2]octan-exo-2-ol (53). colorless oil, Rf= 
0.25. 1H NMR (CDCl3): δ 1.31-1.42 (m, 3H), 1.58 (sextet, J=3 Hz, 1H), 1.65-1.86 (m, 
6H), 1.93 (qt, J= 15.9, 10.5, 3 Hz, 1H), 2.15 (s, N(CH3)2, 6H), 3.89 (dddd, J=9, 4.2, 2.7, 
1.5 Hz, C-2) 13C (CDCl3): δ 18.19, 19.12, 27.59, 32.31, 32.96, 36.57, 44.16, 63.71, 68.43.   
 
5-(N,N-Dimethylamino)bicyclo[2.2.2]oct-2-yl benzoate (56 and 58). The 
transformation from 52 to 56 is illustrated. Triethylamine (126 µL, 0.659 mmol) and 
benzoyl chloride (126 µL, 1.39 mmol) were added to a solution of alcohol 52 (0.189 g, 
1.12 mmol) in benzene (20 mL). DMAP (3 mg, 0.02 mmol) was added and the mixture 
was heated to 50 °C for 24 h. Saturated NaHCO3 (5 mL) was added to the solution and 
the mixture was stirred for 2 h. The aqueous layer was removed and the organic layer was 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure to 
 76
afford a 56 as a yellow oil (180 mg). The pure product (60 mg, 20% yield) was obtained 
by column chromatography (1:1 methanol:chloroform, Rf= 0.41) pale yellow oil.    
 
5-endo-(N,N-Dimethylamino)bicyclo[2.2.2]oct-endo-2-yl benzoate (56). pale 
yellow oil.  1H NMR (CDCl3): δ 1.46-1.60 (m, 3H), 1.61-1.83 (m, 3H), 1.85-1.97 (m, 
4H), 2.04 (dddd, J= 13.5, 8.1, 3.9, 1.5 Hz, 1H, C-3), 2.24 (s, N(CH3)2, 6H), 5.03 (qt, 
J=9.6, 5.7, 1.8 Hz, 1H, C-2), 7.42 (tt, J= 7.2, 1.5 Hz, 2H, Ar3,5), 7.54 (tt, J= 7.5, 1.2 Hz, 
1H, Ar4), 8.08 (dt, J= 7.2, 1.8 Hz, 2H, Ar2,6). 13C (CDCl3): δ 22.67, 24.43, 27.15, 28.15, 
28.27, 30.27, 43.86, 64.58, 73.29 (aliphatic), 128.07, 129.54, 130.71, 132.53 (aryl), 
166.28 (C=O).  
 
56·HCl. mp 220 ºC, decomposed, pale yellow solid. 1H NMR (D2O): δ 1.42-1.60 
(m, 5H), 1.78 (qm, J= 6.7 Hz, 1H), 1.94-2.20 (m, 4H), 2.72 (s, N(CH3)2, 3H), 2.72 (s, 
N(CH3)2, 3H), 3.14 (t, J= 7.2 Hz, 1H, C-5), 4.93 (br s, 1H, C-2), 7.39 (t, J= 7.8 Hz, 2H, 
Ar3,5), 7.54 (t, J= 7.5 Hz, 1H, Ar4), 7.91 (d, J= 7.2 Hz, 2H, Ar2,6). IR (neat): 2954, 2877, 
2610, 2483, 1712, 1452, 1275, 1122, 996 cm-1. MS (EI) M+ 273. Elem Anal cald for 
C17H24NO2Cl·0.13 H2O: C, 65.41; H, 7.83; N, 4.49; O, 10.92; Cl, 11.36. Found: C, 65.07; 
H, 7.75; N, 4.52; Cl, 11.44. 
 
5-exo-(N,N-Dimethylamino)bicyclo[2.2.2]oct-exo-2-yl benzoate (58). 1H NMR 
(CDCl3): δ 1.28-1.55 (m, 4H), 1.75 (dddd, J=18, 12.6, 5.1, 3 Hz, 1H), 1.82-1.94 (m, 4H), 
2.03 (sextet, J= 3.3 Hz, 1H), 2.21 (s, N(CH3)2, 6H), 2.36 (dddd, J=14.7, 9.3, 2.7, 2.4 Hz, 
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1H), 5.15 (ddd, J=9.3, 4.2, 2.7, 1.5 Hz, 1H, C-2). 13C (CDCl3): δ 18.28, 24.80, 27.00, 
28.76, 29.03, 32.01, 43.80, 63.33, 72.55, 128.16, 129.35, 130.80, 132.55, 165.90.  
 
58·HCl. mp 165 ºC, decomposed, white solid. 1H NMR (D2O): δ 1.20-1.80 (m, 
6H), 1.80-2.15 (m, 4H), 2.70 (s, N(CH3)2, 3H), 2.74 (s, N(CH3)2, 3H), 3.11 (br s, 1H, C-
5), 4.88 (br s, 1H, C-2), 7.32 (br s, 2H, Ar3,5), 7.49 (br s, 1H, Ar4), 7.81 (br s, 2H, Ar2,6). 
IR (neat): 2947, 2868, 2585, 2479, 1703, 1453, 1275, 1117 cm-1. MS (EI) M+ 273. 
 
5-(N,N-Dimethylamino)bicyclo[2.2.2]oct-2-yl benzoate (55 and 57). The 
transformation of amino alcohol 52 to benzoate 55 is illustrated. Diethylazodicarboxylate 
(711 uL, 4.52 mmol) was added to a mixture of amino alcohol 52 (382 mg, 2.26 mmol), 
triphenylphosphine (1.19 g, 4.54 mmol), benzoic acid (607 mg, 4.97 mmol) in 20 mL of 
THF at room temperature. The mixture was stirred overnight and the solvent was 
removed by reduced pressure. The triphenylphosphine was removed by recrystallization 
twice from chloroform. The pure product (45 mg, 7.3 % yield) was isolated by flash 
column chromatography (silica, 10:5:1 methanol:acetone:chloroform) as a yellow oil. 
 
5-endo-(N,N-Dimethylamino)bicyclo[2.2.2]oct-2-exo-yl benzoate (55). 1H NMR 
(CDCl3): δ 1.41-1.57 (m, 2H), 1.63 (dt, J=14.1, 3.3 Hz, 1H), 1.80-2.00 (m, 7H), 2.14 (qt, 
J= 14.1, 9.9, 3 Hz, 1H), 2.23 (s, N(CH3)2, 6H), 5.08 (dddd, J=9.6, 4.2, 2.7, 1.8 Hz, 1H, C-
2), 7.44 (tt, J= 7.8, 1.8 Hz, 2H, Ar3,5), 7.56 (tt, J= 7.2, 1.5 Hz, 1H, Ar4), 8.05 (dt, J= 6.9, 
1.8 Hz, 2H, Ar2,6). 13C (CDCl3): δ 18.95, 19.24, 27.32, 29.61, 31.87, 33.96, 44.18, 63.64, 
72.24 (aliphatic), 128.19, 129.39, 130.68, 132.66 (aryl), 166.16 (C=O).  
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55·HCl. mp 185-188 ºC, yellow solid. 1H NMR (D2O): δ 1.35-1.72 (m, 5H), 1.87-
2.22 (m, 5H), 2.71 (s, N(CH3)2, 3H), 2.77 (s, N(CH3)2, 3H), 3.13 (br s, 1H, C-5), 4.91 (br 
s, 1H, C-2), 7.37 (t, J= 7.8 Hz, 2H, Ar3,5), 7.52 (t, J= 7.5 Hz, 1H, Ar4), 7.90 (d, J= 6.9 Hz, 
2H, Ar2,6). IR (neat): 2953, 2874, 2683, 2479, 1716, 1459, 1281, 1117 cm-1. MS (EI) M+ 
273. Elem Anal cald for C17H24NO2Cl·0.5 H2O·0.25 HCl: C, 62.23; H, 7.76; N, 4.27; O, 
12.19; Cl, 13.55. Found: C, 62.08; H, 7.39; N, 3.92; Cl, 13.42. 
 
5-exo-(N,N-Dimethylamino)bicyclo[2.2.2]oct-exo-2-yl benzoate (57). yellow oil. 
1H NMR (CDCl3): δ 1.22-1.37 (m, 2H), 1.42-1.55 (m, 2H), 1.59-1.87 (m, 2H), 1.89-2.07 
(m, 4H), 2.14 (dt, J= 12.9, 3.3 Hz, 1H), 2.23 (s, N(CH3)2, 6H), 5.10 (dt, J=9.3, 3.0 Hz, 
1H, C-2), 7.42-7.47 (m, 2H, Ar3,5), 7.53-7.58 (m, 1H, Ar4), 8.02-8.06 (m, 2H, Ar2,6). 13C 
(CDCl3): δ 18.94, 23.08, 27.12, 28.70, 29.09, 34.77, 43.89, 63.99, 72.38, 128.21, 129.35, 



























57·HCl. mp 243 ºC, decomposed, pale yellow solid. 1H NMR (D2O): δ 1.25-1.65 
(m, 6H), 2.04 (br s, 1H), 2.10-2.30 (m, 2H), 2.39 (t, J= 11 Hz, 2H), 2.72 (s, N(CH3)2, 
3H), 2.77 (s, N(CH3)2, 3H), 3.23 (t, J= 8 Hz, 1H, C-5), 4.96 (dm, J= 9.3 Hz, 1H, C-2), 
7.38 (t, J= 7.8 Hz, 2H, Ar3,5), 7.53 (t, J= 7.2 Hz, 1H, Ar4), 7.87 (d, J= 7.5 Hz, 2H, Ar2,6). 
IR (neat): 2954, 2877, 2680, 2470, 1719, 1452, 1270, 1115 cm-1. MS (EI) M+ 273. Elem 
Anal cald for C17H24NO2Cl·1.0 H2O·0.15 HCl: C, 61.26; H, 7.91; N, 4.20; O, 14.40; Cl, 
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In contrast to the previous chapters which describe synthesis for 
[2.2.2]bicyclooctanes, the work described in Chapter V involves the synthesis of 
disubstituted bicyclo[2.2.1]heptanes that are substituted at the C-2 and C-7 position of the 
bicycle (amino benzoates 66-67, Figure 5.2). The substitution at the C-7 position 
provides compounds which places substituents at a position which is between carbon 
atom 2 and 3 in the [2.2.2]octanes, discussed in Chapters 2 and 4 (Figure 5.1). One can 
imagine the one-carbon bridge occupying a position so as to orient the phenyl substituent 
in an orientation between that occupied in the 2,5 and 2,6 disubstituted [2.2.2]octanes. By 
placing the benzoate on the one-carbon bridge and the dimethyl amine at the C-2 position 
of the bicycle, a direct comparison can be completed by comparing the pharmacology 
data with the compounds previously synthesized. The positions of the benzoate can be 
reversed to give benzoate 67, which provides an arrangement of substituents that closely 
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Figure 5.1. Regiochemistry comparison of C-2 substituted [2.2.2]bicyclooctanes 





will provide us a better understanding of the necessary spatial arrangement, which the 
active site of the DAT can accommodate.  
 
Chemistry 
A synthetic route, which strategically placed alcohol groups on the one- and two-
carbon bridges of the disubstituted bicyclo[2.2.1]heptanes is shown in Figure 6.2. 
Epoxynorbornane was subjected to an acid-catalyzed Wagner-Meerwein rearrangement 
using perchloric acid to obtain the syn diol product 60, which was purified by column 
chromatography.1 The 1H NMR spectrum (D2O) shows two peaks at δ 3.84 and 3.70 ppm 
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for the protons at C-7 and C-2. The stereochemistry of diol 60 was determined using 2-D 
1H NMR spectroscopy and is consistent with the syn diol 60 (Appendix J). The syn diol 
60 was benzoylated using an equimolar amount of benzoyl chloride to afford a mixture of 
benzoate 61, benzoate 62, and dibenzoylated 63 product in a 1:1:1 ratio (determined by 
1H NMR spectroscopy). The 1H NMR spectrum shows a singlet at δ 5.08 ppm for the 
proton alpha to the benzoate for 62 and a multiplet at δ 5.03 ppm for benzoate 61. A 
doublet of doublets at δ 3.92 ppm was assigned to the carbinol proton of alcohol 62 and a 
singlet at δ 4.05 ppm was assigned to the carbinol proton of alcohol 61. The crude 
mixture was treated with DMSO and oxalyl chloride in a Swern oxidation to give a 1:1 
mixture of keto esters 64 and 65, which were separated by column chromatography. The 
structure assignment of keto ester 64 was completed by 1H NMR spectroscopy (Appendix 
K). Keto ester 64 was reductively aminated with dimethylamine (using H2 and Pd over 
carbon as the catalyst) to obtain amino benzoate 66. The benzoate at the C-2 position of 
64 sterically hinders the syn addition of hydrogen to the endo face of the bicycle, thereby 
only allowing hydrogenation of the exo face. When sodium cyanoborohydride was used 
as the reducing agent a 3:2 mixture of keto esters 66 and 67 was obtained. Keto benzoate 
65 was reductively aminated under these conditions to give a 10:1 mixture of keto esters 
68 and 69. Analytically pure samples of keto esters 66-69 were obtained by column 
chromatography. The structure assignments of amino benzoates 66 and 68 were 
completed by x-ray analysis (Appendix L and M).     
 The approach used to synthesize amino norboranyl benzoates (73 and 74) is 
shown in Figure 6.3. Diol 60 was treated with triphenyl phosphine, benzoic acid, and  
diethylazodicarboxylate (DEAD) in a Mitsunobu reaction in an effort to invert the 
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stereochemistry at the C-2 and C-7 positions while placing a benzoate directly on the 
bicycle. A 2:1:1:2 mixture (determined by 1H NMR spectroscopy) of benzoates 70, 71, 
61, 62, and dibenzoates was obtained and separated by column chromatography. For 
benzoate 70, a doublet of triplets at δ 5.63 ppm and a doublet at δ 4.25 were assigned to 
the proton α to the benzoate and to the carbinol proton, respectively. Benzoate 70 was 
treated with DMSO and oxalyl chloride in a Swern oxidation to give keto ester 72. The 
1H NMR spectrum of 72 has a doublet for the carbinol proton at δ 4.25 and a doublet of 
doublet of doublet of doublets for the proton α to the benzoate to δ 5.40 ppm. Keto ester 
72 was reductively aminated using sodium cyanoborohydride to obtain amino benzoates 
73 and 74, which were separated by column chromatography. The relative stereochemical 









































































Reagents: a) HClO4, H2O; b) benzoyl chloride, DMAP, pyridine, CH2Cl2; c) DMSO, 


























































Reagents: a) TPP, DEAD, benzoic acid, THF; b) DMSO, oxalyl chloride, Et3N, CH2Cl2; 










 Benzoates 66-69 and 73-74 were submitted for pharmacological testing and the 
results are pending.   
 
Conclusions 
 A series of new [2.2.1]bicycloheptanes, benzoates 66-69 and 73-74, were 
synthesized using epoxynorbornane as the scaffold. The bicycle undergoes a non-
classical carbocation rearrangement to form a syn diol. This strategically places an 
oxygen substituent at the C-2 and C-7 position of the bicycloheptane skeleton. This was 
used to introduce a benzoate and an amine moiety. The benzoate and amine substituents 
were exchanged so as to place the nitrogen on the one-carbon bridge in one set of 
regioisomers with the benzoate at the C-2 position. In the other set of regioisomers the 
nitrogen is placed at the C-2 position and the benzoate on the one-carbon bridge. The 
pharmacology data is still pending for benzoates 66-69 and 73-74. The new substitution 
pattern on the bicycle, with the amine at C-2 or C-7 and the benzoate at C-2 or C-7, will 















General Methods. The general methods can be found in the experimental section 
of Chapter 2.  
 
 
2-endo-7-exo-bicyclo[2.2.1]heptane diol (60). A catalytic amount of perchloric 
acid (2 drops) was added to a stirred solution of exo epoxy norbornane (25 g, 0.227 mol) 
in H2O (150 mL). The mixture was heated to 60 °C for 20 min, cooled to room 
temperature, and extracted with CH2Cl2 (3 x 150 mL). The combined extracts were dried 
over MgSO4, filtered, and the solvent was removed under reduced pressure to afford the 
crude product (22 g). The final product was obtained by column chromatography (silica, 
1:1 ethyl acetate:hexane, Rf= 0.44) as a white solid (15 g, 53% yield) mp 168.5-170.5 °C, 
lit. 179.5-181 °C2. 1H NMR (D2O): δ 0.79-0.91 (m, 2H, C-6endo, C-7endo), 1.23-1.46 
(m, 2H, C-6exo, C-7exo), 1.59-1.64 (dm, J= 13.8 Hz, 1H, C-3exo), 1.71-1.78 (dd, J= 
13.8, 7.5 Hz, 1H, C-3endo), 1.90 (d, J= 3.3 Hz, 1H, C-1), 1.99 (br s, 1H, C-4), 3.70 (br d, 
J= 6.6 Hz, 1H, C-2endo), 3.84 (s, 1H, C-5). 13C NMR (D2O): δ 21.72, 24.84, 38.77, 





















Benzoylbicyclo[2.2.1]heptanol (61 and 62). Diol  60 (5.9 g, 46 mmol) was added 
to a stirred solution of benzoyl chloride (5.35 mL, 46.1 mmol), pyridine (11.52 mL, 92.2 
mmol), and DMAP (60 mg, 0.49 mmol) in CH2Cl2 (100 mL). The mixture was stirred 
overnight at room temperature and H2O (mL) was added. The mixture was extracted with 
CH2Cl2 (3 x 100 mL), the organic extracts were combined, dried over MgSO4, filtered, 
and the solvent removed under reduced pressure to afford 9.9 g of a mixture of benzoates 
61 and 62, dibenzoate 63, and diol 60 in a 25:51:23:1 ratio. Recrystallization of the 
mixture from ethyl acetate:hexane gave benzoate 62 as colorless solid (1.2 g, 34% 
yield).The solvent was removed from the mother liquor and chromatographed (silica gel, 
1:1 ethyl acetate:hexane eluant) to obtain dibenzoate (2.5 g), benzoate 61 (3.3 g, 46% 
yield, Rf= 0.55) as a yellow oil and benzoate 62 (0.520 g, 14% yield, Rf= 0.52) as a white 
solid. The crude mixture of benzoates and dibenzoate can be used without further 
purification.  
 
7-endo-Benzoylbicyclo[2.2.1]hepta-2-exo-ol (62). mp 106-107 °C, lit. 102-104 
°C1. 1H NMR (CDCl3): δ 1.25-1.09 (m, 2H, C-6endo, C-5endo) 1.75-1.63 (m, 2H, C-
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6exo, C-5exo), 1.87 (dm, J= 14.1 Hz, 1H, C-3exo), 2.05 (dd, J= 14.1, 7.5 Hz, 1H, C-
3endo), 2.41 (d, J= 3 Hz, 1H, C-4), 2.49 (br s, 1H, C-1), 3.92 (dd, J= 6.6, 1.5 Hz, 1H, C-
7endo), 5.08 (s, 1H, C-2), 7.45 (t, J= 7.5 Hz, 2H, Ar3,5), 7.57 (t, J= 7.5 Hz, 1H, Ar4), 7.99 
(d, J= 7.2 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 21.98, 24.75, 38.73, 40.99, 45.59, 75.75, 
82.19 (aliphatic), 128.47, 129.32, 129.88, 133.04 (aromatic), 165.85 (OC=O). 
 
2-exo-Benzoylbicyclo[2.2.1]hepta-7-endo-ol (61). 1H NMR (CDCl3): δ 1.08-1.27 
(m, 2H, C-6endo, C-5endo) 1.55-1.95 (m, 4H, C-6exo, C-5exo, C-3, OH), 2.10 (m, 1H, 
C-3), 2.27 (s, 1H, C-1/C-4), 2.38 (d, J= 4.5 Hz, 1H, C-1/C-4), 4.05 (s, 1H, C-7), 5.03 (m, 
1H, C-2), 7.42 (t, J= 7.5 Hz, 2H, Ar3,5), 7.58 (t, J= 7.5 Hz, 1H, Ar4), 7.97 (d, J= 7.2 Hz, 
2H, Ar2,6). 13C NMR (CDCl3): δ 22.18, 24.96, 36.89, 40.76, 44.88, 78.76, 80.47 

























   Benzoylbicyclo[2.2.1]heptanones (64 and 65). Dimethylsulfoxide (15.6 mL, 
0.22 mol) was added dropwise to a stirred solution of oxalyl chloride (8.0 mL, 91.6 
mmol) in CH2Cl2 (80 mL) at 78 °C. The solution was stirred for 20 min and a solution 
of crude benzoates 60 and 61 and dibenzoate (8.50 g, 36.7 mmol) in 20 mL of CH2Cl2 
was added dropwise to the mixture. Stirring was continued for another 20 min at 78 °C, 
after which triethylamine (51 mL, 0.37 mmol) was added slowly and the mixture was 
allowed to warm to room temperature. The mixture was diluted with H2O (50 mL) and 
extracted with CH2Cl2 (3 x 150 mL). The combined organic extracts were dried over 
MgSO4, filtered and concentrated in vacuo to obtain a 1:1:1 ratio of ketone 64 to ketone 
65 to benzoate as a yellow oil (15 g). Silica gel chromatography using 4:1 hexane:ethyl 
acetate eluant furnished pure samples of keto benzoate 64 (1.7 g, 40% yield, Rf= 0.53) as 
a pale yellow oil and keto benzoate 65 (318 mg, 15% yield, Rf= 0.47) as a pale yellow 
solid.   
 
2-exo-Benzoylbicyclo[2.2.1]hepta-7-one (64).1H NMR (CDCl3): δ 1.34-1.54 (m, 
2H, C-6endo, C-5endo), 1.68-1.91 (m, 2H, C-6exo, C-5exo), 1.91-1.95 (m, 2H, C-3exo, 
C-1 or C-4), 2.03 (d, J= 5.4 Hz, 1H, C-1 or C-4), 2.09 (ddd, J= 15, 8, 1.98 Hz, 1H, C-
3endo), 5.17 (ddd, J= 8, 2.1, 0.9 Hz, 1H, C-2), 7.24 (t, J= 8.1 Hz, 2H, Ar3,5), 7.37 (tt, J= 
7.2, 1.2 Hz, 1H, Ar4), 7.82 (dt, J= 7.2, 1.8 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 18.63, 
22.96, 35.25, 43.28, 72.11 (aliphatic), 128.24, 129.51, 129.61, 133.07 (aromatic), 165.64 
(OC=O), 213.88 (C=O). 
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7-endo-Benzoyl [2.2.1]bicycloheptan-2-one (65). mp 106-107 °C. 1H NMR 
(CDCl3): δ 1.51-1.65 (m, 2H, C-6endo, C-5endo) 1.95-2.19 (m, 3H, C-6exo, C-5exo, C-
3endo), 2.56 (dd, J= 17.7, 4.5 Hz, 1H, C-3exo), 2.77 (br s, 1H, C-1), 2.81-2.90 (m, 1H, 
C-4), 5.25 (q, J= 1.5 Hz, 1H, C-7), 7.43 (tt, J= 7.5, 1.5 Hz, 2H, Ar3,5), 7.57 (tt, J= 7.8, 1.5 
Hz, 1H, Ar4), 7.99 (dd, J= 8.4, 1.5 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 20.55, 22.93, 
24.78, 38.03, 41.25, 52.10, 80.37 (aliphatic), 128.32, 129.33, 129.45, 133.19 (aromatic), 
165.79 (OC=O), 214.83 (C=O). 
 
7-(N,N-Dimethylamino)bicyclo[2.2.1]hepta-7-exo-yl benzoates (66 and 67). 
Ketone 64 (0.638 g, 2.77 mol) was added to a stirred solution of dimethylamine (1.36 g, 
16.6 mmol), triethylamine (4.6 mL, 33.3 mmol), sodium cyanoborohydride(1.22 g, 19.4 
mmol), and 4 Å molecular sieves (3g) in methanol (50 mL). The mixture was stirred for 3 
d, filtered through celite, and the solvent was removed under reduced pressure. CH2Cl2 
(150 mL) was added to the residue and the solution was washed with K2CO3 (3 x 50 mL). 
The organic layer was dried over MgSO4, filtered and concentrated in vacuo to obtain a 
3:2 ratio of amine 66 and amine 67 as a pale yellow oil (0.60 g). Silica gel 
chromatography using 9:1 ethyl acetate:methanol eluant furnished amino benzoate 66 
(181 mg, 38% yield, Rf= 0.68) as a colorless oil and amino benzoate 67 (60 mg, 25% 
yield, Rf= 0.61) as a pale yellow oil.   
 
7-endo-(N,N-Dimethylamino) [2.2.1]bicyclohepta-2-exo-yl benzoate (66). 1H 
NMR (CDCl3): δ 1.13-1.30 (m, 2H, C-6endo, C-5endo) 1.52-1.71 (m, 2H, C-6exo, C-
5exo), 1.90 (dd, J= 12.9, 7.8 Hz, 1H, C-3endo), 2.11 (dq, J= 12.6, 3.6 Hz, 1H, C-3exo), 
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2.24 (br s, 6H, (N(CH3)2), 2.45 (br d, J= 4.5 Hz, 1H, C-1/C-4), 2.58 (d, J= 5.7 Hz, 1H, C-
1/C-4), 4.88 (dd, J= 7.2, 3.3 Hz, 1H, C-2), 7.41 (tt, J= 7.5, 1.5 Hz, 2H, Ar3,5), 7.52 (tt, J= 
7.2, 1.2 Hz, 1H, Ar4), 8.03 (dt, J= 7.2, 1.2 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 24.86, 
26.40, 37.32, 38.61, 42.84, 43.21, 45.23, 76.10, 78.18 (aliphatic), 128.07, 129.44, 130.94, 
132.40 (aromatic), 166.41 (OC=O).  
 
66·HCl. mp 153-163 ûC, decomposed, yellow crystalline solid. 1H NMR (D2O): δ 
1.30-1.33 (m, 2H, C-6endo, C-5endo) 1.55-1.78 (m, 2H, C-6exo, C-5exo), 1.90 (dddd, J= 
15.2, 6.9, 4.2, 3 Hz, 1H, C-3exo), 2.16 (dd, J= 15.6, 7.8 Hz, 1H, C-3endo), 2.57 (t, J= 3.6 
Hz, 1H, C-4), 2.81 (d, J= 4.2 Hz, 1H, C-1), 2.86 (s, 6H, (N(CH3)2), 3.27 (s, 1H, C-5), 
4.96 (dd, J= 7.8, 3 Hz, 1H, C-2), 7.40 (tt, J= 8.1, 1.5 Hz, 2H, Ar3,5), 7.55 (tt, J= 7.5, 1.5 
Hz, 1H, Ar4), 7.84 (dt, J= 7.2, 1.2 Hz, 2H, Ar2,6). IR (neat): 2960, 2683, 1729, 1281, 
1123, 762 cm-1. MS (EI) M+ 259. 
 
7-exo-(N,N-Dimethylamino) [2.2.1]bicyclohepta-2-exo-yl benzoate (67). 1H NMR 
(CDCl3): δ 1.09-1.25 (m, 2H, C-6endo, C-5endo) 1.73 (ddd, J= 12, 4, 3 Hz, 1H, C-3exo), 
1.76-1.95 (m, 2H, C-6exo, C-5exo), 1.91 (dd, J= 14.1, 7.8 Hz, 1H, C-3endo), 2.26 (br s, 
6H, (N(CH3)2, C-4), 2.38 (br d, J= 4.5 Hz, 1H, C-1), 2.41 (s, 1H, C-5), 4.84 (dd, J= 7.5, 
2.7 Hz, 1H, C-2), 7.44 (tt, J= 7.8, 1.5 Hz, 2H, Ar3,5), 7.55 (tt, J= 7.5, 1.5 Hz, 1H, Ar4), 
8.03 (dt, J= 7.2, 1.5 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 22.61, 25.69, 37.44, 38.62, 




67·HCl. mp 230-240 ûC; 210 ûC decomposed, pale yellow crystalline solid. 1H 
NMR (D2O): δ 1.40-1.55 (m, 2H, C-6endo, C-5endo), 1.56-1.74(m, 2H, C-6exo, C-
5exo), 1.74-1.85 (dm, J= 15 Hz, 1H, C-3endo), 2.00 (dd, J= 14.1, 7.5 Hz, 1H, C-3exo), 
2.57 (s, 1H, C-1/C-4), 2.70 (br d, J= 3.9 Hz, 1H, C-1/C-4), 2.82 (s, 6H, (N(CH3)2), 3.50 
(br s, 1H, C-7), 4.82 (dddd, J= 7.8, 2.4, 0.6, 0.3 Hz, 1H, C-2), 7.44 (tt, J= 7.2, 1.2 Hz, 2H, 
Ar3,5), 7.59 (tt, J= 7.5, 1.2 Hz, 1H, Ar4), 7.94 (dt, J= 7.2, 2.1 Hz, 2H, Ar2,6). IR (neat): 
2966, 2881, 2683, 1722, 1274, 1116, 721 cm-1. MS (EI) M+ 259.  
 
2-(N,N-Dimethylamino)bicyclo[2.2.1]hepta-7-endo-yl benzoates (68 and 69). 
The same procedure provided above to make 7-amino-2-endo-norboranyl benzoates 66 
and 67 was used to obtain a 10:1 ratio of amino benzoate 68 and amino benzoate 69 as a 
yellow oil. Silica gel chromatography using 1:1:1 chloroform:methanol:ethyl acetate 
eluant furnished amino benzoate 68 (400 mg, 60% yield, Rf= 0.043) as a colorless oil and 
amino benzoate 69 (60 mg, 10% yield, Rf= 0.36) as a pale yellow oil.   
 
2-endo-(N,N-Dimethylaminobicyclo[2.2.1]hepta-7-exo-yl benzoate (68). 1H NMR 
(CDCl3): δ 1.27 (ddd, J= 12.6, 4.5, 1.2 Hz, 1H, C-3endo) 1.45 (ddd, J= 11.7, 10.2, 4.8 
Hz, 1H, C-5endo), 1.56 (dtd, J= 12, 4.5, 1.2 Hz, 1H, C-6endo), 1.76 (dddd, J= 15.9, 11.4, 
5.2, 4 Hz, 1H, C-5exo), 1.94 (ddd, J= 12.3, 10.5, 4.8 Hz, 1H, C-6exo), 2.15 (dddd, J= 
15.3, 9.9, 5.1, 3 Hz, 1H, C-3exo), 2.24 (s, 6H, (N(CH3)2), 2.32 (t, J= 4.8 Hz, 1H, C-4), 
2.45 (t, J= 3 Hz, 1H, C-1), 2.65 (dt, J= 8.7, 4.5 Hz, 1H, C-2), 5.09 (br d, J= 1.8, 1H, C-7), 
7.45 (tt, J= 8.1, 1.8 Hz, 2H, Ar3,5), 7.57 (tt, J= 7.2, 1.5 Hz, 1H, Ar4), 8.04 (dt, J= 7.5, 1.5 
 95
Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 18.45, 26.69, 34.56, 38.97, 41.92, 45.06, 66.58, 
82.84 (aliphatic), 128.22, 129.38, 130.29, 132.78 (aromatic), 166.05 (OC=O).  
 
68·HCl. mp 260-268 ûC; 237 ûC decomposed, white solid. 1H NMR (D2O): δ 
1.34-1.50 (m, 3H), 1.75-1.95 (m, 2H), 2.35-2.45 (m, 2H), 2.60-3.00 (m, 7H), 3.75 (br s, 
1H, C-2), 5.06 (s, 1H, C-7), 7.43 (t, J= 6.3 Hz, 2H, Ar3,5), 7.59 (t, J= 7.5 Hz, 1H, Ar4), 
7.91 (d, J= 6.9 Hz, 2H, Ar2,6). IR (neat): 2956, 2871, 2825, 2779, 1712, 1467, 1305, 
1282, 1113, 714 cm-1. MS (EI) M+259. 
 
2-exo-(N,N-Dimethylamino)bicyclo[2.2.1]hepta-7-exo-yl benzoate (69). 1H NMR 
(CDCl3): δ 1.10-1.25 (m, 2H, C-5endo, C-6endo), 1.59-1.78 (m, 3H, C-5exo, C-6exo, C-
3endo), 1.96 (ddd, J= 14.1, 4.2, 2.4 Hz, 1H, C-3exo), 2.02 (dd, J= 12.3, 5.1 Hz, 1H, C-
2endo), 2.09 (s, 6H, (N(CH3)2), 2.35 (t, J= 3.9 Hz, 1H, C-1 or C-4), 2.63 (dd, J= 3.9, 1.5 
Hz, 1H, C-1 or C-4), 4.83 (br s, 1H, C-7), 7.38 (tt, J= 7.8, 1.8 Hz, 2H, Ar3,5), 7.50 (tt, J= 
7.2, 1.2 Hz, 1H, Ar4), 8.05 (dt, J= 6.9, 1.2 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 24.78, 
25.39, 36.19, 39.08, 40.48, 44.22, 71.23, 81.05 (aliphatic), 128.01, 129.71, 131.08, 
132.32 (aromatic), 166.85 (OC=O).  
 
69·HCl. mp 208-211ûC. 1H NMR (CDCl3): δ 1.20-1.70 (m, 4H0, 1.70-2.00 (m, 
2H), 2.00-2.45 (m, 2H), 2.45-3.00 (m, 7H), 4.93 (s, 1H, C-7), 7.47 (br s, 2H, Ar3,5), 7.58 
(br s, 1H, Ar4), 7.99 (br s, 2H, Ar2,6), 12.12 (br s, 1H, HCl). IR (neat): 29730, 2664, 2624, 






















2-endo-Benzoylbicyclo[2.2.1]hepta-7-one (72). Benzoic acid (0.954 g, 7.81 
mmol) was added to a stirred solution of diol 60 (1.0 g, 7.81 mmol), 
diethylazodicarboxylate (2.72 g, 15.6 mmol), and triphenylphosphine (4.10 g, 15.6 
mmol) in THF (50 mL). The mixture was stirred for 24 h and the solvent was removed 
under reduced pressure to obtain a dark red oil (9 g). Silica gel chromatography using 4:1 
hexane:ethyl acetate eluant furnished crude alcohol 70 (1.5 g, Rf= 0.25)which was used 
without further purification.   
The same procedure provided above to make benzoyl norboranones 64 and 65 
was used to obtain crude ketone 72 as a yellow oil. Silica gel chromatography using 
chloroform provided keto benzoate 72 (100% yield) as a white solid. 1H NMR (CDCl3): δ 
1.60-1.85 (m, 3H), 1.90-2.25 (m, 2H), 2.45-2.60 (m, 2), 5.40 (dddd, J= 8.4, 6.3, 3.3, 2.1 
Hz, 1H, C-2exo), 7.41 (t, J= 7.5 Hz, 2H, Ar3,5), 7.52 (t, J= 7.2 Hz, 1H, Ar4), 8.03 (d, J= 
7.2 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 15.60, 23.76, 34.63, 40.14, 43.95, 68.48 
(aliphatic), 128.36, 129.41, 129.68, 133.13 (aromatic), 165.78 (OC=O), 212.01 (C=O).  
 
7-(N,N-Dimethylamino)bicyclo[2.2.1]hepta-7-endo-yl benzoates (73 and 74). 
The same procedure described above to make benzoates 66 and 67 was used to obtain a 
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1:1 ratio of amino benzoate 73 and amino benzoate 74 as a yellow oil. Silica gel 
chromatography using 10:1 ethyl acetate:methanol eluant furnished amino benzoate 73 
(25 mg, 25% yield, Rf= 0.60) as a colorless oil and crude amino benzoate 74 (20 mg, 
20% yield, Rf= 0.72) as a pale yellow oil. Amino benzoate 74 (20 mg, 2.90 mmol) was 
converted to the HCl salt and recrystallized from ethyl acetate:CH2Cl2 to obtain pure 
product (10 mg, 50% yield).    
 
7-exo-(N,N-Dimethylamino) [2.2.1]bicyclohepta-2-endo-yl benzoate (73). 1H 
NMR (CDCl3): δ 1.23 (dd, J= 13.2, 3.9 Hz, 1H, C-3endo) 1.33 (ddd, J= 15.6, 9.0, 3.6 Hz, 
1H), 1.70 (tt, J= 12.9, 3.9 Hz, 1H, C-53exo or C-6exo), 1.79-190 (m, 2H), 2.13 (s, 1H, C-
1 or C-4), 2.16-2.22 (m, 1H0, 2.20 (s, 6H, (N(CH3)2), 2.62 (t, J= 4.2 Hz, 1H, C-7endo), 
5.16 (ddd, J= 8.1, 6.3, 3.3 Hz, 1H, C-2), 7.41 (t, J= 7.8 Hz, 2H, Ar3,5), 7.53 (tt, J= 7.8, 2.1 
Hz, 1H, Ar4), 8.02 (d, J= 7.2 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 18.97, 26.98, 36.50, 
38.91, 43.19, 44.36, 74.28, 74.32 (aliphatic), 128.24, 129.39, 130.38, 132.75 (aromatic), 
166.25 (OC=O).  
 
73·HCl. mp 190-196 ûC, decomposed. 1H NMR (CDCl3): δ 1.40-1.80 (m, 2H), 
2.04-2.08 (m, 1H), 2.22-2.40 (m, 2H), 2.41-2.59 (m, 2H), 2.80-3.10 (m, 8H), 5.21 (br s, 
1H, C-2), 7.44 (t, J= 8.1 Hz, 2H, Ar3,5), 7.57 (t, J= 7.5 Hz, 1H, Ar4), 8.00 (d, J= 7.2 Hz, 
2H, Ar2,6), 11.23 (br s, 1H, HCl). IR (neat): 2968, 2659, 2624, 1712, 1284, 1115,  























7-endo-(N,N-Dimethylamino) [2.2.1]bicyclohepta-2-endo-yl benzoate (74·HCl). 
mp 215-218 ûC. 1H NMR (CDCl3): δ 1.45-1.96 (m, 6H), 2.49 (t, J= 3 Hz, 1H), 2.88 (d, J= 
4.2 Hz, 3H, N(CH3), 2.94 (d, J= 4.5 Hz, 3H, N(CH3), 3.02-3.20 (m, 2H, C-7), 5.70-5.80 
(m, 1H, C-2), 7.40 (t, J= 7.5 Hz, 2H, Ar3,5), 7.53 (t, J= 7.2 Hz, 1H, Ar4), 7.96 (d, J= 7.8 
Hz, 2H, Ar2,6), 11.27 (br s, 1H). IR (neat): 2966, 2710, 2453, 1722, 1657, 1281, 1117, 
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 Work previously pursued in our group on 2-substituted-6-amino-5-
phenylbicyclo[2.2.2]octanes1 showed that the incorporation of an oxygen functionality at 
the C-2 position of the bicycle has the following trends: endo-benzoate-endo-amine 6 was 
more potent than the endo-alcohol-endo-amine, which was more potent than the C-2 
ketone (Figure 6.1). The incorporation of the benzoyl ester enhanced the potency of these 
compounds. In another set of experiments previously completed in our group,2 amines 16 
and 17 were synthesized. Both compounds contain a trans stereochemical arrangement at 
C-2 and C-3 with the only difference being the amino methyl substituent is endo in amine 
16 and exo in amine 17. Amines 16 and 17 were of interest because of the difference in 
the inhibitor potency in [3H]WIN 35,428 (WIN) binding at the DAT. This relatively 
minor variation in structure leads to a large difference in potency. The IC50 for the trans 
endo-amine 16 is 515 nM, whereas the trans exo-amine 17 is 2510 nM, a 5-fold increase. 
The work described in this chapter allows for the determination of the effect of 
incorporating a benzoate onto the [2.2.1]bicyclic scaffold of amines 16 and 17. In 
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addition, the 4-chlorobenzoate analogs were synthesized since it is known that the 
incorporation of a halogen on the phenyl ring generally increases the potency relative to 
the unsubstituted phenyl compound.2 The [3H]WIN 35,428 binding and DA uptake will 
indicate the importance of each benzoate and the 4-chlorophenyl at the C-2 position of 































WIN IC50= 515 nM
17
trans exo










An attractive route which places a ketone on the unsubstituted two-carbon bridge 
of 2-amino-3-phenylbicyclo[2.2.1]heptanes is shown in Figure 6.2. A double-Michael 
addition of tert-butyl acrylate to 2-cyclopentenone provides the trans bicyclic ketone 77.3 
The appearance of a doublet at δ 3.51 ppm in the 1H NMR spectrum of 77 with a 
coupling constant of 5.1 Hz for the proton α to the phenyl is consistent with retention of 
the trans stereochemical arrangement. The t-butyl ester 77 was hydrolyzed to the 
carboxylic acid by treatment with trifluoroacetic acid. A complete structure assignment of 
acid 78 was completed (Appendix N). Acid 78 was converted to an acid chloride with 
oxalyl chloride (79, monitored by the appearance of peaks in the IR at 1796 and 1757 cm-
1), aminated with dimethylamine, and recrystallized from ethyl acetate to give amide 80. 
The 1H NMR spectrum shows two singlets at δ 3.06 ppm and δ 2.97 ppm that integrate to 
3 protons each for the dimethyl amide moiety. Amide 80 was reduced with borane to 
provide exclusively the endo-hydroxy amine 81. The hydride was delivered to the least 
sterically hindered face of the bicycle to provide only the endo- alcohol 81. The 1H NMR 
spectrum has a peak at δ 4.32 ppm which we assign to the carbinol proton at C-2. The 
multiplicity, a doublet of triplets, is consistent with a proton in an exo position which 
couples with the exo proton at C-3 with a large coupling constant (10.5 Hz), couples to 
the endo proton at C-3 (4.2 Hz), and couples to the bridgehead proton at C-1 (4.2 Hz). 
The borate salt of the amine was formed during the reduction of amide 80 to amine 81 
but was not cleaved during the acidic work-up. The synthesis was continued with the 












































































Reagents: a) LDA, THF, - 78 °C; b) TFA; c) oxalyl chloride, DMF, CH2Cl2; d) 
NH(CH3)2, CH2Cl2, e) BH3, THF, -78 °C; f) benzoic acid, DEAD, PPh3, THF; and g) 








chloride gave the corresponding benzoates (82 and 83). The structure of benzoate 82 was 
resolved by x-ray analysis (Appendix O). Hydrolysis of the borate salts with a 3:1 
acetone:1M HCl mixture gave the corresponding free amines (86-87). The exo-benzoate 
84 and 4-chlorobenzoate 85 were obtained by Mitsunobu chemistry, using 
triphenylphosphine, diethylazodicarboxylate (DEAD), and benzoic acid or 4-
chlorobenzoic acid. The final products, benzoates 88 and 89, were purified by flash 
column chromatography.  
 
Pharmacology 




 Preliminary investigations in our group on 2-substituted-6-amino-5-
phenylbicyclo[2.2.2]octanes1 showed that the incorporation of a benzoate onto the 
[2.2.2]bicyclooctane increased the binding interaction at the DAT (Figure 6.1). 
Exploration on 2,3-disubstituted [2.2.1]bicycloheptanes pursued previously in our group2 
provided amines 16 and 17, which were synthesized in an effort to further evaluate 
structure-activity relationships that probe the active site of the DAT. In pursuit of the 
most potent of these two amines, 16, and utilizing the trend seen with the 
[2.2.2]bicyclooctanes, we incorporated a benzoyl ester onto the [2.2.1]bicycloheptane 
core. The approach we took involved synthesizing a series of trisubstituted 
[2.2.1]bicycloheptanes by double-Michael addition of tert-butyl acrylate and 
cyclopentenone. Based on the mechanism of the addition, only one product is obtained, 
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the trans ketone 77. This gave the same stereochemistry as in amine 16 at the C-5 and C-
6 stereocenters. Through a series of simple functional group interconversions, the endo 
and exo benzoates and 4-chlorobenzoates were obtained. The pharmacology results for 
























General Methods. The general methods can be found in the experimental section 
of Chapter 2.  
 
5-endo-tert-Butoxycarbonyl- 6-exo-phenyl[2.2.1]bicyclohept-2-one (77). 2-
cyclopentenone (4.08 mL, 48.8 mmol) was added to a cooled (-78 ºC) stirred solution of 
lithium diisopropyl amide (1.8 M, 36.6 mL, 65.9 mmol) in 150 mL of anhydrous THF. 
The solution was stirred at 78 ºC for 1.5 h, and tert-butyl phenyl acrylate (4.98 mL, 24.4 
mmol) was added. The reaction mixture was warmed to room temperature and stirred 
overnight. Distilled water (50 mL) was added to the reaction mixture and the THF was 
removed under reduced pressure. The residual aqueous layer was extracted with CH2Cl2 
(3 x 75 mL), the organic extracts were combined and dried over MgSO4, filtered, and the 
solvent removed under reduced pressure to afford crude product (8.84 g, 100% yield). 
The crude product was dissolved in 50 mL of CH2Cl2 and the solution was passed 
through a plug of silica gel to obtain 6.52 g of a light brown solid (94% yield). 1H NMR 
(CDCl3): δ 1.45 (s, 9H, t-butyl), 1.86 (dd, J=10.5, 1.2 Hz, 1H, C-7), 2.10-2.21 (m, 3H, C-
3, C-7), 2.84 (s, 1H, C-4), 3.02-3.11 (m, 2H, C-1, C-6), 3.51 (d, J=5.1, 1H, C-5), 7.20
7.35 (m, 5H, Ar). 13C NMR (CDCl3): δ 28.07, 36.91, 39.82, 40.01, 43.50. 54.55, 56.53, 
81.20 (aliphatic), 126.63, 126.92, 128.73, 142.43, 172.05, 214.90 (C=O).  
 
5-endo-Carboxyl- 6-exo-phenyl[2.2.1]bicyclohept-2-one (78). A mixture of 
keto ester 77 (6.52 g, 22.8 mmol) and trifluoroacetic acid ( 17 mL, 220 mmol) was stirred 
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for 2 d. The TFA was removed under reduced pressure to obtain crude product (6.35 g, 
100% yield). The brown crude product was recrystallized from a 9:1 mixture of 
hexane:benzene to obtain 78 as a white crystalline solid. 1H NMR (CDCl3): δ1.92 (d, 
J=10.5 Hz, 1H, C-7), 2.142.32 (m, 3H, C-3, C-7), 2.90 (s, 1H, C-4), 3.16 (s, 1H, C-1), 
3.25 (t, J= 4.8 Hz, 1H, C-6), 3.53 (d, J=5.7, 1H, C-5), 7.20-7.37 (m, 5H, Ar). 13C NMR 
(CDCl3): δ 37.04, 39.79, 40.25, 43.65, 53.33, 56.43 (aliphatic), 126.81, 126.99, 128.89, 
141.46, 178.88, 215.56 (C=O). IR cm-1 (neat): 3434, 1749, 1709. 
 
5-endo-Carbonyl chloride- 6-exo-phenyl[2.2.1]bicyclohept-2-one (79). Oxalyl 
chloride (4.83 mL, 55.2 mmol) and two drops of dimethylformamide was added to a 
mixture of acid 78 (6.35 g, 27.6 mmol) in CH2Cl2 (150 mL) at 0 °C.  To was added. The 
reaction mixture was stirred for 4 h and the solvent was removed under reduced pressure 
to give 5.72 g of crude product (84% yield) which was used without further purification. 
1H NMR (CDCl3): δ 1.11 (dddd, J=15.9, 11.4, 4.8, 2 Hz, 1H, C-8endo), 1.25-1.38 (m, 
2H, C-7endo, C-5exo) 1.49 (dddd, J=15.9, 9.9, 5.4, 3 Hz, 1H, C-8exo), 1.61 (septet, J=3 
Hz, 1H, C-4), 1.66 (ddd, J=13.8, 9.6, 3 Hz, 1H, C-5endo) 1.71-1.87 (m, 2H, C-3) 2.17 
(dddd, J=13.8, 11.4, 5.1, 3 Hz, 1H, C-7exo), 2.37 (q, J=3 Hz, 1H, C-1), 2.43 (br s, 1H, 
OH), 3.81-03.92 (m, 1H, C-6). 13C NMR (C6D6): δ 15.88, 24.52, 27.85, 36.30, 43.36, 
51.63, 65.37 (aliphatic), 214.68 (C=O). IR (neat): 2982, 1796, 1757, 1169, 756, 707 cm-1. 
 
5-endo-Amido- 6-exo-phenyl[2.2.1]bicyclohept-2-one (80). Dimethyl amine 
was added subsurface for 30 min to a mixture of acid chloride 79 (5.72 g, 23.1 mmol) in 
dry CH2Cl2 (200 mL) at 0 ºC. The reaction mixture was stirred overnight, followed by the 
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removal of the excess dimethyl amine under reduced pressure. CH2Cl2 (50 mL) was 
added to the mixture, and the solution was washed with H2O (3 x 20 mL), dried over 
MgSO4, filtered, and the solvent removed under reduced pressure to give 6.5 g of crude 
product (100% yield). The product was recrystallized from ethyl acetate to obtain a light 
brown solid, mp 110-113 ûC. 1H NMR (CDCl3): δ 1.89-2.01 (m, 2H), 2.22-2.33 (m, 2H), 
2.85 (s, 1H), 2.97 (s, 3H, N(CH3)), 2.99 (s, 1H), 3.06 (s, 3H, N(CH3)) 3.29 (ddd, J=5.7, 
4.2, 1.5 Hz, 1H ), 3.86 (d, J=6.0 Hz, 1H), 7.17-7.31 (m, 5H, Ar). 13C NMR (CDCl3): δ 
35.75, 36.94, 37.56, 38.88, 39.08, 43.77, 51.75, 55.82 (aliphatic), 126.28, 126.58, 128.53, 
142.84, 171.13 (C=ON(CH3)2), 214.41 (C=O).  
 
5-endo-((N,N-Dimethylamino)methyl)-6-exo-phenyl[2.2.1]bicycloheptan-
endo-2-ol borate salt (81). 1M borane in THF (98 mL, 101 mmol) was added to a 
mixture of amide 80 (6.5 g, 25.3 mmol) in THF (100 mL). The reaction was heated to 
reflux for 2 d, followed by the addition of 6 M HCl until the mixture was acidic (pH<2). 
The mixture was then made basic by addition of NaOH pellets and the solvent was 
removed under reduced pressure. Brine (30 mL) was added and the mixture was extracted 
with CH2Cl2 (3 x 75 mL), the organic extracts combined, dried over MgSO4, filtered, and 
the solvent removed under reduced pressure to obtain 6 g of crude product. The crude 
product was dissolved in ethyl acetate (50 mL) and the solution was passed through a 
plug of silica gel. The solvent was removed to give 81 as a white solid (4.90 g, 73% 
yield). 1H NMR (CDCl3): δ 1.2-1.32 (m, 1H, C-7), 1.45 (dd, J=11.7, 1.5 Hz, 1H, C-3), 
1.80-1.96 (m, 2H, C-3, C-7), 2.04 (s, 1H, C-1), 2.40 (s, 3H, N(CH3)2), 2.47 (s, 3H, 
N(CH3)2), 2.49 (s, 1H, C-4 ), 2.64-2.78 (m, 1H, C-5), 2.97 (dd, J=13.5, 5.1 Hz, 1H, C-8), 
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3.08 (dd, J=6.9, 1.2 Hz, 1H, C-6), 3.15 (dd, J=13.2, 6.9 Hz, 1H, C-8), 4.32 (dt, J=10.5, 
4.2 Hz, 1H, C-2), 7.16-7.31 (m, 5H, ar). 13C NMR (CDCl3): δ 31.46, 36.97, 41.98, 43.79, 
43.80, 51.24, 51.39, 52.36, 65.79, 72.27 (aliphatic), 126.11, 127.57, 128.56, 144.80.  
 
5-endo-((N,N-Dimethylamino)methyl)-6-exo-phenyl[2.2.1]bicycloheptan-2-
benzoylborate salts, (82 and 83). The transformation from alcohol 81 to benzoate 82 
and 83 is illustrated. Alcohol 81 (333 mg, 1.29 mmol) in benzene (1 mL) was added to a 
solution of benzoyl chloride (237 µL, 2.04 mmol), triethylamine (948 µL, 6.8 mmol), 
dimethylaminopyridine (2 mg) in benzene (2 mL). The reaction mixture was heated to 50 
°C for 2 d. The solvent was removed by reduced pressure, CH2Cl2 ( 40 mL) was added 
and the mixture was washed with saturated NaHCO3 (3 x 30 mL). The organic layer was 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure to 
obtain 566 mg (100% yield) of crude product. The product was purified by column 
chromatography using CH2Cl2 as the eluant, followed by recrystallization from 7:2:1 
hexane:CH2Cl2:ethyl acetate to give benzoate 83 (200 mg, 36% yield) as a white solid. 
 
5-endo-((N,N-Dimethylamino)methyl)-6-exo-phenylbicyclo[2.2.1]heptan-2- 
endo-benzoyl borate salt, (82). (125 mg, 30% yield, white solid). 1H NMR (CDCl3): δ 
1.53-1.60 (m, 2H, C-3, C-7endo), 1.96 (dt, J=10.8, 1.8 Hz, 1H, C-7), 2.17 (dddd, J=14.4, 
10.2, 4.5, 1.8 Hz, 1H, C-7exo), 2.47 (s, 3H, N(CH3)2), 2.49 (s, 3H, N(CH3)2), 2.63 (s, 
1H), 2.65 (s, 1H), 2.80 (m, 1H, C-5), 2.98 (d, J=6.9 Hz, 1H, C-6), 3.02 (dd, J=13.8, 4.5 
Hz, 1H, C-8), 3.16 (dd, J=13.8, 6.9 Hz, 1H, C-8), 5.27 (dt, J=10.8, 4.5 Hz, 1H, C-2), 
7.18-7.34 (m, 5H, Ar), 7.50 (tt, J=7.5, 1.5 Hz, 2H, Ar3,5), 7.61 (tt, J=7.2, 1.5 Hz, 1H, 
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Ar4), 8.1 (dd, J=7.2, 1.5 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 29.44, 36.53, 41.40, 
43.04, 45.27, 49.07, 51.37, 52.09, 65.72, 75.49 (aliphatic), 126.45, 127.47, 128.54, 
129.42, 130.15, 133.14, 143.66, 166.28 (C=O). MS (EI) M+ 349. Elem Anal cald for 
C23H30NO2B: C, 76.04; H, 8.32; N, 3.86; O, 8.81; B, 2.98. Found: C, 76.24; H, 8.24; N, 
3.85.   
  
5-endo-((N,N-Dimethylamino)methyl)-6-exo-phenylbicyclo[2.2.1]heptan-2- 
endo- 4-chlorobenzoyl borate salt,(83). 1H NMR (CDCl3): δ 1.52-1.61 (m, 2H, C-3, C-
7endo), 1.96 (dt, J=10.8, 1.5 Hz, 1H, C-7), 2.17 (ddd, J=13.8, 9.9, 4.2 Hz, 1H, C-7exo), 
2.47 (s, 3H, N(CH3)2), 2.48 (s, 3H, N(CH3)2), 2.64 (s, 1H, C-1/C-4), 2.65 (s, 1H, C-1/C-
4), 2.74-2.84 (m, 1H, C-5), 2.92 (d, J=6.6 Hz, 1H, C-6), 3.01 (dd, J=13.8, 4.5 Hz, 1H, C-
8), 3.16 (dd, J=13.5, 7.2 Hz, 1H, C-8), 5.25 (dt, J=10.5, 4.5 Hz, 1H, C-2), 7.19-7.35 (m, 
5H, Ar), 7.47 (dt, J=8.7, 2.1 Hz, 2H, Ar2,6), 8.01 (dt, J=8.4, 2.1 Hz, 2H, Ar3,5) . 13C 
NMR (CDCl3): δ 29.35, 36.57, 41.37, 43.21, 45.27, 48.93, 51.31, 52.09, 65.64, 75.84 




benzoate, (86 and 87). The free amine was obtained by stirring 180 mg of the borate salt 
in 4 mL of a 3:1 mixture of acetone and 1M HCl for 10 min. The solvent was removed 
under reduced pressure and saturated NaHCO3 (30 mL) was added. The aqueous layer 
was extracted with CH2Cl2 (3 x 50 mL), the organic extracts were combined, dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure to obtain 170 mg 
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of crude product. The product was purified by flash column chromatography using a 5:1 
ethyl acetate:methanol eluant to give 86 (169 mg, 98% yield) as a colorless oil. 
 
5-endo-((N,N-Dimethylamino)methyl)-6-exo-phenyl[2.2.1]bicycloheptan-2- 
endo-benzoate, (86). 1H NMR (CDCl3): δ 1.58 (dd, J=10.8, 3.0 Hz, 1H, C-7), 1.61 (dt, 
J=14.1, 3.6 Hz, 1H, C-3endo), 1.87 (dp, J=10.8, 1.8 Hz, 1H, C-7), 2.11 (dddd, J=14.4, 
10.5, 4.8, 1.2 Hz, 1H, C-7exo), 2.22 (s, 6H, N(CH3)2), 2.30-2.40 (m, 1H, C-5), 2.41 (dd, 
J=11.7, 5.1 Hz, 1H, C-8), 2.49 (d, J=3.0 Hz, 1H, C-4), 2.68 (dd, J=11.7, 1.8 Hz, 1H, C-
8), 2.76 (dd, J=4.2, 1.2 Hz, 1H, C-1), 2.94 (d, J=5.1 Hz, 1H, C-6), 5.29 (dt, J=10.5, 4.5 
Hz, 1H, C-2), 7.14-7.34 (m, 5H, Ar), 7.47 (tt, J=7.2, 1.2 Hz, 2H, Ar3,5), 7.58 (tt, J=7.2, 
1.2 Hz, 1H, Ar4), 8.07 (dm, J=8.1 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 29.26, 36.67, 
39.44, 43.06, 45.77, 46.76, 47.72, 60.42, 75.82 (aliphatic), 125.8, 127.2, 128.4, 129.4, 
130.4, 132.9, 145.3, 166.3 (C=O).  
 
86·HCl. (157 mg, 93 % yield). mp 240-244 ûC, . 1H NMR (D2O): δ 1.41 (d, 
J=14.4 Hz, 1H), 1.53 (br s, 1H), 1.84 (br s, 1H), 2.03 (br s, 1H), 2.39-2.46 (m, 3H), 2.63 
(s, 3H, N(CH3)2), 2.70 (s, 3H, N(CH3)2), 2.84 (br s, 1H), 3.18 (br s , 1H), 3.32 (d, J=10.5 
Hz, 1H), 5.03 (br s, 1H, C-2), 7.21 (br s, 5H, Ar), 7.41 (d, J=5.4 Hz, 2H, Ar3,5), 7.54 (br 
s, 1H, Ar4), 7.91 (br s, 2H, Ar2,6). IR (neat): 2954, 2659, 1726, 1277, 1115, 722 cm-1. 
MS (EI) M+ 349. Elem Anal cald for C23H28NO2Cl·0.29 H2O·0.1 HCl: C, 69.97; H, 7.30; 




endo-(4-chlorophenyl) benzoate, (87). (59 mg, 36% yield). pale yellow oil. 1H NMR 
(CDCl3): δ 1.58 (dd, J=9.6, 1.8 Hz, 1H, C-7), 1.61 (dt, J=14.1, 3.6 Hz, 1H, C-3endo), 
1.88 (dp, J=10.8, 2.1 Hz, 1H, C-7), 2.11 (dddd, J=15.0, 10.2, 4.5, 1.2 Hz, 1H, C-7exo), 
2.22 (s, 6H, N(CH3)2), 2.27-2.38 (m, 1H, C-5), 2.39 (dd, J=11.7, 5.4 Hz, 1H, C-8), 2.49 
(d, J=3.0 Hz, 1H, C-4), 2.64 (dd, J=11.7, 1.8 Hz, 1H, C-8), 2.76 (dd, J= 4.2, 1.2 Hz, 1H, 
C-1), 2.88 (d, J=5.4 Hz, 1H, C-6), 5.28 (dt, J=10.8, 4.2 Hz, 1H, C-2), 7.16-7.33 (m, 5H, 
Ar), 7.45 (dt, J=9.0, 2.1 Hz, 2H, Ar2,6), 8.00 (dt, J=8.7, 2.1 Hz, 2H, Ar2,6) . 13C NMR 
(CDCl3): δ 29.23, 36.70, 39.44, 43.09, 45.86, 46.91, 47.64, 60.50, 76.21 (aliphatic), 
125.93, 127.21, 128.45, 128.80, 128.89, 130.85, 139.38, 145.33, 165.53 (C=O).  
 
 87·HCl. (55 mg, 93 % yield). mp193-196 ûC.  1H NMR (D2O): δ 1.43 (dm, 
J=15.0 Hz, 1H, C-3), 1.56 (dm, J=11.1 Hz, 1H, C-7), 1.87 (dm, J=11.1 Hz, 1H, C-7), 
2.00-2.12 (m, 1H, C-3), 2.41 (br s, 1H), 2.46-2.56 (m, 2H, C-5), 2.65 (s, 3H, N(CH3)2), 
2.71 (s, 3H, N(CH3)2), 2.85 (d, J=6.3 Hz, 1H, C-6), 3.19 (dd, J=13.2, 5.4 Hz, 1H, C-8), 
3.34 (dd, J=13.5, 9.6 Hz, 1H, C-8), 5.15-5.30 (m, 1H, C-2), 7.15-7.30 (m, 5H, Ar), 7.41 
(d, J=8.4 Hz, 2H, Ar2,6), 7.88 (d, J=8.4 Hz, 2H, Ar3,5). IR (neat):  2961, 2645, 1726, 
1270, 1129, 722 cm-1. MS (EI) M+ 383. Elem Anal cald for C23H27NO2Cl2·0.1HCl 
·0.74H2O: C, 63.17; H, 6.57; N, 3.20; O, 10.04; Cl, 17.02. Found: C, 63.17; H, 6.20; N, 
3.22; Cl, 17.12.   
 
5-endo-((N,N-Dimethylamino)methyl)-6-exo-phenyl[2.2.1]bicycloheptan-2- 
exo-benzoyl borate salt, (84 and 85). The transformation from 81 to 84 is illustrated. 
DEAD (.658 mL, 4.18 mmol) was added to a mixture of benzoic acid (562 mg, 4.6 
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mmol), triphenylphosphine (1.15 g, 4.39 mmol), and borane alcohol 81 (513 mg, 1.98 
mmol) in THF (2 mL). The mixture was stirred at room temperature overnight and the 
solvent was removed by reduced pressure. The product was purified by flash column 
chromatography using 7:2:1 hexane:CH2Cl2:ethyl acetate as the eluant, followed by 
recrystallization from 7:2:1 hexane:CH2Cl2:ethyl acetate to give 153 mg of benzoate 84 
(150 mg, 21% yield) as a colorless oil.  
 
5-endo-(N,N-Dimethylaminomethyl)-6-exo-phenylbicyclo[2.2.1]heptan-2- 
endo-benzoyl borate salt, (84). 1H NMR (CDCl3): δ 1.65 (dm, J=14.7 Hz, 1H, C-3endo), 
1.80 (dd, J=10.5, 1.5 Hz, 1H, C-7), 1.89 (dm, J=10.5 Hz, 1H, C-7), 2.13 (d, J=6.3 Hz, 
1H, C-1/C-4), 2.24 (ddd, J=14.4, 6.9, 2.1 Hz, 1H, C-3 exo), 2.43 (s, 3H, N(CH3)2), 2.48 
(s, 1H, C-1/C-4), 2.49 (s, 3H, N(CH3)2), 2.59-2.74 (m, 2H, C-5, C-6), 2.84 (dd, J=13.5, 
4.8 Hz, 1H, C-8), 3.02 (dd, J=13.8, 6.6 Hz, 1H, C-8), 5.00 (dd, J=6.9, 1.2 Hz, 1H, C-2), 
7.19-7.36 (m, 5H, Ar), 7.42 (tt, J=7.8, 1.8 Hz, 2H, Ar3,5), 7.54 (tt, J=7.5z, 1.8 Hz, 1H, 
Ar4), 8.00 (dt, J=6.6, 1.5 Hz, 2H, Ar2,6). 13C NMR (CDCl3): 32.46, 35.22, 40.29, 42.71, 
50.13, 50.86, 51.34, 52.51, 66.16, 77.28 (aliphatic), 126.60, 127.27, 128.30, 128.73, 
129.42, 130.32, 132.91, 143.21, 166.02 (C=O). Elem Anal cald for C23H29NO2BCl: C, 
69.45; H, 7.35; N, 3.52; O, 8.04; B, 2.72; Cl, 8.91. Found: C, 69.36; H, 7.29; N, 3.48; Cl, 
8.97.   
 
5-endo-(N,N-Dimethylaminomethyl)-6-exo-phenylbicyclo[2.2.1]heptan-2- 
endo-(4-chlorophenyl)benzoyl borate salt, (85).(45 mg, 21% yield) pale yellow oil. 1H 
NMR (CDCl3): δ 1.64 (dm, 1H, C-3), 1.79 (dd, J=10.5, 1.5 Hz, 1H, C-7), 1.90 (dm, 
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J=10.5 Hz, C-7), 2.12 (d, J=6.6 Hz, 1H) 2.24 (ddd, J=14.4, 6.6, 2.1, 1Hz, C-3) 2.43 (s, 
3H, N(CH3)2), 2.46 (s, 1H), 2.50 (s, 3H, N(CH3)2), 2.60-2.72 (m, 2H, C-5, C-6), 2.83 (dd, 
J=13.5, 4.5 Hz, 1H, C-8), 3.02 (dd, J=13.5, 6.9 Hz, 1H, C-8), 4.98 (dm, J=6.9 Hz, 1H, C-
2), 7.20-7.36 (m, 5H, Ar), 7.40 (dt, J=8.4, 2.1 Hz, 2H, Ar2,6), 7.93 (dt, J=8.7, 2.4 Hz, 2H, 
Ar3,5) . 13C NMR (CDCl3): δ 32.45, 35.22, 40.28, 42.69, 50.11, 50.84, 51.33, 52.51, 
66.16, 77.6 (aliphatic), 126.66, 127.27, 128.66, 128.77, 130.83, 139.37, 143.13, 165.17 
(C=O). Elem Anal cald for C23H30NO2B: C, 76.04; H,8.32; N, 3.86; O, 8.81; B, 2.98. 
Found: C, 76.23; H, 8.33; N, 3.87.   
 
5-endo-((N,N-Dimethylamino)methyl)-6-exo-phenyl[2.2.1]bicycloheptan-2- 
benzoates (88 and 89). The same procedure as is shown for benzoate 86 was used for the 
conversion of benzoates 84 and 85 to free amines 88 and 89. 
 
5-endo-((N,N-Dimethylamino)methyl)-6-exo-phenyl[2.2.1]bicycloheptan-2- 
endo-benzoate (88). (60 mg, 56% yield). pale yellow oil.1H NMR (CDCl3): δ 1.60 (dt, 
J=14.1, 2.4 Hz, 1H, C-3endo), 1.79 (d, J= 11.4 Hz, 1H, C-7), 1.81 (d, J=11.4 Hz, 1H, C-
7), 2.08 (d, J=6.3 Hz), 2.10-2.20 (m, 1H, C-7exo), 2.19 (s, 6H, N(CH3)2), 2.25 (d, J=5.7 
Hz, 1H), 2.28 (dd, J=12.7, 5.1 Hz, 1H, C-8), 2.44 (dd, J=12.0, 1.8 Hz, 1H, C-8), 2.50-
2.56 (m, 1H, C-5), 2.57 (s, 1H), 4.98 (dd, J=6.9, 2.1 Hz, 1H, C-2), 7.16-7.34 (m, 5H, Ar), 
7.41 (tt, J=8.1, 1.5 Hz, 2H, Ar3,5), 7.53 (tt, J=7.8, 1.2 Hz, 1H, Ar4), 8.02 (dt, J=7.5, 1.5 
Hz, 2H, Ar2,6) . 13C NMR (CDCl3): δ 32.46, 35.19, 38.09, 45.77, 46.29, 48.49, 48.85, 
60.89, 77.82 (aliphatic), 125.96, 127.04, 128.22, 128.39, 129.44, 130.53, 132.76, 144.78, 
166.02 (C=O).  
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88·HCl. (55 mg, 92% yield). mp 241-243 ûC, pale yellow solid. 1H NMR (D2O): 
δ 1.55 (dm, J=14.1 Hz, 1H, C-3), 1.72 (d, J=12 Hz, 1H, C-7), 1.77 (d, J=12 Hz, 1H, C-7), 
2.06 (dd, J=14.1, 6.9 Hz, 1H, C-3), 2.13 (d, J=6.9 Hz, 1H), 2.21-2.36 (m, 1H), 2.33 (s, 
6H, N(CH3)2), 2.44 (s, 1H), 2.67 (s, 1H), 3.09 (dd, J=13.5, 5.4 Hz, 1H, C-8), 3.22 (dd, 
J=13.2, 9.9 Hz, 1H, C-8), 4.79 (dm, J=4.8 Hz, 1H, C-2), 7.16-7.30 (m, 5H, Ar), 7.36 (t, 
J=7.5 Hz, 2H, Ar3,5), 7.52 (t, J=7.5 Hz, 1H, Ar4), 7.84 (d, J=7.5 Hz, 2H, Ar2,6). IR 
(neat): 2973, 2696, 1716, 1275, 762 cm-1. MS (EI) M+ 349. Elem Anal cald for 
C23H28NO2Cl: C, 71.58; H, 7.31; N, 3.63; O, 8.29; Cl, 9.19. Found: C, 71.16; H, 7.29; N, 




endo-(4-chlorophenyl) benzoate (89). (130 mg, 96% yield). pale yellow oil.  1H NMR 
(CDCl3): δ 1.58 (dm, J=14.4 Hz, 1H, C-3), 1.78 (s, 2H), 2.07 (d, J=6.3 Hz, 1H), 2.10-
2.19 (s, 6H, N(CH3)2), 2.24-2.31 (m, 2H), 2.44 (dd, J=10.2, 2.1 Hz, 1H, C-8), 2.51-2.56 
(m, 1H), 2.56 (s, 1H, C-8), 4.96 (dd, J=6.9, 2.4 Hz, 1H, C-2), 7.16-7.32 (m, 5H, ar), 7.39 
(dt, J=8.7, 2.7 Hz, 2H, Ar2,6), 7.95 (dt, J=8.7, 2.4 Hz, 2H, Ar2,6). 13C NMR (CDCl3): δ 
32.46, 35.21, 38.09, 45.79, 46.29, 48.47, 48.84, 60.91, 78.13 (aliphatic), 126.01, 127.04, 
128.42, 128.59, 128.92, 130.87, 139.2, 144.72, 165.23 (C=O).  
 
89·HCl. (60 mg, 46% yield). mp 244-247 ûC, pale yellow solid. 1H NMR (D2O): 
δ 1.59 (m, 1H), 1.72-1.86 (m, 1H), 2.04-2.14 (m, 1H), 2.17 (d, J=6.9 Hz, 1H), 2.26-2.36 
(m, 1H), 2.39 (s, 1H), 2.46 (s, 1H) 2.69 (s, 3H, N(CH3)2), 3.08-3.16 (m, 1H), 3.20-3.30 
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(m, 1H), 4.81-4.87 (m, 1H, C-2), 7.16-7.31 (m, 5H, Ar), 7.38 (d, J=8.7 Hz, 2H, Ar2,6), 
7.83 (d, J=8.7 Hz, 2H, Ar3,5). IR (neat): 2960, 2683, 1629, 1123, 762 cm-1. MS (EI) M+ 
383. Elem Anal cald for C23H27NO2Cl2: C, 65.72; H, 6.47; N, 3.33; O, 7.61; Cl, 16.87. 
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To continue probing the constraints of binding at the DAT, additional analogs are 
proposed in this chapter for synthesis and pharmacological evaluation. The proposed 
compounds take into consideration the importance of the relative stereochemistry and the 
regiochemistry of the amine and phenyl group. Also, the optimal length between the 
nitrogen and the phenyl ring is explored by varying the number of carbons in a tether. 
This will allow for the construction of further SARs which, in turn, provides an insight 
into the binding at the DAT.  
 
Chemistry 
Synthesis of 2-amino-7-exo-norboranyl benzoate (76 and 78). 
 Since the other regioisomer of 71 (i.e. the exo-alcohol-exo-benzoate) was 




































Reagents: a) 15% KOH, THF; b) DMSO, oxalyl chloride, Et3N, CH2Cl2; c)NaBH4, 












to synthesize benzoates 76 and 78 (Figure 7.1). Amino benzoate 76 can be made by the 
hydrolysis of benzoate 68 to the corresponding alcohol, the alcohol subjected to Swern 
oxidation conditions, reduced with NaBH4 to obtain a mixture of endo and exo alcohols, 
followed by benzoylation and separation. Amino benzoate 78 can be made by similar 
chemistry; hydrolysis of benzoate 69, Swern oxidation of the corresponding alcohol, a 
 120
borane reduction to obtain solely the exo-alcohol, followed by benzoylation to obtain the 
final product.   
  
Prospective Synthesis of 2-amino-3-phenyl-7-norboranyl benzoates (79). 
The work described in this section takes advantage of the oxygen functionality on 
the C-7 carbon on the [2.2.1] skeleton, i.e. in Chapter 6 (Figure 6.2), and places an arene 
(phenyl, 4-chlorophenyl, benzyl, phenethyl, etc.) substituent at the C-5 position of the 
bicycle. Placing an oxygen functionality at the C-7 position of the [2.2.1]bicyclic scaffold 
and the introduction of an arene at the C-5 position allows for comparison to previously 
synthesized 6-(N,N-dimethylamino)-5-phenyl bicyclo[2.2.2]octanes.1 The substitution at 











































Figure 7.2. Regiochemistry comparison of C-2 substituted [2.2.2]octanes (A), C-




between carbons 2 and 3 on the triisubstituted  [2.2.2]octanes A and C (Figure 7.2). This 
chemistry can be achieved by selectively protecting diol 60 on the two-carbon bridge 
using TMSCl (Figure 7.3). The alcohol on the C-7 carbon can then be protected using 
benzyl chloride, followed by the hydrolysis of the TMS protecting group at the C-2 
position. The alcohol is then exposed to Swern oxidation conditions, followed by addition 
of a phenyl or 4-chlorophenyl Grignard reagent to the ketone. Dehydration of the 
Grignard adduct, hydroboration of the resulting alkene, and exposing the alcohol to 
Swern oxidation conditions will provide a ketone at the C-6 position on the bicycle. 
Reductive amination of the ketone and concomitant deprotection of the benzyl group 
gives diastereomeric amino alcohols, which will be separated by column 
chromatography. The amino alcohol will then be exposed to Swern oxidation conditions, 
reduced with sodium borohydride, and followed by benzoylation to obtain the 



























































Reagents: a) HClO4, H2O; b) LDA, TMSCl, -78 ûC; c) NaH, benzyl chloride, CH2Cl2; d) 
1) HCl, THF; 2) Swern oxidation conditions; e) phenyl or 4-chlorophenyl magnesium 
bromide, ether, -20 ûC, f) p-TSA, toluene, heat; g) BH3, H2O2, THF; h) Swern oxidations 
conditions, i) 1) NH(CH3)2·HCl, Et3N; and 2) H2, Pd/C, CH2Cl2; j) 1) Swern oxidation 
















1. Javanmard, S. Synthesis and pharmacology of site-specific cocaine abuse treatment 





































































Signal a at δ 2.60 ppm in the 1H NMR (Figure A.1) appears as a quartet with a 
coupling constant of 3 Hz, which can be assigned to the bridgehead carbon on C-1. This 
bridgehead carbon is coupled to one proton on C-6 and two protons on C-7, apparently 
with similar coupling constants. Signal b at δ 2.40 ppm, was assigned to the exo proton 
on C-6 since this is the only proton that couples to protons in cis (9.3 Hz, C-5) and trans 
(4.5 Hz, C-5) methinine positions on the bicycle, and is coupled to a bridgehead proton 
(3.0 Hz, C-1). Signal d at δ 2.21-2.23 ppm was assigned to the bridgehead proton at C-4 
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and the dimethylamine protons (7H). The signals c (δ 2.30 ppm) and e (δ 2.18 ppm) were 
assigned to the endo and exo protons on C-3, respectively. These two signals both contain 
geminal coupling (18 Hz), coupling to the bridgehead proton at C-4 (2.1 Hz), and a long 
range in-plane W-coupling to the exo protons on C-5 and C-8 (2.1 Hz) as illustrated in 
the above structure with the highlighted bonds. The peak at δ 1.93 (quartet of triplets), 
signal f, was assigned to the exo proton on C-5. The exo proton on C-5 is the only proton 
on the bicycle, which has geminal coupling (13.2 Hz, C-5 endo), cis coupling (9.3 Hz, C-
6 exo), coupled to the bridgehead proton at C-4 (3.0 Hz), and a long range in-plane W-
coupling with the exo proton on C-2. It is this long range W-coupling between the exo 
proton on C-2 and the exo proton on C-5 and the cis coupling between the exo proton on 

















































































The stereochemistry at the C-6 stereocenter is the opposite of that assigned to 
amino ketone 19 (Appendix A).  Signal a (δ 3.89 ppm) was assigned to the endo proton 
of the hydroxy substituted methine, C-2. The multiplicity of this peak, dddd, arises from a 
cis coupling with the endo proton on C-3 (9.6 Hz), a trans coupling with the exo proton 
on C-3 (6.6 Hz), coupling to the bridgehead proton on C-1 (3.3 Hz), and a long range in-
plane W-coupling with the exo proton on C-7 (0.9 Hz) as illustrated by the highlighted 
bonds in the structure above. Since this is the only arrangement on the bicycle, which 
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would allow W-coupling of the proton on C-2, this piece of evidence establishes the 
stereochemistry at the C-2 stereocenter. The relative stereochemical assignment was 









































































Table B.1. Crystal data and structure refinement for amino alcohol 24. 
   
   
      Identification code   coons3  
   
      Empirical formula    C10 H21 N O2  
   
      Formula weight    187.28  
   
      Temperature    203(2) K  
   
      Wavelength    0.71073 A  
   
      Crystal system, space group  Monoclinic,  P2(1)/c  
   
      Unit cell dimensions   a = 8.4903(6) A   alpha = 90 deg.  
             b = 11.7029(9) A    beta = 98.055(2) deg.  
            c = 21.9146(16) A   gamma = 90 deg.  
   
     Volume     2156.0(3) A^3  
   
      Z, Calculated density   8,  1.154 Mg/m^3  
   
     Absorption coefficient   0.079 mm^-1  
   
      F(000)     832  
   
      Crystal size    0.65 x 0.54 x 0.15 mm  
   
      Theta range for data collection  1.88 to 25.05 deg.  
   
      Limiting indices    -10<=h<=7, -13<=k<=13, -26<=l<=20  
   
      Reflections collected / unique  11043 / 3810 [R(int) = 0.0381]  
   
      Completeness to theta = 25.05  99.9 %  
   
      Absorption correction   None  
   
      Max. and min. transmission  0.9880 and 0.9508  
   
      Refinement method   Full-matrix least-squares on F^2  
   
      Data / restraints / parameters  3810 / 0 / 266  
   
      Goodness-of-fit on F^2   0.857  
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      Final R indices [I>2sigma(I)]  R1 = 0.0380, wR2 = 0.0859  
   
      R indices (all data)   R1 = 0.0727, wR2 = 0.0921  
   
      Extinction coefficient   0.0017(6)  
   




Table B.2. Atomic coordinates ( x 10^4) and equivalent isotropic displacement 
parameters (A^2 x 10^3) for amino alcohol 24. U(eq) is defined as one third of the trace 
of the orthogonalized Uij tensor.  
   
         ________________________________________________________________  
   
                          x  y  z  U(eq)  
         ________________________________________________________________  
   
O(1) 7581(1) 8615(1) 2041(1) 37(1)  
N(1) 11034(2) 10938(1) 1449(1) 29(1)  
C(1) 9163(2) 9258(1) 1258(1) 25(1)  
C(2) 8218(2) 9600(1) 1772(1) 28(1)  
C(3) 6840(2) 10381(1) 1507(1) 37(1)  
C(4) 6891(2) 10600(1) 828(1)  34(1)  
C(5) 8477(2) 11128(1) 747(1)  39(1)  
C(6) 9871(2) 10334(1) 999(1)  27(1)  
C(7) 8080(2) 8673(1) 737(1)  33(1)  
C(8) 6701(2) 9469(1) 482(1)  45(1)  
C(9) 12290(2) 10183(2) 740(1)  44(1)  
C(10) 11800(2) 11864(1) 1142(1) 47(1)  
O(1') 2557(1) 7235(1) 2070(1) 33(1)  
N(1') 5766(2) 4821(1) 1373(1) 34(1)  
C(1') 3954(2) 6540(1) 1240(1) 26(1)  
C(2') 3086(2) 6228(1) 1782(1) 28(1)  
C(3') 1635(2) 5499(2) 1550(1) 41(1)  
C(4') 1557(2) 5268(1) 866(1)  37(1)  
C(5') 3086(2) 4677(1) 753(1)  41(1)  
C(6') 4540(2) 5447(1) 955(1)  30(1)  
C(7') 2822(2) 7155(1) 739(1)  33(1)  
C(8') 1387(2) 6396(1) 514(1)  45(1)  
C(9') 6359(2) 3837(2) 1052(1) 59(1)  
C(10') 7127(2) 5544(2) 1591(1) 55(1)  
O(2) -38(1)  2547(1) 2283(1) 48(1)  
O(3) 4923(1) 3323(1) 2310(1) 43(1)  




           Table B.3.  Bond lengths [A] and angles [deg] for amino alcohol 24.  
           _____________________________________________________________  
   
O(1)-C(2)  1.4348(17)  
N(1)-C(9)  1.460(2)  
N(1)-C(10)  1.4740(18)  
N(1)-C(6)  1.4752(19)  
C(1)-C(7)  1.524(2)  
C(1)-C(2)  1.525(2)  
C(1)-C(6)  1.5377(19)  
C(2)-C(3)  1.534(2)  
C(3)-C(4)  1.516(2)  
C(4)-C(5)  1.514(2)  
C(4)-C(8)  1.523(2)  
C(5)-C(6)  1.545(2)  
C(7)-C(8)  1.539(2)  
O(1')-C(2')  1.4370(17)  
N(1')-C(10')  1.458(2)  
N(1')-C(9')  1.474(2)  
N(1')-C(6')  1.4813(19)  
C(1')-C(2')  1.5280(19)  
C(1')-C(7')  1.533(2)  
C(1')-C(6')  1.5364(19)  
C(2')-C(3')  1.525(2)  
C(3')-C(4')  1.516(2)  
C(4')-C(5')  1.521(2)  
C(4')-C(8')  1.526(2)  
C(5')-C(6')  1.542(2)  
C(7')-C(8')  1.532(2)  
  
C(9)-N(1)-C(10) 107.59(13)  
C(9)-N(1)-C(6) 112.43(11)  
C(10)-N(1)-C(6) 110.13(12)  
C(7)-C(1)-C(2) 110.27(12)  
C(7)-C(1)-C(6) 108.47(13)  
C(2)-C(1)-C(6) 109.35(12)  
O(1)-C(2)-C(1) 111.12(12)  
O(1)-C(2)-C(3) 108.87(12)  
C(1)-C(2)-C(3) 109.19(13)  
C(4)-C(3)-C(2) 110.35(13)  
C(5)-C(4)-C(3) 109.40(13)  
C(5)-C(4)-C(8) 109.27(13)  
C(3)-C(4)-C(8) 109.06(14)  
C(4)-C(5)-C(6) 111.22(13)  
N(1)-C(6)-C(1) 113.89(12)  
N(1)-C(6)-C(5) 110.99(12)  
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C(1)-C(6)-C(5) 107.78(13)  
C(1)-C(7)-C(8) 110.40(12)  
C(4)-C(8)-C(7) 108.83(13)  
C(10')-N(1')-C(9') 107.61(14)  
C(10')-N(1')-C(6') 111.81(12)  
C(9')-N(1')-C(6') 110.34(14)  
C(2')-C(1')-C(7') 110.27(13)  
C(2')-C(1')-C(6') 109.64(12)  
C(7')-C(1')-C(6') 107.88(13)  
O(1')-C(2')-C(3') 108.50(12)  
O(1')-C(2')-C(1') 111.08(11)  
C(3')-C(2')-C(1') 109.22(12)  
C(4')-C(3')-C(2') 110.53(13)  
C(3')-C(4')-C(5') 108.78(14)  
C(3')-C(4')-C(8') 109.49(14)  
C(5')-C(4')-C(8') 109.48(14)  
C(4')-C(5')-C(6') 110.80(13)  
N(1')-C(6')-C(1') 113.58(13)  
N(1')-C(6')-C(5') 110.72(12)  
C(1')-C(6')-C(5') 108.12(12)  
C(8')-C(7')-C(1') 110.39(13)  
C(4')-C(8')-C(7') 108.91(14)  
           _____________________________________________________________  
   
           Symmetry transformations used to generate equivalent atoms:  




    Table B.4. Anisotropic displacement parameters (A^2 x 10^3) for amino alcohol 24.  
    The anisotropic displacement factor exponent takes the form:  
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]  
   
    
_______________________________________________________________________  
   
U11  U22  U33  U23  U13  U12  
    
_______________________________________________________________________  
   
O(1) 35(1)  29(1)  48(1)  9(1)  13(1)  -3(1)  
N(1) 33(1)  21(1)  34(1)  -2(1)  8(1)  -4(1)  
C(1) 26(1)  17(1)  31(1)  2(1)  3(1)  4(1)  
C(2) 29(1)  22(1)  32(1)  1(1)  6(1)  -4(1)  
C(3) 36(1)  31(1)  46(1)  -4(1)  10(1)  7(1)  
C(4) 34(1)  27(1)  40(1)  -1(1)  -3(1)  12(1)  
C(5) 48(1)  27(1)  40(1)  7(1)  5(1)  7(1) 
C(6) 35(1)  20(1)  28(1)  1(1)  10(1)  3(1)  
C(7) 35(1)  22(1)  39(1)  -5(1)  2(1)  2(1)  
C(8) 42(1)  40(1)  48(1)  -12(1)  -9(1)  7(1)  
C(9) 33(1)  40(1)  57(1)  -5(1)  0(1)  -5(1) 
C(10) 58(1)  34(1)  53(1)  -2(1)  21(1)  -17(1)  
O(1') 32(1)  27(1)  42(1)  -9(1)  10(1)  2(1)  
N(1') 36(1)  26(1)  41(1)  7(1)  13(1)  10(1)  
C(1') 27(1)  17(1)  34(1)  0(1)  5(1)  -1(1)  
C(2') 33(1)  20(1)  30(1)  -2(1)  6(1)  2(1)  
C(3') 46(1)  37(1)  43(1)  -5(1)  15(1)  -15(1)  
C(4') 38(1)  30(1)  42(1)  -8(1)  2(1)  -9(1)  
C(5') 54(1)  24(1)  44(1)  -6(1)  7(1)  -3(1)  
C(6') 38(1)  23(1)  31(1)  4(1)  11(1)  4(1)  
C(7') 43(1)  23(1)  36(1)  6(1)  8(1)  7(1)  
C(8') 44(1)  40(1)  48(1)  1(1)  -5(1)  5(1)  
C(9') 78(2)  43(1)  61(1)  12(1)  34(1)  31(1)  
C(10') 34(1)  59(1)  71(1)  21(1)  7(1)  8(1)  
O(2) 50(1)  38(1)  62(1)  -23(1)  26(1)  -18(1)  
O(3) 43(1)  39(1)  50(1)  17(1)  20(1)  15(1)  





         Table B.5. Hydrogen coordinates ( x 10^4) and isotropic  
         displacement parameters (A^2 x 10^3) for amino alcohol 24.  
   
         ________________________________________________________________  
   
x  y  z  U(eq)  
         ________________________________________________________________  
   
H(1A)  8500  8172  2245  66(6)  
H(1)  10006  8748  1419  25(4)  
H(2)  8902  10006  2085  22(4)  
H(3A)  5847  10029  1559  49(4)  
H(3B)  6914  11094  1726  49(4)  
H(4)  6045  11109  670  34(4)  
H(5A)  8592  11846  961  50(4)  
H(5B)  8506  11272  318  50(4)  
H(6)  10400  10106  659  20(4)  
H(7A)  7661  7982  888  38(3)  
H(7B)  8683  8473  413  38(3)  
H(8A)  6714  9598  50  64(4)  
H(8B)  5703  9124  533  64(4)  
H(9A)  11840  9625  1986  54(3)  
H(9B)  13072  10625  1997  54(3)  
H(9C)  12782  9803  1427  54(3)  
H(10A) 12337  11548  823  58(3)  
H(10B) 12556  12250  1438  58(3)  
H(10C) 11006  12397  964  58(3)  
H(1A)  3515  7649  2270  75(6)  
H(1')  4843  7025  1379  22(4)  
H(2')  3788  5801  2080  26(4)  
H(3'1)  1695  4788  1770  64(4)  
H(3'2)  687  5888  1626  64(4)  
H(4')  664  4785  729  40(5)  
H(5'1)  3033  4500  323  53(4)  
H(5'2)  3201  3973  980  53(4)  
H(6')  4992  5658  593  27(4)  
H(7'1)  2463  7855  902  47(3)  
H(7'2)  3376  7341  399  47(3)  
H(8'1)  423  6772  582  60(4)  
H(8'2)  1339  6255  80  60(4)  
H(9'1)  5486  3343  903  67(3)  
H(9'2)  7122  3423  1332  67(3)  
H(9'3)  6853  4104  710  67(3)  
H(10D) 7937  5094  1829  63(3)  
H(10E) 6799  6145  1844  63(3)  
H(10F) 7541  5871  1245  63(3)  
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H(2A)  -1013  2350  2420  86(7)  
H(2B)  173  1940  2047  104(8)  
H(3C)  4090  3561  2525  69(6)  
H(3D)  5111  3884  1997  106(8)  










































Table C.1.  Crystal data and structure refinement for benzoate 27. 
   
   
Identification code   coons4  
   
Empirical formula   C17 H24 Cl N O2  
   
Formula weight   309.82  
   
Temperature    198(2) K  
   
Wavelength    0.71073 A  
   
Crystal system, space group  Monoclinic,  P2(1)/c  
   
Unit cell dimensions   a = 6.3245(9) A   alpha = 90 deg.  
b = 10.8229(15) A    beta = 96.448(2) deg.  
c = 24.494(3) A   gamma = 90 deg.  
   
Volume    1666.0(4) A^3  
   
Z, Calculated density   4,  1.235 Mg/m^3  
   
Absorption coefficient  0.234 mm^-1  
   
F(000)     664  
   
Crystal size    0.24 x 0.22 x 0.04 mm  
   
Theta range for data collection 1.67 to 25.00 deg.  
   
Limiting indices   -7<=h<=4, -11<=k<=12, -29<=l<=27  
   
Reflections collected / unique 8320 / 2925 [R(int) = 0.0664]  
   
Completeness to theta = 25.00 99.8 %  
   
Absorption correction   None  
   
Max. and min. transmission  0.9907 and 0.9465  
   
Refinement method   Full-matrix least-squares on F^2  
   
Data / restraints / parameters  2925 / 0 / 208  
   




Final R indices [I>2sigma(I)]  R1 = 0.0754, wR2 = 0.1543  
   
R indices (all data)   R1 = 0.1277, wR2 = 0.1875  
   











































Table C.2. Atomic coordinates ( x 10^4) and equivalent isotropic displacement 
parameters (A^2 x 10^3) for benzoate 27. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
   
         ________________________________________________________________  
   
   x     y     z  U(eq)  
         ________________________________________________________________  
   
N(1)  -889(6) -1525(3) 2283(2) 33(1)  
Cl(1)  -3655(2)  6216(1) 2438(1) 41(1)  
O(1)  -736(5)  1111(3) 1024(1) 49(1)  
O(2)  -1860(6)  2068(4) 225(2)  64(1)  
C(1)  -2882(8) -281(5) 1512(2) 43(1)  
C(2)  -2562(9)  269(5) 939(2)  49(1)  
C(3)  -2084(11) -737(5) 544(2)  66(2)  
C(4)  -2400(9) -2031(5) 811(2)  56(2)  
C(5)  -783(9) -2153(5) 1302(2) 54(1)  
C(6)  -933(7) -1036(4) 1703(2) 39(1)  
C(7)  -4875(8) -1066(5) 1424(2) 52(1)  
C(8)  -4646(9) -2092(5) 991(2)  54(2)  
C(9)  -1373(8) -576(4) 2696(2) 41(1)  
C(10)   1227(7) -2080(4) 2470(2) 48(1)  
C(11)  -596(9)  1984(5) 631(2)  47(1)  
C(12)   1302(8)  2784(4) 760(2)  38(1)  
C(13)   1447(10)  3860(5) 452(2)  64(2)  
C(14)   3170(11)  4646(6) 557(3)  73(2)  
C(15)   4761(10)  4362(5) 961(3)  60(2)  
C(16)   4652(9)  3295(5) 1263(2) 56(2)  
C(17)  2913(8)  2508(5) 1168(2) 43(1)  
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Table C.3.  Bond lengths [A] and angles [deg] for benzoate 27.  
           _____________________________________________________________  
   
N(1)-C(10)   1.491(6)  
N(1)-C(9)   1.499(6)  
N(1)-C(6)                     1.514(6)  
O(1)-C(11)                   1.358(6)  
O(1)-C(2)                     1.467(6)  
O(2)-C(11)                   1.209(6)  
C(1)-C(6)                     1.508(7)  
C(1)-C(7)                     1.515(7)  
C(1)-C(2)                      1.561(7)  
C(2)-C(3)                      1.510(8)  
C(3)-C(4)                      1.567(8)  
C(4)-C(5)                      1.494(7)  
C(4)-C(8)                      1.536(7)  
C(5)-C(6)                      1.568(7)  
C(7)-C(8)                      1.553(7)  
C(11)-C(12)                    1.485(7)  
C(12)-C(17)                    1.378(6)  
C(12)-C(13)                    1.395(7)  
C(13)-C(14)                    1.383(8)  
C(14)-C(15)                    1.365(8)  
C(15)-C(16)                    1.378(8)  
C(16)-C(17)                    1.390(7)  
   
C(10)-N(1)-C(9)              108.2(4)  
C(10)-N(1)-C(6)              110.6(4)  
C(9)-N(1)-C(6)               114.2(3)  
C(11)-O(1)-C(2)             116.4(4)  
C(6)-C(1)-C(7)               112.2(4)  
C(6)-C(1)-C(2)               107.5(4)  
C(7)-C(1)-C(2)               106.0(4)  
O(1)-C(2)-C(3)               109.1(5)  
O(1)-C(2)-C(1)               106.8(4)  
C(3)-C(2)-C(1)               110.9(4)  
C(2)-C(3)-C(4)               109.4(5)  
C(5)-C(4)-C(8)               109.6(5)  
C(5)-C(4)-C(3)               107.9(5)  
C(8)-C(4)-C(3)               108.9(5)  
C(4)-C(5)-C(6)              110.6(5)  
C(1)-C(6)-N(1)              114.1(4)  
C(1)-C(6)-C(5)              109.2(4)  
N(1)-C(6)-C(5)              108.8(4)  
C(1)-C(7)-C(8)              111.0(5)  
C(4)-C(8)-C(7)              109.0(4)  
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O(2)-C(11)-O(1)              123.1(5)  
O(2)-C(11)-C(12)            125.0(5)  
O(1)-C(11)-C(12)            111.8(4)  
C(17)-C(12)-C(13)          119.0(5)  
C(17)-C(12)-C(11)          122.8(4)  
C(13)-C(12)-C(11)          118.2(4)  
C(14)-C(13)-C(12)          120.8(6)  
C(15)-C(14)-C(13)          119.8(6)  
C(14)-C(15)-C(16)          120.0(6)  
C(15)-C(16)-C(17)          120.7(5)  
C(12)-C(17)-C(16)          119.7(5)  
           _____________________________________________________________  
   
           Symmetry transformations used to generate equivalent atoms:  


































    Table C.4.  Anisotropic displacement parameters (A^2 x 10^3) for benzoate 27.  
    The anisotropic displacement factor exponent takes the form:  
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]  
   ______________________________________________________________________  
   
U11  U22  U33  U23  U13  U12  
    
_______________________________________________________________________  
   
N(1) 25(2)  28(2)  46(2)   1(2)  -3(2)  -3(2)  
Cl(1) 33(1)  30(1)  59(1)   0(1)   3(1)  -6(1) 
O(1) 48(2)  51(2)  46(2)   18(2)  -8(2)  -16(2) 
O(2) 71(3)  70(3)  44(2)   22(2)  -17(2)  -18(2) 
C(1) 45(3)  38(3)  44(3)  -4(2)  -6(2)   1(2)  
C(2) 54(4)  42(3)  49(3)   0(3)  -1(3)  -1(3)  
C(3) 84(5)  66(4)  50(4)   3(3)   16(3)  -5(4)    
C(4) 56(4)  52(3)  60(4)  -19(3)   10(3)  -9(3) 
C(5) 42(3)  59(3)  62(4)  -15(3)   9(3)   3(3) 
C(6) 36(3)  35(2)  46(3)   6(2)  -2(2)  -10(2)  
C(7) 34(3)  46(3)  76(4)  -2(3)   3(3)   3(3)  
C(8) 52(3)  49(3)  58(3)  -7(3)  -9(3)  -10(3)  
C(9) 43(3)  40(3)  42(3)  -2(2)   7(2)  -4(2) 
C(10) 30(3)  32(2)  78(4)   7(3)  -8(3)   1(2)  
C(11) 60(4)  46(3)  34(3)   9(3)   1(3)  -4(3) 
C(12) 47(3)  35(2)  32(3)   3(2)   4(2)  -1(2)  
C(13) 75(4)  55(3)  58(4)   24(3)  -10(3)  -10(3)  
C(14) 85(5)  49(3)  83(5)   16(3)  -3(4)  -24(4) 
C(15) 61(4)  46(3)  72(4)  -5(3)   5(3)  -12(3)  
C(16) 49(3)  52(3)  63(4)   5(3)  -9(3)  -1(3) 
C(17) 46(3)  40(3)  43(3)   3(2)   2(2)   1(2)  





















Table C.5. Hydrogen coordinates ( x 10^4) and isotropic displacement parameters (A^2 
x 10^3) for benzoate 27. 
           ______________________________________________________________  
   
   x    y    z  U(eq)  
         ________________________________________________________________  
   
H(1)  -1884  -2133  2280  57(16)  
H(1A)  -3062   370  1769  56(16)  
H(2)  -3811   716  793  15(10)  
H(3A)  -646  -659  458  94(16)  
H(3B)  -3018  -662  208  94(16)  
H(4)  -2215  -2677  552  72(18)  
H(5A)   616  -2183  1185  106(18)  
H(5B)  -1016  -2911  1490  106(18)  
H(6)   297  -523  1686  52(15)  
H(7A)  -6071  -551  1301  91(16)  
H(7B)  -5136  -1439  1766  91(16)  
H(8A)  -4876  -2888  1147  82(14)  
H(8B)  -5689  -1975  679  82(14)  
H(9A)  -380   95  2695  48(8)  
H(9B)  -1256  -944  3055  48(8) 
H(9C)  -2793  -270  2604  48(8) 
H(10A)  2268  -1436  2534  66(10)  
H(10B)  1632  -2630  2192  66(10)  
H(10C)  1142  -2532  2804  66(10)  
H(13)   337   4058  165  68(18)  
H(14)   3247   5389  345  130(30)  
H(15)   5958   4907  1034  75(19)  
H(16)   5790   3093  1542  69(18)  
H(17)   2834   1776  1386  54(15)  















































The stereochemistry at the C-6 stereocenter was previously assigned for amino 
ketone 19 (Appendix A).  Signal a at δ 2.31-2.41 ppm in the 1H NMR spectrum appears 
as a multiplet and is assigned to the six protons of dimethyl amine and the exo proton on 
C-3 (Figure D.1). The 2-D NOESY spectrum shows cross-coupling between the meta 
protons on the phenyl ring and signal a, since the exo proton on C-3 is cis to the phenyl 
ring (Figure D.2). The HMQC spectrum indicates that one of the protons assigned to 
signal a (the exo proton on C-3) and the proton assigned to signal e apparently are on the 
 149 
 
same carbon, C-3 (Figure D.3). Signal e appears as a dt at δ 2.00 with couplings of 14 Hz 
(geminal coupling with the exo proton on C-3), and 2.1 Hz with the bridgehead proton at 
C-4 and the exo proton at C-8. The NOESY spectrum also shows a cross-coupling peak 
between signal e and signal g, assigned as the endo proton on C-5. Signal g appears as a 
qt at δ 1.81 ppm due to geminal coupling (13.2 Hz with the exo proton on C-5), trans 
coupling (7.5 Hz with the exo proton on C-6), coupling to the C-4 bridgehead proton (1.8 
Hz), and an in-plane W-coupling with the endo proton on C-8 (2.4 Hz). This peak was 
assigned to the endo proton on C-5 because this is the only proton on the bicycle with 








































Figure D.1. The 1H NMR spectrum (Bruker AMX 500 MHz, CDCl3) of endo-amino-












Figure D.2. The NOESY spectrum (Bruker AMX 500 MHz, CDCl3) of endo-amino-exo-























Figure D.3. The HMQC NMR (Bruker AMX 500 MHz, CDCl3) of endo-amino-exo-












































The stereochemistry at the C-6 stereocenter was previously assigned for amino 
ketone 19 (Appendix A). The signal at δ 3.31 ppm (signal a) in the 1H NMR spectrum 
(Figure E.1) of 31 was assigned to the endo proton on C-6 based on cross-coupling seen 
in the HMBC spectrum between the ipso carbon of the exo phenyl ring and the benzylic 
proton on C-6 (Figure E.2). The 1H NMR spectrum shows a qt for signal a, which is 
consistent with cis coupling (with the endo proton on C-3, 10.5 Hz), trans coupling (with 
the exo proton on C-3, 8 Hz), coupling with the bridgehead proton on C-1 (1.5 Hz), and 
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an in-plane W-coupling with the exo proton on C-7 (1.5 Hz). A cross-coupling exists in 
the NOESY spectrum between the endo proton on C-6, signal a, and the endo dimethyl 
amine six proton singlet, signal b (Figure E.3.). This is the only arrangement on the 
bicycle, which will give rise to a NOESY between the endo proton on C-6 and the endo 




























































































































































Table E.1. Crystal data and structure refinement for arene 31. 
   
   
      Identification code   coons6  
   
      Empirical formula    C16 H24 Cl N  
   
      Formula weight     265.81  
   
      Temperature    301(2) K  
   
      Wavelength    0.71073 A  
   
      Crystal system, space group  Orthorhombic,  Pca2(1)  
   
      Unit cell dimensions   a = 25.700(19) A   alpha = 90 deg.  
            b = 7.189(5) A    beta = 90 deg.  
            c = 16.001(12) A   gamma = 90 deg.  
   
      Volume     2956(4) A^3  
   
      Z, Calculated density   8,  1.194 Mg/m^3  
   
      Absorption coefficient   0.243 mm^-1  
   
      F(000)     1152  
   
      Crystal size    0.37 x 0.27 x 0.20 mm  
   
      Theta range for data collection  1.58 to 25.10 deg.  
   
      Limiting indices    -30<=h<=22, -6<=k<=8, -19<=l<=16  
   
      Reflections collected / unique  12554 / 4719 [R(int) = 0.1068]  
   
      Completeness to theta = 25.10  99.4 %  
   
      Absorption correction   None  
   
      Max. and min. transmission  0.9522 and 0.9147  
   
      Refinement method   Full-matrix least-squares on F^2  
   
      Data / restraints / parameters  4719 / 1 / 369  
   
      Goodness-of-fit on F^2   1.039  
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      Final R indices [I>2sigma(I)]  R1 = 0.0980, wR2 = 0.2242  
   
      R indices (all data)   R1 = 0.1570, wR2 = 0.2775  
   
      Absolute structure parameter  0.13(16)  
   
      Largest diff. peak and hole  0.788 and -0.454 e.A^-3  
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Table E.2. Atomic coordinates ( x 10^4) and equivalent isotropic 
displacement parameters (A^2 x 10^3) for arene 31. 
U(eq) is defined as one third of the trace of the orthogonalized 
Uij tensor. 
           ________________________________________________________________  
x  y  z  U(eq)  
         ________________________________________________________________  
   
            Cl(1)  1808(1) 5517(3) 2747(2) 55(1)  
            Cl(1')  5701(1) -9266(3) 729(2)  55(1)  
            Cl(1A)  1806(9) 4290(30) 2761(18) 23(7)  
            Cl(1B)  5707(8) -10700(20) 708(18) 14(6)  
            N(1)  1784(3) -167(7) 2765(5) 40(2)  
            C(1)  2691(3) 927(10) 3225(5) 53(2)  
            C(2)  2111(3) 689(11) 3459(5) 47(2)  
            C(3)  2056(4) -425(13) 4279(7) 59(3)  
            C(4)  2623(5) -863(12) 4629(6) 71(3)  
            C(5)  2921(4) -2026(11) 3977(6) 59(2)  
            C(6)  2952(4) -973(10) 3135(5) 55(2)  
            C(7)  2940(4) 2045(10) 3941(6) 55(2)  
            C(8)  2891(4) 968(12) 4761(6) 65(3)  
            C(9)  1226(4) 74(11)  2952(9) 60(3)  
            C(10)  1904(4) 493(13) 1921(6) 58(2)  
            C(11)  3511(3) -685(9) 2772(7) 60(2)  
            C(12)  3580(5) -611(12) 1921(7) 67(3)  
C(13)  4074(6) -339(13) 1557(10) 84(4)  
C(14)  4493(6) -127(14) 2065(13) 88(5)  
C(15)  4439(5) -196(13) 2919(13) 81(4)  
C(16)  3947(4) -449(14) 3285(9) 73(3)  
N(1')  5709(3) -4987(7) 710(6)  41(2)  
C(1')  4797(3) -3893(10) 242(6)  50(2)  
C(2')  5379(3) -4089(11) 29(5)  47(2)  
C(3')  5432(4) -5173(12) -786(6) 59(3)  
C(4')  4904(4) -5595(10) -1170(6) 54(2)  
C(5')  4599(4) -6810(11) -542(6) 60(2)  
C(6')  4544(4) -5800(11) 300(5)  56(2)  
C(7')  4560(4) -2748(11) -464(6) 55(2)  
C(8')  4624(5) -3774(14) -1295(7) 81(3)  
C(9')  6279(4) -4758(11) 534(8)  53(3)  
C(10')  5586(4) -4302(12) 1583(6) 59(2)  
C(11')  3997(3) -5617(10) 655(6)  53(2)  
C(12')  3914(4) -5596(13) 1523(7) 67(3)  
C(13')  3428(6) -5340(15) 1874(10) 87(4)  
C(14')  3001(6) -5182(13) 1377(14) 88(5)  
C(15')  3056(5) -5180(14) 526(15) 94(5)  
C(16')  3546(5) -5408(12) 156(9)  73(3)  
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           Table E.3. Bond lengths [A] and angles [deg] for arene 31.  
           _____________________________________________________________  
   
Cl(1)-Cl(1A)   0.88(2)  
Cl(1')-Cl(1B)   1.034(17)  
N(1)-C(10)   1.464(13)  
N(1)-C(9)   1.476(12)  
N(1)-C(2)   1.523(11)  
C(1)-C(6)   1.528(11)  
C(1)-C(7)   1.539(11)  
C(1)-C(2)   1.547(12)  
C(2)-C(3)   1.544(12)  
C(3)-C(4)   1.592(16)  
C(4)-C(8)   1.501(13)  
C(4)-C(5)   1.540(13)  
C(5)-C(6)   1.547(12)  
C(6)-C(11)   1.563(13)  
C(7)-C(8)   1.529(12)  
C(11)-C(12)   1.374(15)  
C(11)-C(16)   1.401(14) 
C(12)-C(13)   1.410(18)  
C(13)-C(14)   1.36(2)  
C(14)-C(15)   1.37(2)  
C(15)-C(16)   1.405(17)  
N(1')-C(9')   1.501(11)  
N(1')-C(10')   1.514(13)  
N(1')-C(2')   1.525(11)  
C(1')-C(6')   1.520(12)  
C(1')-C(7')   1.524(12)  
C(1')-C(2')   1.541(11) 
C(2')-C(3')   1.526(12)  
C(3')-C(4')   1.520(14)  
C(4')-C(8')   1.507(14)  
C(4')-C(5')   1.546(13) 
C(5')-C(6')   1.537(13)  
C(6')-C(11')   1.521(13)  
C(7')-C(8')   1.530(14)  
C(11')-C(12')   1.406(15)  
C(11')-C(16')   1.415(15)  
C(12')-C(13')   1.380(16)  
C(13')-C(14')   1.36(2)  
C(14')-C(15')   1.37(2)  
C(15')-C(16')   1.402(19)  
C(10)-N(1)-C(9)  110.7(8)  
C(10)-N(1)-C(2)  115.2(6)  
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C(9)-N(1)-C(2)  109.9(8)  
C(6)-C(1)-C(7)  110.8(7)  
C(6)-C(1)-C(2)  110.2(7)  
C(7)-C(1)-C(2)  106.1(7)  
N(1)-C(2)-C(3)  111.1(6)  
N(1)-C(2)-C(1)  113.6(7)  
C(3)-C(2)-C(1)  110.6(7)  
C(2)-C(3)-C(4)  108.5(7)  
C(8)-C(4)-C(5)  110.1(9)  
C(8)-C(4)-C(3)  107.3(8)  
C(5)-C(4)-C(3)  108.9(8)  
C(4)-C(5)-C(6)  110.5(7)  
C(1)-C(6)-C(5)  109.5(7)  
C(1)-C(6)-C(11)  108.6(6)  
C(5)-C(6)-C(11)  115.8(8)  
C(8)-C(7)-C(1)  109.9(7)  
C(4)-C(8)-C(7)  111.1(7)  
C(12)-C(11)-C(16)  118.2(11)  
C(12)-C(11)-C(6)  119.5(9)  
C(16)-C(11)-C(6)  122.3(10)  
C(11)-C(12)-C(13)  122.1(12)  
C(14)-C(13)-C(12)  118.8(14)  
C(13)-C(14)-C(15)  120.8(14)  
C(14)-C(15)-C(16)  120.6(14)  
C(11)-C(16)-C(15)  119.5(13)  
C(9')-N(1')-C(10')  110.0(8)  
C(9')-N(1')-C(2')  111.3(7)  
C(10')-N(1')-C(2')  113.9(6)  
C(6')-C(1')-C(7')  111.2(7)  
C(6')-C(1')-C(2')  110.2(7)  
C(7')-C(1')-C(2')  105.8(7)  
N(1')-C(2')-C(3')  110.1(7)  
N(1')-C(2')-C(1')  114.9(7)  
C(3')-C(2')-C(1')  108.9(7)  
C(4')-C(3')-C(2')  111.5(8)  
C(8')-C(4')-C(3')  107.9(7)  
C(8')-C(4')-C(5')  109.6(8)  
C(3')-C(4')-C(5')  107.7(8)  
C(6')-C(5')-C(4')  110.4(7)  
C(11')-C(6')-C(1')  109.8(7)  
C(11')-C(6')-C(5')  117.0(8)  
C(1')-C(6')-C(5')  109.5(7)  
C(1')-C(7')-C(8')  110.0(7)  
C(4')-C(8')-C(7')  110.8(8)  
C(12')-C(11')-C(16')  115.6(9)  
C(12')-C(11')-C(6')  120.8(8)  
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C(16')-C(11')-C(6')  123.6(10)  
C(13')-C(12')-C(11')  122.8(11)  
C(14')-C(13')-C(12')  120.2(14)  
C(13')-C(14')-C(15')  119.8(14)  
C(14')-C(15')-C(16')  120.9(15)  
C(15')-C(16')-C(11')  120.6(13)  
           _____________________________________________________________  
   
           Symmetry transformations used to generate equivalent atoms:  





Table E.4. Anisotropic displacement parameters (A^2 x 10^3) for arene 31. 
The anisotropic displacement factor exponent takes the form: 
-2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]. 
    ______________________________________________________________________ 
U11  U22  U33  U23  U13 U12  
  _______________________________________________________________________  
   
    Cl(1) 45(1)  43(2)  76(2)  -2(1)  -3(1) -1(1)  
    Cl(1') 46(1)  45(1)  74(2)  3(1)  -7(1) 2(1)  
    N(1)  32(4)  43(3)  45(4)  1(3)  -8(4) -3(2)  
    C(1)  67(7)  44(4)  46(5)  3(3)  -19(5) -4(4)  
    C(2)  45(5)  42(5)  53(5)  -2(3)  -3(4) -3(3) 
    C(3)  52(7)  75(6)  51(6)  7(4)  -11(5) -9(4)  
    C(4)  107(10) 65(6)  42(5)  4(4)  -1(5) -22(5)  
    C(5)  58(6)  46(4)  72(6)  17(4)  -6(5) -6(4)  
    C(6)  71(7)  43(4)  50(5)  4(4)  -8(5) 5(4) 
    C(7)  65(6)  39(4)  60(6)  -5(4)  -10(5) -3(4)  
    C(8)  72(7)  72(6)  51(5)  3(4)  -12(5) 1(5)  
    C(9)  39(6)  74(6)  67(9)  2(4)  -4(6) 3(4)  
    C(10) 43(5)  92(7)  38(5)  6(4)  -7(4) -8(4)  
    C(11) 55(6)  42(4)  83(7)  -2(5)  -6(5) 4(3)  
    C(12) 70(8)  55(6)  77(7)  -3(4)  7(6) 7(4)  
    C(13) 90(11)  62(6)  99(10)  -1(6)  34(9) 17(6)  
    C(14) 51(10)  55(6)  156(18) 12(6)  26(11) 15(5)  
    C(15) 50(9)  63(6)  131(14) 9(6)  -8(9) 4(4)  
    C(16) 39(7)  84(7)  97(10)  16(6)  -22(6) -4(5)  
    N(1') 26(4)  46(3)  50(4)  7(3)  3(4) -2(2)  
    C(1') 51(6)  46(4)  53(5)  -3(4)  5(4) 7(4)  
    C(2') 53(5)  46(4)  43(4)  -2(3)  -4(4) 1(3)  
    C(3') 55(7)  81(6)  42(6)  -5(4)  14(5) 12(4)  
    C(4') 52(6)  59(5)  50(5)  -6(4)  -14(4) 2(4)  
    C(5') 52(6)  52(5)  75(7)  -15(4)  0(5) 0(4)  
    C(6') 70(7)  47(5)  52(5)  4(4)  -16(5) -1(4)  
    C(7') 54(6)  51(5)  59(6)  6(4)  -11(5) 3(4)  
    C(8') 91(9)  72(6)  80(7)  -4(5)  -13(6) 8(6)  
    C(9') 30(6)  72(5)  57(7)  0(4)  1(5) -8(3)  
    C(10') 49(5)  70(6)  58(6)  -2(4)  -3(5) 1(4)  
    C(11') 39(5)  55(5)  64(6)  1(4)  -1(4) -1(3)  
    C(12') 53(7)  70(6)  78(7)  6(5)  -4(6) 0(5)  
    C(13') 75(10)  79(7)  106(11) -5(6)  50(9) -9(6)  
    C(14') 52(10)  63(7)  149(16) 2(7)  37(11) -10(5)  
    C(15') 33(8)  78(7)  172(19) 15(7)  -12(9) -1(4)  
    C(16') 55(8)  74(7)  91(9)  14(6)  -10(6) -5(5)  





         Table E.5. Hydrogen coordinates ( x 10^4) and isotropic  
         displacement parameters (A^2 x 10^3) for arene 31.  
   
         ________________________________________________________________  
  
X  y  z  U(eq)  
         ________________________________________________________________  
   
H(1)  1850  -1439  2771  26(14)  
H(1)  2721  1606  2710  60(20)  
H(2)  1974  1910  3563  80(30)  
H(3A)  1872  -1564  4176  100(20)  
H(3B)  1863  286  4682  100(20)  
H(4)  2600  -1530  5147  60(20)  
H(5A)  2746  -3194  3896  62(16)  
H(5B)  3266  -2277  4177  62(16)  
H(6)  2756  -1672  2732  60(20)  
H(7A)  3300  2268  3820  80(20)  
H(7B)  2769  3227  3993  80(20)  
H(8A)  3232  755  4989  120(30)  
H(8B)  2698  1695  5157  120(30)  
H(9A)  1160  -276  3522  50(12)  
H(9B)  1024  -697  2586  50(12)  
H(9C)  1131  1353  2872  50(12)  
H(10D) 1640  72  1541  130(30)  
H(10E) 2236  14  1750  130(30)  
H(10F) 1914  1828  1919  130(30)  
H(12)  3283  -750  1563  70(30)  
H(13)  4113  -304  961  80(30)  
H(14)  4830  73  1825  120(50)  
H(15)  4741  -69  3268  150(70)  
H(16)  3911  -460  3882  70(30)  
H(1')  5639  -6255  700  80(30)  
H(1')  4757  -3245  763  37(17)  
H(2')  5513  -2862  -66  100  
H(3'A)  5636  -4463  -1175  66(18)  
H(3'B)  5612  -6319  -680  66(18)  
H(4')  4944  -6233  -1693  50(20)  
H(5'A)  4260  -7078  -763  90(20)  
H(5'B)  4777  -7968  -461  90(20)  
H(6')  4742  -6501  699  38(17)  
H(7'1)  4730  -1560  -494  71(19)  
H(7'2)  4198  -2540  -355  71(19)  
H(8'1)  4288  -4003  -1535  80(20)  
H(8'2)  4818  -3011  -1677  80(20)  
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H(9'1)  6363  -3458  511  73(16)  
H(9'2)  6362  -5330  8  73(16)  
H(9'3)  6477  -5341  970  73(16)  
H(10A) 5855  -4691  1959  56(14)  
H(10B) 5259  -4812  1761  56(14)  
H(10C) 5565  -2969  1581  56(14)  
H(12')  4207  -5766  1887  100(40)  
H(13')  3392  -5274  2470  100  
H(14')  2661  -5073  1623  130(50)  
H(15')  2755  -5019  178  90(40)  
H(16')  3577  -5423  -442  40(20)  





























































The stereochemistry at the C-6 stereocenter was previously assigned for the 
amino ketone 19 (Appendix A). The HMQC spectrum of benzyl amine 39, indicates the 
peaks at δ 2.67 ppm (dd, 13.2  and 6.6 Hz, signal a) and δ 2.49 ppm (dd, 13.2 and 9.3 Hz, 
signal b) in the 1H NMR spectrum are on the same carbon (Figure F.1). Signals a and b 
were assigned to the two benzylic protons at C-9. The COSY spectrum shows cross-
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coupling between signals a and b and signal c (Figure F.2). The peak at δ 2.20 ppm (1H, 
signal c) was assigned to the proton at C-6. The COSY spectrum also shows cross-
coupling between signal c and the peaks labeled f and l. Signal l, a quartet of triplets, was 
assigned to the exo proton on C-5 based on the 1H NMR spectrum (Figure F.3) coupling 
constants (J= 12geminal, 7trans, 2bridgehead and W Hz). Also, the NOESY spectrum shows a 
cross-coupling between signals a and l, which indicates the close proximity of the protons 
on C-5 to the benzyl proton on C-9 (Figure F.4). The HMQC spectrum indicates the 
multiplet labeled  f at δ 1.81-1.73 ppm has two protons on the same carbon. Signal f was 
assigned to the protons at C-7. The COSY spectrum indicates a long-range coupling 
between the endo proton at C-6, signal f and signal e, the exo proton on C-2. This piece 
of evidence provides the correct relative stereochemistry at C-6.   
Further analysis of compounds that contain protons on the same face of the 
bicycle and whose chemical shifts are affected by the dimethylamine moiety can be 
found in Appendix P. This provides additional evidence with the relative stereochemical 

























































































































The relative stereochemical assignment of the endo-phenethyl arene 42 was 




































Table G.1. Crystal data and structure refinement for endo-phenethyl arene 42. 
Identification code  sc0520s 
Empirical formula  C18 H28 Cl N 
Formula weight  293.86 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 13.157(4) Å α= 90°. 
 b = 17.972(5) Å β= 105.466(7)°. 
 c = 7.271(2) Å γ = 90°. 
Volume 1657.0(9) Å3 
Z 4 
Density (calculated) 1.178 Mg/m3 
Absorption coefficient 0.223 mm-1 
F(000) 640 
Crystal size 0.22 x 0.06 x 0.02 mm3 
Theta range for data collection 1.61 to 24.71°. 
Index ranges -15<=h<=15, -21<=k<=21, -8<=l<=8 
Reflections collected 17186 
Independent reflections 2836 [R(int) = 0.1100] 
Completeness to theta = 24.71° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9956 and 0.9527 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2836 / 0 / 292 
Goodness-of-fit on F2 1.159 
Final R indices [I>2sigma(I)] R1 = 0.0895, wR2 = 0.1666 
R indices (all data) R1 = 0.1140, wR2 = 0.1780 
Largest diff. peak and hole 0.264 and -0.241 e.Å-3 
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Table G.2. Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for endo-phenethyl arene 42. U(eq) is defined as one third of  the 
trace of the orthogonalized Uij tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
C(1) 7802(4) 1305(2) 6385(6) 24(1) 
C(2) 7092(4) 618(3) 6322(6) 24(1) 
C(3) 6224(4) 893(3) 7204(7) 35(1) 
C(4) 5521(5) 1468(3) 5875(8) 41(1) 
C(5) 6033(4) 1675(3) 4281(7) 30(1) 
C(6) 7171(4) 1930(3) 5156(7) 30(1) 
C(7) 6525(3) 331(2) 4303(6) 21(1) 
C(8) 6064(4) 1005(3) 3017(7) 33(1) 
C(9) 7157(3) -189(3) 3358(6) 23(1) 
C(10) 6457(4) -503(3) 1477(7) 27(1) 
C(11) 6996(3) -1025(2) 405(6) 21(1) 
C(12) 6533(4) -1699(3) -271(7) 28(1) 
C(13) 6997(4) -2180(3) -1296(7) 37(1) 
C(14) 7927(4) -1986(3) -1674(7) 42(1) 
C(15) 8405(4) -1316(3) -1049(7) 38(1) 
C(16) 7932(4) -841(3) 1(6) 26(1) 
C(17) 9394(4) 490(3) 6820(7) 34(1) 
C(18) 9532(5) 1830(3) 6423(9) 40(1) 
Cl(1) 8873(1) 1163(1) 1687(2) 31(1) 




 Table G.3. Bond lengths [Å] and angles [°] for endo-phenethyl arene 42. 
________________________________________________________________________ 
C(1)-N(1)   1.509(6) 
C(1)-C(6)   1.535(6) 
C(1)-C(2)   1.541(6) 
C(1)-H(1)   0.98(5) 
C(2)-C(3)   1.534(6) 
C(2)-C(7)   1.547(6) 
C(2)-H(2)   0.93(4) 
C(3)-C(4)   1.542(7) 
C(3)-H(3)   0.96(5) 
C(3)-H(4)   0.97(5) 
C(4)-C(5)   1.533(7) 
C(4)-H(5)   0.96(6) 
C(4)-H(6)   1.01(6) 
C(5)-C(8)   1.523(6) 
C(5)-C(6)   1.532(7) 
C(5)-H(7)   0.96(5) 
C(6)-H(8)   0.97(5) 
C(6)-H(9)   0.99(5) 
C(7)-C(9)   1.530(6) 
C(7)-C(8)   1.552(6) 
C(7)-H(10)   1.02(4) 
C(8)-H(11)   0.91(4) 
C(8)-H(12)   1.08(5) 
C(9)-C(10)   1.538(6) 
C(9)-H(13)   1.01(5) 
C(9)-H(14)   0.95(5) 
C(10)-C(11)   1.511(6) 
C(10)-H(15)   0.96(5) 
C(10)-H(16)   1.03(5) 
C(11)-C(16)   1.381(6) 
C(11)-C(12)   1.386(6) 
C(12)-C(13)   1.384(7) 
C(12)-H(17)   0.90(4) 
C(13)-C(14)   1.370(8) 
C(13)-H(18)   0.95(5) 
C(14)-C(15)   1.378(8) 
C(14)-H(19)   0.91(5) 
C(15)-C(16)   1.397(7) 
C(15)-H(20)   0.96(5) 
C(16)-H(21)   0.84(5) 
C(17)-N(1)   1.490(6) 
C(17)-H(22)   1.09(5) 
C(17)-H(23)   0.97(5) 
C(17)-H(24)   0.85(4) 
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C(18)-N(1)   1.494(6) 
C(18)-H(25)   0.87(4) 
C(18)-H(26)   0.93(4) 
C(18)-H(27)   1.01(6) 
N(1)-H(28)   0.91(5) 
 
N(1)-C(1)-C(6)  111.2(4) 
N(1)-C(1)-C(2)  115.9(3) 
C(6)-C(1)-C(2)  109.9(4) 
N(1)-C(1)-H(1)  100(3) 
C(6)-C(1)-H(1)  113(3) 
C(2)-C(1)-H(1)  106(3) 
C(3)-C(2)-C(1)  104.0(4) 
C(3)-C(2)-C(7)  106.3(4) 
C(1)-C(2)-C(7)  115.5(4) 
C(3)-C(2)-H(2)  112(2) 
C(1)-C(2)-H(2)  112(2) 
C(7)-C(2)-H(2)  107(2) 
C(2)-C(3)-C(4)  110.0(4) 
C(2)-C(3)-H(3)  107(3) 
C(4)-C(3)-H(3)  114(3) 
C(2)-C(3)-H(4)  107(3) 
C(4)-C(3)-H(4)  111(3) 
H(3)-C(3)-H(4)  107(4) 
C(5)-C(4)-C(3)  109.0(4) 
C(5)-C(4)-H(5)  108(3) 
C(3)-C(4)-H(5)  109(3) 
C(5)-C(4)-H(6)  106(3) 
C(3)-C(4)-H(6)  112(3) 
H(5)-C(4)-H(6)  114(5) 
C(8)-C(5)-C(6)  107.9(4) 
C(8)-C(5)-C(4)  110.6(4) 
C(6)-C(5)-C(4)  109.6(4) 
C(8)-C(5)-H(7)  111(3) 
C(6)-C(5)-H(7)  110(3) 
C(4)-C(5)-H(7)  108(3) 
C(5)-C(6)-C(1)  109.8(4) 
C(5)-C(6)-H(8)  107(3) 
C(1)-C(6)-H(8)  111(3) 
C(5)-C(6)-H(9)  112(3) 
C(1)-C(6)-H(9)  112(3) 
H(8)-C(6)-H(9)  104(4) 
C(9)-C(7)-C(2)  116.6(4) 
C(9)-C(7)-C(8)  112.3(4) 
C(2)-C(7)-C(8)  108.9(4) 
C(9)-C(7)-H(10)  106(2) 
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C(2)-C(7)-H(10)  106(2) 
C(8)-C(7)-H(10)  106(2) 
C(5)-C(8)-C(7)  108.9(4) 
C(5)-C(8)-H(11)  109(3) 
C(7)-C(8)-H(11)  108(3) 
C(5)-C(8)-H(12)  108(2) 
C(7)-C(8)-H(12)  105(2) 
H(11)-C(8)-H(12)  117(4) 
C(7)-C(9)-C(10)  110.8(4) 
C(7)-C(9)-H(13)  110(2) 
C(10)-C(9)-H(13)  108(2) 
C(7)-C(9)-H(14)  113(3) 
C(10)-C(9)-H(14)  108(3) 
H(13)-C(9)-H(14)  107(4) 
C(11)-C(10)-C(9)  115.7(4) 
C(11)-C(10)-H(15)  107(3) 
C(9)-C(10)-H(15)  114(3) 
C(11)-C(10)-H(16)  108(3) 
C(9)-C(10)-H(16)  109(3) 
H(15)-C(10)-H(16)  102(4) 
C(16)-C(11)-C(12)  117.8(4) 
C(16)-C(11)-C(10)  121.9(4) 
C(12)-C(11)-C(10)  120.2(4) 
C(13)-C(12)-C(11)  121.4(5) 
C(13)-C(12)-H(17)  121(3) 
C(11)-C(12)-H(17)  118(3) 
C(14)-C(13)-C(12)  119.6(5) 
C(14)-C(13)-H(18)  121(3) 
C(12)-C(13)-H(18)  119(3) 
C(13)-C(14)-C(15)  120.7(5) 
C(13)-C(14)-H(19)  120(3) 
C(15)-C(14)-H(19)  119(3) 
C(14)-C(15)-C(16)  118.9(5) 
C(14)-C(15)-H(20)  124(3) 
C(16)-C(15)-H(20)  117(3) 
C(11)-C(16)-C(15)  121.5(5) 
C(11)-C(16)-H(21)  116(3) 
C(15)-C(16)-H(21)  122(3) 
N(1)-C(17)-H(22)  110(3) 
N(1)-C(17)-H(23)  108(3) 
H(22)-C(17)-H(23)  110(4) 
N(1)-C(17)-H(24)  110(3) 
H(22)-C(17)-H(24)  109(4)  
H(23)-C(17)-H(24)  108(4) 
N(1)-C(18)-H(25)  105(3) 
N(1)-C(18)-H(26)  108(3) 
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H(25)-C(18)-H(26)  106(4) 
N(1)-C(18)-H(27)  105(3) 
H(25)-C(18)-H(27)  116(5) 
H(26)-C(18)-H(27)  117(4) 
C(17)-N(1)-C(18)  109.6(4) 
C(17)-N(1)-C(1)  113.3(4) 
C(18)-N(1)-C(1)  109.8(4) 
C(17)-N(1)-H(28)  108(3) 
C(18)-N(1)-H(28)  106(3) 
C(1)-N(1)-H(28)  110(3) 
_____________________________________________________________  




Table G.4. Anisotropic displacement parameters  (Å2x 103) for endo-phenethyl arene 
42. The anisotropic displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  
+ 2 h k a* b* U12 ] 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
C(1) 32(2)  22(2) 19(2)  -5(2) 6(2)  1(2) 
C(2) 28(2)  26(2) 19(2)  5(2) 8(2)  4(2) 
C(3) 36(3)  42(3) 28(3)  -6(2) 13(2)  -5(2) 
C(4) 40(3)  38(3) 47(3)  -10(3) 16(3)  6(3) 
C(5) 33(3)  25(3) 29(3)  -2(2) 0(2)  9(2) 
C(6) 39(3)  24(3) 28(3)  0(2) 9(2)  0(2) 
C(7) 19(2)  23(2) 22(2)  1(2) 6(2)  2(2) 
C(8) 35(3)  32(3) 26(3)  -1(2) 0(2)  6(2) 
C(9) 22(2)  22(2) 25(2)  2(2) 7(2)  2(2) 
C(10) 18(2)  34(3) 29(3)  -3(2) 4(2)  4(2) 
C(11) 24(2)  20(2) 15(2)  3(2) 0(2)  2(2) 
C(12) 28(3)  29(3) 26(2)  0(2) 5(2)  0(2) 
C(13) 38(3)  36(3) 37(3)  -13(2) 9(2)  4(3) 
C(14) 43(3)  50(3) 29(3)  -12(3) 5(2)  20(3) 
C(15) 30(3)  55(4) 29(3)  6(2) 11(2)  7(3) 
C(16) 27(3)  27(3) 22(2)  -3(2) 4(2)  -2(2) 
C(17) 29(3)  43(3) 28(3)  0(2) 5(2)  5(3) 
C(18) 36(3)  48(4) 34(3)  -7(3) 5(3)  -16(3) 
Cl(1) 37(1)  34(1) 25(1)  0(1) 13(1)  -6(1) 




Table G.5. Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 
10 3) for endo-phenethyl arene 42. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(1) 8070(30) 1440(20) 7740(70) 30 
H(2) 7460(30) 210(20) 6990(50) 9(10) 
H(3) 6570(30) 1080(20) 8440(70) 26(12) 
H(4) 5820(40) 460(30) 7390(70) 49(16) 
H(5) 5490(40) 1910(30) 6590(80) 61(18) 
H(6) 4810(50) 1260(30) 5220(90) 70(20) 
H(7) 5630(40) 2070(30) 3550(70) 39(14) 
H(8) 7460(40) 2060(30) 4100(70) 35(13) 
H(9) 7210(40) 2400(30) 5870(70) 39(14) 
H(10) 5890(30) 30(20) 4440(50) 11(10) 
H(11) 5390(40) 880(20) 2350(60) 22(12) 
H(12) 6620(40) 1120(20) 2210(60) 33(12) 
H(13) 7430(30) -620(20) 4220(60) 26(12) 
H(14) 7750(40) 50(30) 3100(70) 45(15) 
H(15) 5840(40) -750(30) 1600(60) 33(13) 
H(16) 6140(40) -70(30) 580(70) 38(13) 
H(17) 5930(30) -1830(20) 20(60) 15(11) 
H(18) 6690(30) -2650(30) -1640(60) 29(13) 
H(19) 8230(40) -2300(30) -2370(70) 40(14) 
H(20) 9060(40) -1150(30) -1270(70) 51(16) 
H(21) 8170(30) -420(30) 340(60) 26(13) 
H(22) 8960(40) -10(30) 6220(70) 45(14) 
H(23) 9450(30) 520(20) 8180(70) 30(12) 
H(24) 10010(30) 470(20) 6660(60) 15(11) 
H(25) 9760(30) 1810(20) 7660(70) 13(11) 
H(26) 10120(40) 1750(20) 5960(60) 19(12) 
H(27) 9070(50) 2270(30) 5890(90) 70(20) 





Table G.6. Hydrogen bonds for endo-phenethyl arene 42 [Å and °]. 
________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________ 
 N(1)-H(28)...Cl(1) 0.91(5) 2.19(5) 3.072(4) 163(4) 
________________________________________________________________________  





























































The assignment of endo amino endo alcohol 52 was elucidated by single crystal 





































































The assignment of exo-amino-exo-benzoate 57 was elucidated by single crystal X-














































Table I.1. Crystal data and structure refinement for exo-amino-exo-benzoate 57. 
Identification code  sc04_109 
Empirical formula  C17 H23 N O2 
Formula weight  273.36 
Temperature  173(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 9.0507(8) Å α= 90°. 
 b = 11.2442(9) Å β= 97.826(5)°. 
 c = 14.8498(14) Å γ = 90°. 
Volume 1497.2(2) Å3 
Z 4 
Density (calculated) 1.213 Mg/m3 
Absorption coefficient 0.621 mm-1 
F(000) 592 
Crystal size 0.48 x 0.34 x 0.23 mm3 
Theta range for data collection 4.95 to 66.68°. 
Index ranges -10<=h<=9, -12<=k<=12, -15<=l<=17 
Reflections collected 7017 
Independent reflections 2485 [R(int) = 0.1101] 
Completeness to theta = 66.68° 93.7 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2485 / 0 / 183 
Goodness-of-fit on F2 1.104 
Final R indices [I>2sigma(I)] R1 = 0.0823, wR2 = 0.2242 
R indices (all data) R1 = 0.1097, wR2 = 0.2374 
Largest diff. peak and hole 0.736 and -0.379 e.Å-3 
 190 
 
Table I.2. Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for exo-amino-exo-benzoate 57. U(eq) is defined as one third of  
the trace of the orthogonalized Uij tensor. 
________________________________________________________________________
______ 
 x y z U(eq) 
________________________________________________________________________
______  
C(1) -2444(3) 3613(3) 2433(2) 33(1) 
C(2) -1093(4) 4090(4) 2016(3) 52(1) 
C(3) 266(4) 4248(4) 2714(3) 54(1) 
C(4) 548(4) 3058(3) 3167(3) 56(1) 
C(5) -705(5) 2758(4) 3697(3) 70(1) 
C(6) -2049(4) 3648(4) 3462(3) 49(1) 
C(7) -1497(5) 4868(5) 3758(3) 74(2) 
C(8) -71(4) 5172(3) 3420(3) 56(1) 
C(9) 2752(4) 2167(3) 3977(2) 38(1) 
C(10) 4160(3) 2362(3) 4611(2) 29(1) 
C(11) 5220(3) 1468(3) 4693(2) 36(1) 
C(12) 6533(4) 1595(3) 5274(3) 41(1) 
C(13) 6801(4) 2612(3) 5776(3) 45(1) 
C(14) 5764(4) 3509(3) 5702(3) 49(1) 
C(15) 4432(4) 3392(3) 5124(2) 40(1) 
C(16) -5079(4) 3958(3) 2513(3) 46(1) 
C(17) -4158(4) 4182(4) 1116(3) 54(1) 
N(1) -3775(3) 4307(2) 2095(2) 34(1) 
O(1) 1947(3) 3150(2) 3820(2) 55(1) 





Table I.3. Bond lengths [Å] and angles [°] for exo-amino-exo-benzoate 57. 
_____________________________________________________ 
C(1)-N(1)  1.466(4) 
C(1)-C(6)  1.522(5) 
C(1)-C(2)  1.540(5) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.506(5) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.504(5) 
C(3)-C(8)  1.535(6) 
C(3)-H(3)  1.0000 
C(4)-O(1)  1.490(4) 
C(4)-C(5)  1.505(6) 
C(4)-H(4)  1.0000 
C(5)-C(6)  1.577(6) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(7)  1.505(6) 
C(6)-H(6)  1.0000 
C(7)-C(8)  1.487(6) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-O(2)  1.196(4) 
C(9)-O(1)  1.328(4) 
C(9)-C(10)  1.494(4) 
C(10)-C(11)  1.384(4) 
C(10)-C(15)  1.390(4) 
C(11)-C(12)  1.378(4) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.369(5) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.372(5) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.388(5) 
C(14)-H(14)  0.9500 
C(15)-H(15)  0.9500 
C(16)-N(1)  1.461(4) 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-N(1)  1.454(4) 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
































































































Table I.4. Anisotropic displacement parameters  (Å2x 103) for exo-amino-exo-benzoate 
57. The anisotropic displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  
+ 2 h k a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
C(1) 28(2)  35(2) 35(2)  2(1) 1(1)  4(1) 
C(2) 31(2)  81(3) 47(3)  0(2) 13(2)  2(2) 
C(3) 38(2)  78(3) 47(3)  13(2) 7(2)  -5(2) 
C(4) 35(2)  46(2) 83(3)  -6(2) -1(2)  9(2) 
C(5) 64(3)  73(3) 70(3)  38(2) -4(2)  2(2) 
C(6) 33(2)  72(3) 42(2)  20(2) 3(2)  -5(2) 
C(7) 65(3)  106(4) 47(3)  -23(2) -9(2)  23(3) 
C(8) 42(2)  39(2) 81(3)  -2(2) -10(2)  3(2) 
C(9) 32(2)  31(2) 51(2)  0(2) 5(2)  4(1) 
C(10) 25(2)  30(2) 34(2)  4(1) 8(1)  2(1) 
C(11) 34(2)  32(2) 43(2)  2(1) 9(2)  4(1) 
C(12) 29(2)  44(2) 51(2)  12(2) 6(2)  9(1) 
C(13) 36(2)  49(2) 46(2)  9(2) -8(2)  -6(2) 
C(14) 53(2)  39(2) 50(2)  -6(2) -7(2)  -1(2) 
C(15) 41(2)  34(2) 45(2)  -2(2) 1(2)  10(1) 
C(16) 31(2)  59(2) 47(2)  5(2) 3(2)  3(2) 
C(17) 48(2)  76(3) 33(2)  5(2) -7(2)  -1(2) 
N(1) 28(1)  39(2) 32(2)  5(1) 0(1)  2(1) 
O(1) 35(1)  44(1) 79(2)  -15(1) -18(1)  14(1) 
O(2) 58(2)  36(2) 97(2)  -13(1) -30(2)  5(1) 
________________________________________________________________________
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Table I.5. Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 
10 3) for exo-amino-exo-benzoate 57. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(1) -2617 2766 2240 39 
H(2A) -854 3532 1542 62 
H(2B) -1358 4865 1721 62 
H(3) 1143 4501 2417 65 
H(4) 650 2429 2703 67 
H(5A) -340 2797 4356 84 
H(5B) -1050 1935 3552 84 
H(6) -2919 3410 3771 59 
H(7A) -2263 5464 3529 89 
H(7B) -1352 4907 4430 89 
H(8A) 749 5183 3934 67 
H(8B) -146 5973 3140 67 
H(11) 5041 760 4346 43 
H(12) 7254 975 5327 49 
H(13) 7707 2698 6177 54 
H(14) 5959 4216 6049 59 
H(15) 3711 4012 5080 48 
H(16A) -5267 3106 2416 69 
H(16B) -5950 4411 2238 69 
H(16C) -4896 4123 3167 69 
H(17A) -3316 4444 815 81 
H(17B) -5034 4671 908 81 













































Signal a at δ 3.84 ppm (singlet) in the 1H NMR spectrum (Figure J.1) was 
assigned to the proton on C-7. Signal b at δ 3.70 appears as a broad doublet and can be 
assigned to the endo proton on C-2 due to the 6.6 Hz coupling with the endo proton on C-
3. The exo position of the hydroxyl group on C-2 can be discerned from the lack of 
coupling between the endo proton on C-2 and the proton on C-1. Also, a signal in the  
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COSY spectrum (Figure J.2) for coupling between signal a and signal b suggests the 
proton on C-7 is exo and the proton on C-2 is endo. This is the only arrangement, which 
would give rise to a COSY between these two protons. A COSY exists between signal b 
and the peak assigned as signal c at δ 1.99 ppm. Signal c was assigned to the proton on 
C-4. Signal d at δ 1.90 ppm appears as a doublet and can be assigned to the bridgehead 
proton on C-1. The peak at δ 1.75 ppm, which appears as a doublet of doublets (13.8 and 
7.5 Hz), was assigned to the endo proton on C-3 (signal e). Signal f at δ 1.60 ppm 
(doublet) was assigned to the exo proton on C-3. The multiplet at δ 1.46-1.23 ppm was 
assigned to the endo protons on C-6 and C-5, signal g. The HMQC spectrum (Figure J.3) 
shows the two protons are on different carbons. A COSY between signal g and signal d, 
and signal g and signal c suggests the two protons in signal g are the endo protons on C-6 
and C-5. The multiplet at δ 0.91-0.79 ppm was assigned to the exo protons on C-6 and C-






















































































































Signals a, b, c between δ 7.24-7.82 ppm in the 1H NMR spectrum (Figure K.1) 
were assigned to the aromatic protons of the benzoate. Signal d at δ 5.17 appears as a ddd 
and can be assigned to the endo proton on C-2 due to the cis coupling (8 Hz) with the 
endo proton on C-3, trans coupling (2.1 Hz) with the exo proton on C-3, and coupling to 
the bridgehead proton on C-1 (0.9 Hz). This peak alone provides the correct regioisomer 




























L1. The Elllipsoid Diagram of amino benzoate 66. 
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Table 1.  Crystal data and structure refinement for benzoate 66. 
Identification code sc0533s 
Empirical formula  C16 H22 Cl N O2 
Formula weight  295.80 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 5.8976(6) Å α= 90°. 
 b = 11.3060(12) Å β= 103.544(2)°. 
 c = 11.6317(12) Å γ = 90°. 
Volume 754.01(14) Å3 
Z 2 
Density (calculated) 1.303 Mg/m3 
Absorption coefficient 0.255 mm-1 
F(000) 316 
Crystal size 0.33 x 0.14 x 0.08 mm3 
Theta range for data collection 1.80 to 28.36°. 
Index ranges -7<=h<=7, -15<=k<=15, -15<=l<=15 
Reflections collected 10540 
Independent reflections 3739 [R(int) = 0.0249] 
Completeness to theta = 28.36° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9811 and 0.9207 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3739 / 1 / 269 
Goodness-of-fit on F2 1.058 
Final R indices [I>2sigma(I)] R1 = 0.0363, wR2 = 0.0882 
R indices (all data) R1 = 0.0376, wR2 = 0.0891 
Absolute structure parameter 0.01(4) 
Largest diff. peak and hole 0.344 and -0.154 e.Å-3 
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Table L.2. Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for benzoate 66.  U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________
______ 
 x y z U(eq) 
________________________________________________________________________
______ 
C(1) 7402(3) 7852(1) 3214(1) 23(1) 
C(2) 5716(3) 6949(1) 2507(1) 25(1) 
C(3) 6639(4) 5725(2) 2973(2) 38(1) 
C(4) 8917(3) 5595(2) 2543(2) 38(1) 
C(5) 8973(3) 6727(2) 1815(1) 27(1) 
C(6) 9561(2) 7773(1) 2679(1) 25(1) 
C(7) 6351(2) 6906(1) 1299(1) 23(1) 
C(8) 6195(3) 7662(2) -683(1) 34(1) 
C(9) 3353(3) 8402(2) 374(2) 31(1) 
C(10) 7370(3) 9852(1) 3768(1) 25(1) 
C(11) 5931(3) 10943(1) 3708(1) 25(1) 
C(12) 3581(3) 10969(1) 3142(1) 27(1) 
C(13) 2304(3) 11993(2) 3163(1) 32(1) 
C(14) 3377(3) 12991(2) 3735(2) 34(1) 
C(15) 5730(4) 12973(2) 4296(2) 36(1) 
C(16) 6999(3) 11950(2) 4286(1) 30(1) 
Cl(1) 1507(1) 5299(1) 9388(1) 34(1) 
N(1) 5797(2) 7965(1) 508(1) 23(1) 
O(1) 6273(2) 8997(1) 3053(1) 24(1) 




Table L.3.   Bond lengths [Å] and angles [°] for benzoate 66. 
_____________________________________________________ 
C(1)-O(1)  1.4478(18) 
C(1)-C(2)  1.525(2) 
C(1)-C(6)  1.5454(19) 
C(1)-H(1)  0.937(17) 
C(2)-C(7)  1.537(2) 
C(2)-C(3)  1.539(2) 
C(2)-H(2)  0.931(18) 
C(3)-C(4)  1.547(3) 
C(3)-H(3)  0.94(3) 
C(3)-H(4)  0.92(2) 
C(4)-C(5)  1.539(2) 
C(4)-H(5)  0.97(2) 
C(4)-H(6)  0.95(3) 
C(5)-C(7)  1.535(2) 
C(5)-C(6)  1.538(2) 
C(5)-H(7)  0.966(19) 
C(6)-H(8)  0.977(18) 
C(6)-H(9)  1.00(2) 
C(7)-N(1)  1.4990(19) 
C(7)-H(10)  0.996(19) 
C(8)-N(1)  1.498(2) 
C(8)-H(12)  1.00(3) 
C(8)-H(13)  0.93(3) 
C(8)-H(14)  0.92(2) 
C(9)-N(1)  1.497(2) 
C(9)-H(15)  0.95(2) 
C(9)-H(16)  0.96(2) 
C(9)-H(17)  0.95(2) 
C(10)-O(2)  1.2076(19) 
C(10)-O(1)  1.3390(19) 
C(10)-C(11)  1.489(2) 
C(11)-C(12)  1.389(2) 
C(11)-C(16)  1.395(2) 
C(12)-C(13)  1.384(2) 
C(12)-H(18)  0.92(2) 
C(13)-C(14)  1.385(3) 
C(13)-H(19)  0.92(3) 
C(14)-C(15)  1.388(3) 
C(14)-H(20)  0.88(2) 
C(15)-C(16)  1.380(3) 
C(15)-H(21)  0.78(3) 
C(16)-H(22)  1.00(2) 






















































































Symmetry transformations used to generate 







Table L.4. Anisotropic displacement parameters  (Å2x 103) for benzoate 63. The 
anisotropic displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k 
a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
C(1) 25(1)  23(1) 21(1)  0(1) 6(1)  3(1) 
C(2) 25(1)  24(1) 27(1)  2(1) 7(1)  -2(1) 
C(3) 53(1)  25(1) 33(1)  5(1) 6(1)  -3(1) 
C(4) 48(1)  25(1) 35(1)  0(1) -2(1)  12(1) 
C(5) 25(1)  30(1) 25(1)  -2(1) 3(1)  8(1) 
C(6) 20(1)  29(1) 23(1)  -2(1) 4(1)  3(1) 
C(7) 24(1)  21(1) 23(1)  -1(1) 3(1)  2(1) 
C(8) 38(1)  43(1) 20(1)  1(1) 5(1)  0(1) 
C(9) 24(1)  31(1) 34(1)  4(1) 0(1)  4(1) 
C(10) 25(1)  28(1) 22(1)  -2(1) 6(1)  0(1) 
C(11) 28(1)  27(1) 21(1)  -1(1) 8(1)  -1(1) 
C(12) 27(1)  26(1) 28(1)  -2(1) 8(1)  0(1) 
C(13) 30(1)  36(1) 33(1)  4(1) 12(1)  7(1) 
C(14) 50(1)  26(1) 31(1)  6(1) 17(1)  12(1) 
C(15) 54(1)  26(1) 28(1)  -4(1) 9(1)  -4(1) 
C(16) 35(1)  29(1) 25(1)  -3(1) 6(1)  -4(1) 
Cl(1) 29(1)  28(1) 43(1)  -9(1) 3(1)  2(1) 
N(1) 22(1)  24(1) 20(1)  0(1) 2(1)  -1(1) 
O(1) 24(1)  25(1) 24(1)  -3(1) 4(1)  4(1) 
O(2) 28(1)  36(1) 32(1)  -4(1) -2(1)  4(1) 
________________________________________________________________________
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Table L.5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 
10 3) for benzoate 66. 
________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________ 
  
H(1) 7680(30) 7675(14) 4023(15) 10(3) 
H(2) 4160(30) 7069(17) 2528(15) 22(4) 
H(3) 5540(50) 5150(30) 2610(20) 56(7) 
H(4) 6820(40) 5680(20) 3780(20) 43(6) 
H(5) 10270(40) 5574(18) 3199(18) 33(5) 
H(6) 8870(40) 4940(20) 2030(20) 47(7) 
H(7) 9980(30) 6658(18) 1271(17) 27(5) 
H(8) 11010(30) 7640(17) 3270(16) 21(4) 
H(9) 9590(40) 8556(19) 2283(17) 28(5) 
H(10) 5580(30) 6229(17) 813(16) 22(4) 
H(11) 6640(40) 8550(20) 766(18) 29(5) 
H(12) 7780(40) 7300(20) -555(19) 42(6) 
H(13) 5000(50) 7190(30) -1100(20) 53(7) 
H(14) 6110(40) 8380(20) -1080(20) 37(5) 
H(15) 2380(40) 7740(20) 90(19) 34(5) 
H(16) 3180(40) 9090(20) -126(19) 31(5) 
H(17) 3080(40) 8740(20) 1080(20) 41(6) 
H(18) 2900(40) 10310(20) 2745(18) 38(5) 
H(19) 720(50) 12010(30) 2820(20) 48(6) 
H(20) 2570(40) 13650(20) 3718(19) 36(5) 
H(21) 6390(40) 13510(30) 4630(20) 45(7) 
H(22) 8710(40) 11950(30) 4650(20) 50(6) 
________________________________________________________________________
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Table L.6. Hydrogen bonds for benzoate 66 [Å and °]. 
________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________  
 N(1)-H(11)...Cl(1)#1 0.84(2) 2.28(2) 3.0684(14) 155.1(18) 
________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,y+1/2,-z+1       
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The stereochemistry at the C-7 stereocenter was established in the formation of 2,7-syn 
diol 58 (Appendix J). The stereochemistry does not change upon benzoylation. Signals a, 
b, c between δ 7.45-8.04 ppm in the 1H NMR spectrum (Figure M.1) were assigned to the 
aromatic protons of the benzoate. Signal d at δ 5.09 ppm appears as a broad doublet and 
can be assigned to the exo proton on C-7. Signal e at δ 2.65 ppm appears as a doublet of 
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triplets and can be assigned to the exo proton on C-2 due to the cis coupling (8 Hz) with 
the exo proton on C-3, trans coupling (2.1 Hz) with the endo proton on C-3, and coupling 
to the bridgehead proton on C-1 (4.5 Hz). This peak alone suggests the proton at the C-2 
stereocenter is exo and is consistent with the structure shown above. The structure was 


















































Table M.1. Crystal data and structure refinement for benzoate 68. 
Identification code  SC_05_32 
Empirical formula  C16 H22 Cl N O2 
Formula weight  295.80 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 5.9958(16) Å α= 90°. 
 b = 10.766(3) Å β= 95.822(5)°. 
 c = 24.750(7) Å γ = 90°. 
Volume 1589.3(7) Å3 
Z 4 
Density (calculated) 1.236 Mg/m3 
Absorption coefficient 0.242 mm-1 
F(000) 632 
Crystal size 0.27 x 0.13 x 0.04 mm3 
Theta range for data collection 1.65 to 23.53°. 
Index ranges -6<=h<=6, -12<=k<=12, -27<=l<=27 
Reflections collected 13757 
Independent reflections 2360 [R(int) = 0.1488] 
Completeness to theta = 23.53° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.876477 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2360 / 7 / 195 
Goodness-of-fit on F2 1.262 
Final R indices [I>2sigma(I)] R1 = 0.1771, wR2 = 0.4184 
R indices (all data) R1 = 0.1966, wR2 = 0.4299 
Largest diff. peak and hole 0.710 and -0.794 e.Å-3 
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Table M.2. Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for benzoate 68.  U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
Cl(1) 3902(4) 2300(2) 2252(1) 45(1) 
C(1) 7767(16) 9477(8) 1749(4) 31(2) 
C(2) 5743(19) 9041(12) 1367(5) 56(3) 
C(3) 6170(30) 9581(14) 821(5) 85(5) 
C(4) 5710(30) 10955(14) 838(5) 95(6) 
C(5) 7680(30) 11485(12) 1211(6) 85(5) 
C(6) 9100(20) 10307(10) 1393(5) 58(3) 
C(7) 8690(30) 9555(13) 852(6) 83(5) 
O(1) 9900(30) 8456(12) 964(6) 25(4) 
O(2) 9560(30) 8202(12) 62(5) 52(4) 
C(8) 10060(30) 7828(17) 505(8) 29(4) 
C(9) 11026(7) 6550(13) 618(7) 26(4) 
C(10) 11516(13) 6092(16) 1132(8) 32(4) 
C(11) 12410(20) 4850(20) 1220(10) 56(9) 
C(12) 12720(20) 4180(20) 765(9) 56(6) 
C(13) 12250(20) 4610(20) 242(11) 73(7) 
C(14) 11380(20) 5818(19) 159(9) 51(5) 
O(1B) 9240(40) 8100(20) 874(10) 55(7) 
O(2B) 11650(30) 8534(15) 290(8) 61(5) 
C(8B) 11020(40) 7850(20) 603(9) 32(5) 
C(9B) 12021(17) 6640(14) 747(5) 27(4) 
C(10B) 11010(30) 5771(19) 1098(7) 35(6) 
C(11B) 12140(30) 4710(30) 1191(7) 46(9) 
C(12B) 14020(30) 4338(19) 1015(7) 34(5) 
C(13B) 14880(30) 5170(20) 694(7) 69(8) 
C(14B) 13950(30) 6290(20) 557(7) 45(6) 
C(15) 5900(30) 9247(11) 2586(5) 103(6) 
C(16) 9080(17) 10616(11) 2588(5) 54(3) 
N(1) 7057(13) 10114(7) 2244(3) 35(2) 
________________________________________________________________________
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Table M.3. Bond lengths [Å] and angles [°] for benzoate 68. 
_____________________________________________________ 
C(1)-N(1)   1.503(12) 
C(1)-C(2)   1.535(15) 
C(1)-C(6)   1.536(14) 
C(2)-C(3)   1.516(18) 
C(3)-C(4)   1.505(19) 
C(3)-C(7)   1.51(2) 
C(4)-C(5)   1.53(2) 
C(5)-C(6)   1.568(15) 
C(6)-C(7)   1.563(19) 
C(7)-O(1)   1.402(18) 
C(7)-O(1B)   1.60(2) 
O(1)-C(8)   1.34(2) 
O(2)-C(8)   1.18(2) 
C(8)-C(9)   1.51(2) 
C(9)-C(10)   1.37(2) 
C(9)-C(14)   1.42(3) 
C(10)-C(11)   1.45(3) 
C(11)-C(12)   1.37(3) 
C(12)-C(13)   1.38(3) 
C(13)-C(14)   1.40(3) 
O(1B)-C(8B)   1.34(3) 
O(2B)-C(8B)   1.16(3) 
C(8B)-C(9B)   1.46(3) 
C(9B)-C(14B)   1.35(3) 
C(9B)-C(10B)   1.45(3) 
C(10B)-C(11B)  1.33(3) 
C(11B)-C(12B)  1.32(3) 
C(12B)-C(13B)  1.33(3) 
C(13B)-C(14B)  1.36(4) 
C(15)-N(1)   1.478(14) 
C(16)-N(1)   1.509(13) 
 
N(1)-C(1)-C(2)  111.8(8) 
N(1)-C(1)-C(6)  114.2(8) 
C(2)-C(1)-C(6)  104.4(9) 
C(3)-C(2)-C(1)  103.8(10) 
C(4)-C(3)-C(7)  101.5(14) 
C(4)-C(3)-C(2)  107.8(11) 
C(7)-C(3)-C(2)  101.9(10) 
C(3)-C(4)-C(5)  104.6(11) 
C(4)-C(5)-C(6)  103.5(11) 
C(1)-C(6)-C(7)  98.3(10) 
C(1)-C(6)-C(5)  109.6(9) 
C(7)-C(6)-C(5)  98.0(10) 
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O(1)-C(7)-C(3)  121.5(14) 
O(1)-C(7)-C(6)  103.5(11) 
C(3)-C(7)-C(6)  96.0(10) 
O(1)-C(7)-O(1B)  21.0(11) 
C(3)-C(7)-O(1B)  102.8(15) 
C(6)-C(7)-O(1B)  117.6(12) 
C(8)-O(1)-C(7)  109.7(14) 
O(2)-C(8)-O(1)  126.0(17) 
O(2)-C(8)-C(9)  122.8(17) 
O(1)-C(8)-C(9)  111.2(15) 
C(10)-C(9)-C(14)  120.6(14) 
C(10)-C(9)-C(8)  123.0(15) 
C(14)-C(9)-C(8)  116.4(15) 
C(9)-C(10)-C(11)  121.0(18) 
C(12)-C(11)-C(10)  116(2) 
C(11)-C(12)-C(13)  124(2) 
C(12)-C(13)-C(14)  119(2) 
C(13)-C(14)-C(9)  119(2) 
C(8B)-O(1B)-C(7)  110.6(18) 
O(2B)-C(8B)-O(1B)  122(2) 
O(2B)-C(8B)-C(9B)  125(2) 
O(1B)-C(8B)-C(9B)  112.8(19) 
C(14B)-C(9B)-C(10B) 117.2(16) 
C(14B)-C(9B)-C(8B)  120.7(17) 






C(15)-N(1)-C(1)  111.5(8) 
C(15)-N(1)-C(16)  107.5(10) 
C(1)-N(1)-C(16)  110.2(8) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table M.4. Anisotropic displacement parameters  (Å2x 103) for benzoate 68. The 
anisotropic displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k 
a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
Cl(1) 48(2)  18(1) 70(2)  -3(1) 8(1)  5(1) 
C(1) 35(5)  24(5) 35(5)  6(4) 11(4)  3(4) 
C(2) 41(6)  58(7) 67(8)  -17(6) 3(6)  18(6) 
C(3) 132(13)  78(9) 41(7)  -9(7) -8(8)  58(9) 
C(4) 151(13)  92(10) 37(7)  7(7) -8(8)  100(10) 
C(5) 128(12)  49(7) 89(10)  45(7) 65(9)  51(8) 
C(6) 58(7)  46(6) 72(8)  30(6) 20(6)  33(6) 
C(7) 114(11)  72(9) 68(8)  35(7) 38(8)  71(8) 
O(1) 37(8)  7(7) 28(7)  -5(5) -6(6)  8(6) 
O(2) 104(12)  30(7) 21(6)  -3(5) -8(7)  25(8) 
O(1B) 82(17)  36(13) 53(14)  14(10) 35(12)  10(11) 
O(2B) 67(12)  35(9) 85(13)  20(9) 31(10)  17(9) 
C(15) 230(20)  20(6) 72(9)  11(6) 89(11)  8(9) 
C(16) 29(6)  53(7) 78(8)  -3(6) 0(6)  5(5) 

















Table M.5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 
103) for benzoate 68. 
________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________ 
  
H(1) 8702 8738 1867 37 
H(2A) 5671 8123 1351 67 
H(2B) 4325 9362 1486 67 
H(3) 5387 9140 500 102 
H(4A) 4272 11122 986 114 
H(4B) 5665 11323 470 114 
H(5A) 7143 11912 1528 102 
H(5B) 8564 12077 1013 102 
H(6) 10704 10461 1530 69 
H(7) 9248 10016 541 99 
H(10) 11269 6596 1435 38 
H(11) 12755 4522 1574 67 
H(12) 13294 3363 812 67 
H(13) 12505 4105 -59 87 
H(14) 11035 6135 -198 61 
H(10B) 9644 5943 1249 42 
H(11B) 11480 4141 1420 55 
H(12B) 14702 3558 1106 40 
H(13B) 16239 4964 551 82 
H(14B) 14671 6832 325 54 
H(15A) 4663 8842 2364 154 
H(15B) 5313 9708 2882 154 
H(15C) 6966 8616 2738 154 
H(16A) 9939 9925 2762 80 
H(16B) 8589 11169 2867 80 
H(16C) 10025 11079 2358 80 





Table M.6. Hydrogen bonds for benzoate 68 [Å and °]. 
________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________ 
 N(1)-H(1A)...Cl(1)#1 0.93 2.15 3.021(8) 155.8 
________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  



































































The connectivity of the atoms is established based on the mechanism of the 
reaction of the double-Michael addition of tert-butyl acrylate and cyclopentenone. 
Deprotection of the t-butyl ester does not change the connectivity or the stereochemistry. 
Signal a at δ 8.80 ppm (br s) in the 1H NMR spectrum of 78 (Figure N.1) was assigned to 
the OH of the carboxylic acid. Signal b at δ 7.20-7.37 appears as a multilplet and can be 
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assigned to the aromatic protons on the phenyl ring at C-6. Signal c at δ 3.53 ppm was 
assigned to the endo proton on C-6. The multiplicity of signal c is consistent with a 
proton with trans coupling (d, 4.5 Hz) to the proton at C-5. Since no coupling is seen 
between signal c and the bridgehead proton on C-1, this indicates the proton must be in 
the endo position. To further corroborate this stereochemical assignment, signal d at δ 
3.25 ppm was assigned to the proton at C-5. The multiplicity of this peak, a triplet (4.8 
Hz) is consistent with a exo proton at C-5 that trans couples to the endo proton on C-6 
and couples with the bridgehead proton on C-4 with a similar coupling constant. This 
establishes the stereochemistry at the C-5 and C-6 stereocenters of the bicycle. The peak 
at δ 3.16 (br s) was assigned to the bridgehead proton on C-4, signal e. The peak at δ 2.90 
ppm (singlet) was assigned to the proton on C-1, signal f. Signal g, was assigned to the 
endo and exo proton on C-3 and one of the protons on C-7. The peak at δ 1.92 ppm (d) 
was assigned to one of the protons on C-7, signal h. The coupling of 10.5 Hz is consistent 




























































The signals at δ 8.10 ppm (2H, signal a), δ 7.61 ppm (1H, signal b), δ 7.50 ppm 
(2H, signal c) and δ 7.34 - 7.18 ppm (5H, signal d) account for all of the protons of the 
two phenyl rings in the 1H NMR spectrum of benzoate 82 (Figure O.1). The absorption at 
δ 5.27 ppm (1H, signal e) was assigned to the proton at C-2. The absorptions at δ 3.16 
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ppm (1H, 13.8 Hz, 6.9 Hz, signal f) and δ 3.02 ppm (1H, 13.8 Hz, 4.5 Hz, signal g) were 
assigned to the protons at C-8. The doublet at δ 2.98 (1H, 6.9 Hz, signal h) was assigned 
to the proton at C-6. This shows trans stereochemistry between the protons on C-6 and C-
5. There doesnt appear to be coupling to the bridgehead proton at C-1 and the proton at 
C-6, signal f, so this suggests the proton at C-6 is endo. The multiplet at δ 2.84  2.77 
ppm (1H, signal i) was assigned to the proton of C-3. The absorptions at δ 2.65 ppm (1H, 
singlet, signal j) and δ 2.63 ppm (1H, singlet, signal k) were assigned to the bridgehead 
protons of C-1 and C-4. The singlets at δ 2.49 ppm (3H, singlet, signal l) and 2.47 ppm 
(3H, singlet, signal m) were assigned to the two methyl groups on the amine. The signal 
at δ 2.17 ppm (1H, 14.4 Hz, 10.2 Hz, 4.5 Hz, 1.8 Hz, signal n) was assigned to the exo 
proton on C-5. The COSY NMR spectrum (Figure O.2) shows that the proton on C-5 is 
coupled to signal i, corresponding to the proton on C-3. The only possible stereochemical 
assignment which allows coupling between the protons on C-5 and C-3 is when both 
protons are exo. The signal at δ 1.96 ppm (1H, signal o) corresponds to one of the protons 
on C-7. The absorption at δ 1.60  1.53 ppm (signal p) corresponds to the endo proton on 
C-5 and C-7.  










































Figure O.1. The 1H NMR (Gemini 300 MHz, CDCl3) and 13C (Bruker AMX 500 MHz, 





























































































Relative Stereochemical Assignment of Compounds 31, 32, 39, 41, 10, 22, 21, 50, 51, 54, 







In most cases throughout this thesis, stereochemistry assignments of 
diastereomers has been assigned based on 1- and 2-D spectroscopy techniques and either 
validated or determined by x-ray diffraction. exo-Amino-endo- benzoate 69 and endo-
amino-exo-benzoate 70 is the only case in this thesis where the assignment of the relative 
stereochemistry could not be done with a certain level of confidence and further 
evaluation was needed to provide additional evidence. A common feature that may not  
  










Figure P.1. Comparison of amines 69 and 70. 
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seem immediately apparent found in some sets of diastereomers is the proximity of a 
proton to the dimethylamine group, whose 1H NMR chemical shift could be affected by 
the electronegative nitrogen atom. These protons can be assigned in the 1H NMR of 
certain compounds and allow for a direct comparison with the corresponding 
diastereomer (Figure P.1). The protons syn to the nitrogen, either directly above (i.e. 
amine 41) or below (i.e. amines 70) should be shifted further downfield than their 
corresponding diastereomers in the free amine. In the case of final products where the 
amine is converted to an HCl salt, the difference in chemical shifts between the two free 
amines and two salts should increase due to the protonation of the nitrogen.  
   
Results 
A table was constructed with all the compounds synthesized in this thesis that 
contain the same relationship as noted above: a proton on the same face of the bicycle as 
the nitrogen which can be assigned in the 1H NMR (Table P.1). Only final products were 
converted to HCl salts and some HCl salts were evaluated in different solvents. As a 
result, not all the compounds allow for comparison of the difference in chemical shifts 
between the free amine and salt. In all cases illustrated in the table with respect to the free 
amine, the diastereomer with the syn proton either directly above or below the 
dimethylamine is further downfield than its corresponding diastereomer. For example, the 
benzylic proton on amine 31 is shifted further at δ 3.31 ppm than amine 32 at δ 2.98 ppm. 
The structure assignment of amine 31 was verified by x-ray analysis (Appendix E). The 
proton α to the benzoate in amine 26a is also further downfield (δ 5.41 ppm) than amine 
10 (δ 5.15 ppm). These results were confirmed by x-ray diffraction of amine 10.1 This 
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trend is consistent throughout the table, even when the proton is four carbons away, as is 
the case with alcohols 50 and 51 (δ 3.90 ppm vs δ 3.73 ppm, respectively; Appendix H) 
and benzoates 54 and 55 (δ 5.15 ppm and δ 5.03 ppm). 
The difference in chemical shifts between the two diastereomers when comparing 
the free amine and the HCl salt does not show a clear trend with respect to the relative 
stereochemistry. For example, the difference in the chemical shift of the proton α to the 
benzoate in the free amines 26a and 10 is 0.26 while in the HCl salt the difference is 
0.09. For benzoates 54 and 55 there wasnt a difference between seen between the free 
amine and the salts, the difference in both cases is 0.05. In the case of amines 69 and 70, 
the difference between the free amines is 0.34 and 0.53 for the salts, the opposite of that 
seen between 26a and 10.  
Table P.1 indicates the proton α to the benzoate in amine 70 is further downfield 
at δ 5.50 ppm than the same proton on amine 69 at δ 5.16 ppm. Using the same argument 
that the nitrogen affects the chemical shifts of protons in close proximity, the amine of 
compound 70 is endo, while the amine of compound 69 must be exo.   
 
 
     
 233
 
Table P.1. Comparison of endo vs exo Substituents Directly Above or Below a Nitrogen 








(ppm) of free 
amine (A) 
Chemical shift 
(ppm) of HCl salt 
(B) 
Same face  














3.31  2.98 = 0.33 
 




























(proton α to 
benzoate, D2O) 
 
5.41-5.15 = 0.26 
 














(proton α to 
benzoate, D2O) 
 
5.12  5.03 = 0.09 
 















4.90  3.90 = 0.30 
 























Table P.1. Comparison of endo vs exo Substituents Directly Above or Below a Nitrogen 








(ppm) of free 
amine (A) 
Chemical shift 

















3.90  3.73 = 0.17 
 



























 (proton α to 
benzoate, D2O)  
 
5.15  5.03 = 0.12 
 














 (proton α to 
benzoate, D2O)  
 
4.93  4.88 =  
0.05 
 




   69 
 
5.16 




(proton α to 
benzoate, CDCl3) 
 
5.50  5.16 = 0.34 
 





  70        
 
5.50 




(proton α to 
benzoate, CDCl3)  
 
5.74  5.21 = 0.53 
 
(salt: 70  69) 
*The salts were not evaluated in the same solvents. 
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